data_2apn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2apn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.601 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.562 HG21 HD12 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' CG ' ' A' ' 78' ' ' TYR . 15.4 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.411 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.3 mt-30 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.431 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.619 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.605 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 20' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.696 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.494 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.696 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.512 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.514 ' CA ' HD12 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.583 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.746 0.308 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.655 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.655 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HB2' HG23 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.637 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 35' ' ' VAL . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 33' ' ' LEU . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 78' ' ' TYR . 11.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 32.8 mt-30 . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE1' HG22 ' A' ' 35' ' ' VAL . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.9 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.703 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.487 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.703 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.481 ' CA ' HD12 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 84' ' ' VAL . 4.0 t80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG13 ' CB ' ' A' ' 84' ' ' VAL . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.69 ' HB2' HG23 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB1' ' HE2' ' A' ' 11' ' ' PHE . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.435 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.519 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.508 ' N ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.49 HD11 ' CG ' ' A' ' 78' ' ' TYR . 13.7 mm . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 16.8 mt-30 . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.494 0.187 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.55 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.6 mt . . . . . 0 CA--C 1.521 -0.167 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.667 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.485 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.49 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.571 ' CA ' HD12 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.607 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' THR . 68.8 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.618 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.705 ' HB2' HG23 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.549 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' HG13 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.48 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.627 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.543 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.808 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.439 HD11 ' CG ' ' A' ' 78' ' ' TYR . 21.6 mm . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.412 0.149 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.599 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.2 mt . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.543 ' HG2' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 11' ' ' PHE . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.453 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.439 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.569 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.705 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.3 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.561 ' HD2' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.561 ' CG2' ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.554 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CG ' ' A' ' 74' ' ' MET . 12.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 28.2 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.554 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 35' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.434 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.689 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.491 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.588 ' CA ' HD12 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.694 0.283 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.635 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.542 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.855 ' CZ ' ' HG2' ' A' ' 64' ' ' LYS . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.584 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 12' ' ' THR . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' N ' ' HE2' ' A' ' 11' ' ' PHE . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.564 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.478 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.763 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.461 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.2 mm . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD2' HG23 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.5 mt . . . . . 0 CA--C 1.524 -0.057 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.663 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.462 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.685 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.474 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 98' ' ' ASN . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.552 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.455 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 . . . . . 0 CA--C 1.522 -0.133 0 CA-C-O 120.649 0.262 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 83' ' ' THR . 63.9 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.548 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' THR . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.524 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.663 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.545 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.635 HG21 HD12 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 HD11 ' CG ' ' A' ' 78' ' ' TYR . 9.3 mm . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.435 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 24.8 mt-30 . . . . . 0 CA--C 1.522 -0.098 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.545 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.8 mt . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.706 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.706 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.688 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.514 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.561 ' CA ' HD12 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.584 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE2' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.76 0.314 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.453 HG11 ' O ' ' A' ' 83' ' ' THR . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.712 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.6 mm . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 11.9 mt-30 . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.686 0.279 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 76' ' ' LEU . 5.2 mt . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 HG21 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.671 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.464 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.671 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.514 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.574 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 46' ' ' GLN . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.583 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' HA ' ' CE ' ' A' ' 64' ' ' LYS . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' C ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.493 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.57 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.599 HG21 HD12 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 25.3 mt-30 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.582 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 3.8 mt . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' HZ ' ' A' ' 11' ' ' PHE . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 HG21 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.408 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.778 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' ' 37' ' ' ILE . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.778 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.576 ' CA ' HD12 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.7 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.737 0.303 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.532 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.601 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.645 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.477 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.7 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 . . . . . 0 C--O 1.228 -0.074 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.601 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HG3' ' HZ ' ' A' ' 11' ' ' PHE . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.436 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 64' ' ' LYS . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 35' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.475 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.637 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.637 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.564 ' CA ' HD12 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.707 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.49 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.555 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 23.9 mt-30 . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.3 mt . . . . . 0 C--O 1.227 -0.086 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.707 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.512 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.671 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.707 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.589 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.572 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 . . . . . 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.631 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.536 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' THR . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.517 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.411 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.49 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.565 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.813 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' A' ' 78' ' ' TYR . 25.2 mm . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.579 0.228 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.556 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.779 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.419 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.649 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.649 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.563 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.876 0.369 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 83' ' ' THR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.542 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.731 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 HD11 ' CG ' ' A' ' 78' ' ' TYR . 24.4 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 . . . . . 0 CA--C 1.522 -0.127 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 4.4 mt . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.44 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.657 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.657 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.521 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.578 ' CA ' HD12 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.573 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.563 HD12 ' CA ' ' A' ' 83' ' ' THR . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CE ' ' A' ' 64' ' ' LYS . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.417 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.783 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.508 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.6 mm . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 . . . . . 0 CA--C 1.525 0.006 0 CA-C-O 120.572 0.225 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.478 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.2 mt . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.718 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.718 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.592 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 9' ' ' LEU . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.563 ' CA ' HD12 ' A' ' 9' ' ' LEU . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.525 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 83' ' ' THR . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CE2' ' O ' ' A' ' 12' ' ' THR . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG11 HG23 ' A' ' 23' ' ' ILE . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.415 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.636 HG21 HD12 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 HD11 ' CG ' ' A' ' 78' ' ' TYR . 21.7 mm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 19.9 mt-30 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.461 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE1' ' CG2' ' A' ' 35' ' ' VAL . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.6 mt . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.607 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 HG21 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.461 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.483 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.648 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.465 ' CG ' HD11 ' A' ' 37' ' ' ILE . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.572 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.6 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.528 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.679 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.628 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.447 HD11 ' CG ' ' A' ' 78' ' ' TYR . 20.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 34.5 mt-30 . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.552 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 76' ' ' LEU . 3.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.431 HD12 ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.683 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.583 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.542 ' CA ' HD12 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 83' ' ' THR . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.555 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.786 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.625 HG21 HD12 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.44 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.1 mt-30 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.649 0.261 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.582 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.656 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.464 ' O ' HD11 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.625 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.617 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.627 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' CA ' HD23 ' A' ' 9' ' ' LEU . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.564 ' CA ' HD12 ' A' ' 9' ' ' LEU . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.575 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.481 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 83' ' ' THR . 30.4 m-80 . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.71 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.544 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.474 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.1 mm . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 . . . . . 0 C--O 1.228 -0.077 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 76' ' ' LEU . 3.4 mt . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HG2' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' A' ' 11' ' ' PHE . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.411 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.659 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.659 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.562 ' CA ' HD12 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.549 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.711 ' HB2' HG23 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 68' ' ' GLN . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.7 mm . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 22.9 mt-30 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.488 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.557 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 76' ' ' LEU . 4.7 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.668 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.575 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 84' ' ' VAL . 4.1 t80 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.685 0.279 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.588 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.692 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.47 HG12 ' HG2' ' A' ' 74' ' ' MET . 12.0 mm . . . . . 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 29.9 mt-30 . . . . . 0 C--O 1.227 -0.112 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.557 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.684 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.684 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.582 ' CA ' HD12 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.69 0.281 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 83' ' ' THR . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mmm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.559 0.219 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.01 -161.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.709 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -166.29 27.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -52.04 1.12 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.334 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.25 162.37 27.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.028 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 60.46 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -133.02 -71.2 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.698 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.601 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG21 HD12 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' CG ' ' A' ' 78' ' ' TYR . 15.4 mm -87.44 113.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.1 m -145.89 17.56 1.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.335 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.614 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -55.17 -158.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.181 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.88 -85.76 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.528 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.52 -159.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.32 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.759 0.314 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.3 m -77.68 -70.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.51 133.32 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.259 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.424 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -148.92 6.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.614 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 2.3 mt-30 -114.37 -77.77 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.431 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.619 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.442 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.06 -23.67 41.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.5 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.707 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.21 -66.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.231 0.539 . . . . 0.0 111.605 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.19 84.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.561 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.5 134.72 15.11 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.38 40.13 41.03 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.94 108.65 7.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.302 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt -59.49 146.36 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.605 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 20' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.696 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.494 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.696 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.458 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.512 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.514 ' CA ' HD12 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.698 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.583 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.8 m -147.57 89.52 1.78 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 45.4 mt-10 -98.1 162.65 13.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.003 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.87 -129.96 2.2 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.623 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.87 -53.31 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.983 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.65 -18.71 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 151.22 11.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.677 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 22.2 p -59.94 91.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.048 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.11 140.92 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.691 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 -123.82 136.53 54.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -139.34 128.58 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.38 167.58 13.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.261 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 14.4 Cg_endo -57.31 -42.12 65.74 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.447 2.098 . . . . 0.0 112.721 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -28.73 68.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.74 -68.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.2 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.9 p -57.35 -44.42 84.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.042 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t 60.52 -173.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 m -113.88 136.74 52.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.6 p -113.65 -40.5 3.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 15.05 11.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.649 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m 58.74 92.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.56 75.85 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.445 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.2 m 60.68 157.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.786 0.327 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.11 116.1 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -147.45 -80.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 -161.77 0.76 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.506 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.59 -162.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.72 14.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.475 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -131.55 -50.32 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.142 0.496 . . . . 0.0 110.408 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.407 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -156.08 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.993 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -165.27 -27.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.655 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -144.64 -72.08 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.655 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.722 ' HB2' HG23 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.637 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.637 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 35' ' ' VAL . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG22 HD12 ' A' ' 33' ' ' LEU . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 78' ' ' TYR . 11.7 mm -82.68 119.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 m -158.94 37.45 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.069 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -62.39 -142.35 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.713 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 25.86 21.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.644 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.08 -76.0 2.0 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.2 p -75.48 -29.31 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -116.73 -168.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.57 101.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.13 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -142.27 3.06 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 32.8 mt-30 -116.56 -73.34 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.696 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE1' HG22 ' A' ' 35' ' ' VAL . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.3 -24.57 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.49 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.39 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.18 -67.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.723 0.773 . . . . 0.0 111.633 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.8 m120 84.59 84.74 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.811 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.85 133.12 18.03 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.439 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 78.87 38.97 21.99 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -138.36 110.31 7.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.9 mt -62.52 156.5 22.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.133 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.703 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.487 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.551 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.703 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.51 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.481 ' CA ' HD12 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.423 ' HB ' ' NE ' ' A' ' 94' ' ' ARG . 96.6 m -148.79 89.64 1.7 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 30.6 mt-10 -99.79 164.95 11.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.77 -110.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.277 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.33 88.3 4.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.528 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.19 25.7 9.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.712 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.35 38.69 2.16 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 2.9 p -59.79 89.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NE ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -89.5 158.23 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.265 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.521 ' CE1' HG22 ' A' ' 84' ' ' VAL . 4.0 t80 -136.48 137.64 40.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -140.48 132.48 27.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -148.81 167.51 12.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.195 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 11.2 Cg_endo -55.29 -49.07 17.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.455 2.103 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -42.39 93.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 111.071 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.16 60.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.26 56.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -90.13 53.46 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 58.63 1.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.791 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.95 22.3 16.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 3.44 47.75 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.002 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.8 m 59.03 -170.58 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.46 174.33 31.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.9 p -120.19 -168.17 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.28 172.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 59.91 -169.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.4 p -76.36 -165.3 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.442 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.449 HG23 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.476 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.58 -161.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -107.66 -48.75 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.815 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.78 -45.27 94.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.462 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mmt 52.78 173.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.819 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.545 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . -179.21 91.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.176 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.702 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t -94.26 -60.3 0.19 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.69 ' HB2' HG23 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB1' ' HE2' ' A' ' 11' ' ' PHE . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.613 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG13 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.508 ' N ' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.49 HD11 ' CG ' ' A' ' 78' ' ' TYR . 13.7 mm -84.91 118.05 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -158.72 37.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -62.69 -143.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.644 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.62 -77.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.687 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.74 139.35 5.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.52 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m 54.45 24.76 5.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.2 p -177.24 -160.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.2 108.34 0.35 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.007 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -139.07 1.48 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 16.8 mt-30 -111.12 -72.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.4 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.55 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.438 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.01 -23.63 48.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.36 -99.51 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.491 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.55 -67.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.281 0.562 . . . . 0.0 111.182 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 83.84 83.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.766 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.47 133.66 16.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.811 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.35 37.99 30.21 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 120.249 -0.976 . . . . 0.0 111.114 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -131.88 105.72 7.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.6 mt -59.27 139.22 57.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.613 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.475 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.667 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.485 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.667 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.49 ' CG ' HD11 ' A' ' 37' ' ' ILE . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.615 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.571 ' CA ' HD12 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.607 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.0 m -142.6 89.49 2.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 24.4 mt-10 -105.49 162.89 13.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.1 -76.2 0.33 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.042 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 4.1 tp -50.64 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 5.3 mt-10 -75.72 -4.85 42.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.992 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.77 -79.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.115 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 86.9 p -150.36 89.94 1.62 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.805 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.1 139.27 30.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -134.88 130.33 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' THR . 68.8 m-20 -143.54 159.47 42.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.77 160.62 1.07 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.43 -41.56 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.661 2.241 . . . . 0.0 112.813 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -25.34 63.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.76 45.98 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.423 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 p -148.57 74.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.775 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -148.74 152.86 37.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 81.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.4 t -111.75 94.44 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.09 17.33 37.99 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -176.77 95.66 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.52 -137.98 4.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.76 119.32 31.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.78 160.1 16.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 60.23 -171.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.969 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.2 m -132.33 160.33 36.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.526 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.907 0.384 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -100.15 -162.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -132.75 -23.43 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.473 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -77.56 -45.2 26.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.012 0.434 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 0.5 OUTLIER 56.15 -171.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.023 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.509 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 73.8 66.61 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 110.101 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.618 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -84.6 -65.55 0.21 Allowed Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.751 -178.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.526 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.705 ' HB2' HG23 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.549 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' HG13 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.48 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.627 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.543 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.808 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 33' ' ' LEU . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.439 HD11 ' CG ' ' A' ' 78' ' ' TYR . 21.6 mm -89.62 109.68 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 m -124.32 -33.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.25 -147.65 22.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.509 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.08 -70.99 0.3 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.582 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.98 -85.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.884 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 40' ' ' GLY . 3.8 t -119.35 9.39 11.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.65 0.262 . . . . 0.0 110.711 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.26 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.049 0.452 . . . . 0.0 110.822 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.511 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 165.14 115.94 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.726 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -144.64 1.31 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -110.03 -79.42 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.471 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.599 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD2' ' CG ' ' A' ' 54' ' ' LYS . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.594 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -54.26 -95.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.827 -178.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 7.2 p 168.89 -20.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 56' ' ' ASN . 1.9 m-80 47.13 91.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.477 0.656 . . . . 0.0 110.072 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.315 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.25 53.72 4.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.257 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -146.81 113.68 6.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.192 0.197 . . . . 0.0 111.105 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.2 mt -62.54 160.73 13.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.543 ' HG2' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HG ' ' CD1' ' A' ' 11' ' ' PHE . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.453 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.619 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.439 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.569 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.705 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m -149.81 89.62 1.63 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -96.78 163.49 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.258 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.12 -36.15 4.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.936 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.35 104.2 16.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.512 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.38 12.46 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.457 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.42 156.56 15.3 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.975 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 40.8 t -59.59 98.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.628 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.33 153.78 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.781 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.3 t80 -136.12 132.32 35.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 45' ' ' PHE . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -149.57 128.77 12.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -142.91 168.1 14.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.6 Cg_endo -54.44 -60.5 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.497 2.132 . . . . 0.0 112.74 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -30.85 61.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.218 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.54 -32.3 57.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.6 p 53.18 100.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 111.1 17.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.78 -174.98 3.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 55.8 m -106.89 106.91 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.45 -18.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 164.49 26.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.65 114.5 4.42 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -154.1 79.61 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -131.45 149.5 52.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -129.33 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.975 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.1 m -135.39 160.97 36.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 HG22 HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.303 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.4 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.69 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.11 9.19 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.54 -41.88 3.2 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.472 ' CE ' ' CB ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -103.19 -164.27 1.06 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.392 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . 69.33 46.21 0.79 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.277 0.561 . . . . 0.0 110.158 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -55.49 -67.75 0.66 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.263 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.538 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.561 ' HD2' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.561 ' CG2' ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.554 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.708 HG21 HD12 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 HG13 ' CG ' ' A' ' 74' ' ' MET . 12.9 mm -84.68 116.81 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -152.67 33.24 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.884 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.89 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.82 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.9 28.55 9.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.713 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.43 -96.16 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 36.4 m -73.41 -29.43 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 m -96.18 -167.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.49 93.86 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.286 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' O ' ' N ' ' A' ' 97' ' ' VAL . 4.6 p90 -133.28 -2.91 3.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 28.2 mt-30 -109.14 -74.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.554 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.521 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.79 -14.25 56.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.01 -107.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.29 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.9 t -162.49 -55.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 65.73 72.77 0.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -46.53 -28.83 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.893 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.59 48.7 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -153.73 112.57 3.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.377 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -58.81 149.26 27.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.565 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.708 HD12 HG21 ' A' ' 35' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.434 HG22 HG21 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.689 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.491 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.588 ' CA ' HD12 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.694 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m -150.36 89.55 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.526 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.0 pp20? -99.01 163.54 12.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.074 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.36 -111.52 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.737 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.77 -53.9 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 110.83 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -56.97 -22.34 37.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.943 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.53 148.63 8.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.345 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.526 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 42.1 p -59.61 103.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.318 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.85 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 -122.78 128.87 51.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.269 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 45' ' ' PHE . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -147.8 127.65 13.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.406 ' CB ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.22 166.93 17.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.363 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 99' ' ' ASN . 18.6 Cg_endo -60.43 -47.98 12.71 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.47 2.113 . . . . 0.0 112.782 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -13.3 61.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.99 35.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.7 p -124.1 134.87 53.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m 59.8 100.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -153.52 77.48 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 8.0 p -147.49 38.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.769 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.43 -32.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.849 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.63 84.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.086 0.443 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.73 110.87 0.66 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.8 168.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 82.5 p -130.19 -170.95 2.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 60.67 -172.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.8 p -100.96 161.45 13.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 HD13 HG23 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.601 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.25 -162.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.234 0.54 . . . . 0.0 110.851 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.08 -56.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.578 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.65 -67.68 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.3 mmt -82.01 -176.3 6.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.534 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . 61.07 37.93 17.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.635 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -42.14 -77.34 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.542 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.855 ' CZ ' ' HG2' ' A' ' 64' ' ' LYS . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.584 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 12' ' ' THR . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' N ' ' HE2' ' A' ' 11' ' ' PHE . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' O ' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.564 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.478 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.763 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.2 mm -88.15 117.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 15.2 m -115.84 -50.03 2.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.355 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 43' ' ' SER . . . -71.83 -114.53 0.05 OUTLIER Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.781 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.483 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . 80.29 97.16 0.35 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.415 -0.392 . . . . 0.0 113.431 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 102.68 0.87 Allowed Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.68 20.49 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.817 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 7.8 p -173.53 -3.13 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.323 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . -59.66 68.19 0.01 OUTLIER Glycine 0 C--N 1.349 1.28 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.19 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.817 ' CZ ' ' HA ' ' A' ' 43' ' ' SER . 1.3 p90 179.23 16.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 -106.69 -72.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.998 -0.439 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD2' HG23 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.77 -21.04 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.49 -100.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.872 0.306 . . . . 0.0 111.153 -178.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.86 -66.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 111.703 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 86.18 84.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.243 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.51 135.59 14.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.43 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.04 40.41 51.27 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.304 -0.95 . . . . 0.0 110.863 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.38 108.11 7.99 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.942 0.436 . . . . 0.0 110.56 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' CD1' HD11 ' A' ' 76' ' ' LEU . 2.5 mt -60.12 144.18 50.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.663 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.763 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.685 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.474 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 98' ' ' ASN . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.552 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.455 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.417 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 95.2 m -145.51 89.45 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -81.52 172.38 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.79 -46.94 1.1 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mp -85.72 105.89 16.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 67.41 12.44 8.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.54 -94.81 0.6 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.353 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 91.8 p -150.37 93.64 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.383 0.273 . . . . 0.0 110.911 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.4 147.41 26.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 110.384 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 -136.53 129.05 30.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.415 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 45' ' ' PHE . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 83' ' ' THR . 63.9 m-80 -138.01 133.99 34.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.776 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 18.1 p30 -175.84 175.91 0.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.337 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 40.1 Cg_endo -72.38 -37.69 4.16 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.067 1.845 . . . . 0.0 112.41 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -18.09 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.11 9.7 3.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 61.09 94.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.46 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 p -100.79 -79.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.7 t -178.31 38.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.4 -14.01 77.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t 61.58 79.64 0.25 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.46 -160.6 13.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.07 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.729 0.299 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.5 p -125.82 154.07 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -71.41 -171.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -125.19 160.42 29.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.659 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.705 0.288 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -95.09 -161.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.23 -30.76 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.798 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -103.06 -49.38 3.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.414 ' HG2' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -128.15 -156.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.74 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' N ' ' CG2' ' A' ' 62' ' ' ILE . . . -172.61 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -131.81 -78.51 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.548 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 12' ' ' THR . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.524 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.663 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.427 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.545 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.751 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.635 HG21 HD12 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 HD11 ' CG ' ' A' ' 78' ' ' TYR . 9.3 mm -77.84 118.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.2 m -158.75 40.08 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.762 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.35 -140.89 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.79 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.62 27.33 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.52 -73.6 2.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.329 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.6 m -68.72 -29.19 67.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 t -130.59 179.87 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.63 104.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.276 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.2 p90 -145.37 3.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.435 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 24.8 mt-30 -117.12 -72.18 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.852 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.545 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' CG ' ' A' ' 54' ' ' LYS . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.02 -26.4 59.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -51.6 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.035 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.7 p 169.46 -19.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.632 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.5 m-80 60.09 83.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.531 0.205 . . . . 0.0 110.705 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -49.93 125.61 12.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.39 40.17 10.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.323 -0.942 . . . . 0.0 110.945 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.632 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -143.75 115.46 8.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.8 mt -59.53 158.68 9.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.572 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 59' ' ' ASP . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.706 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.706 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.688 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.514 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.561 ' CA ' HD12 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.584 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE2' ' HE2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.419 ' HB ' ' NE ' ' A' ' 94' ' ' ARG . 88.5 m -150.12 89.48 1.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.51 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 1.2 pm0 -99.24 162.75 12.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.66 -109.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.431 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.69 -54.13 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.66 -23.03 38.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.46 148.4 7.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.415 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 89.1 p -59.61 91.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.366 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' NE ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.02 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 -123.49 129.26 50.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.17 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 45' ' ' PHE . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -136.92 128.81 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.473 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.98 168.77 10.46 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.197 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.8 Cg_endo -54.7 -57.27 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.069 . . . . 0.0 112.566 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -22.79 63.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.72 9.93 7.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 p 50.25 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.427 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 m -80.41 126.77 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 175.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.71 123.34 17.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.43 17.48 3.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.631 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 56.9 m -115.65 31.47 6.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.3 -117.51 5.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.428 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.25 170.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.873 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.61 173.67 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.98 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 77.1 p -111.92 162.55 15.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.606 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.548 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mmm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.792 0.33 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.863 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 1.8 t70 89.86 -9.56 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.218 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.89 -42.99 4.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.233 0.54 . . . . 0.0 110.017 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.0 -151.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.908 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.32 -33.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.45 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.712 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -136.97 -77.11 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.545 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.481 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.6 mm -87.35 110.73 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.2 m -127.45 -33.31 2.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.944 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.37 168.3 12.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.677 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.523 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . 127.34 -56.99 0.71 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.004 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 -59.86 2.58 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.652 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -120.51 -6.18 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.488 0.185 . . . . 0.0 111.171 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.2 m -148.93 -83.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.342 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' HA3' ' A' ' 40' ' ' GLY . . . 145.89 117.23 1.06 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.626 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.7 p90 -142.86 -1.79 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 11.9 mt-30 -113.55 -73.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.175 -0.328 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.548 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.01 -28.45 60.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.575 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.65 -96.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.09 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.1 p 167.76 -19.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 56' ' ' ASN . 2.0 m-80 48.71 92.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -46.97 -44.16 19.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.0 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.07 53.66 4.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.35 -0.929 . . . . 0.0 110.964 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.33 114.12 2.7 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 122.457 0.303 . . . . 0.0 110.445 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' A' ' 76' ' ' LEU . 5.2 mt -59.06 151.57 22.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.541 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.631 HD12 HG21 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.671 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.464 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.671 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.514 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.574 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 92.2 m -150.29 89.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 7.3 pt-20 -103.14 165.22 11.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.673 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.71 -111.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.72 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.52 -68.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.779 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -59.25 -19.84 49.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.972 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.09 157.03 22.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.168 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.537 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 7.9 t -59.6 89.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.049 0.452 . . . . 0.0 110.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -104.26 133.71 48.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 -112.56 132.85 54.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.322 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -149.25 158.31 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.542 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 4.1 p30 -175.59 166.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.543 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 9.2 Cg_endo -53.41 -35.22 74.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.786 2.324 . . . . 0.0 113.05 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -77.81 -31.52 51.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.346 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' ' OD1' ' A' ' 99' ' ' ASN . . . -92.75 46.94 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.287 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p -99.9 71.79 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -93.19 -47.79 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.038 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -121.37 128.21 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.2 p -118.38 30.38 7.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.13 17.18 6.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.618 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.39 136.25 34.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.855 0.359 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.56 -71.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.66 102.42 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -145.11 116.79 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 60.42 -171.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.2 m -142.26 160.19 40.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.494 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.555 0.217 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.71 -160.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 110.681 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -169.48 -38.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.186 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.43 -49.76 76.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.8 mmt 48.51 -173.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.178 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.584 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 74.65 72.82 0.1 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.418 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.583 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -87.56 -64.98 0.2 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.223 -179.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.554 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.684 ' HB2' HG23 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' HA ' ' CE ' ' A' ' 64' ' ' LYS . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' C ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.493 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.583 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.437 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.57 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.599 HG21 HD12 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm -87.82 113.23 24.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.9 m -150.55 32.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.249 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.83 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.076 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.88 65.19 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.573 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . 162.38 51.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 5.0 m 66.62 -64.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.723 0.297 . . . . 0.0 111.282 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.94 -66.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.149 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.78 135.72 4.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.144 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.1 p90 -146.62 3.02 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 25.3 mt-30 -109.14 -73.11 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.455 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.582 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.64 -21.05 45.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HG2' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -56.58 -101.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.588 -178.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -163.48 -62.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.046 0.45 . . . . 0.0 112.151 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.2 m120 71.39 72.52 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -47.01 -29.6 2.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.606 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.47 47.66 1.73 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -150.99 111.53 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 3.8 mt -59.2 147.09 36.73 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' HZ ' ' A' ' 11' ' ' PHE . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 HG21 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.408 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.489 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.778 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.519 ' HA ' HD11 ' A' ' 37' ' ' ILE . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.778 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CD2' HD11 ' A' ' 37' ' ' ILE . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.576 ' CA ' HD12 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.684 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.411 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 98.7 m -148.1 89.86 1.77 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 28.8 mt-10 -51.23 159.36 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.457 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.48 27.67 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.327 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.15 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.303 . . . . 0.0 111.177 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -59.23 -23.25 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 109.64 0.26 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.396 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 16.2 m -60.0 122.33 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.091 0.472 . . . . 0.0 111.18 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -82.46 144.41 30.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.883 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 -132.35 133.64 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -145.2 158.21 43.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.521 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.7 p30 -178.87 164.1 1.04 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 19.2 Cg_endo -60.35 -40.54 57.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.639 2.226 . . . . 0.0 112.594 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -35.92 77.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.92 37.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -151.15 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.18 123.86 33.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.818 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -149.54 129.95 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 2.6 t -170.91 34.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.96 11.61 3.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.76 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 56.02 30.29 15.94 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.735 0.303 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.04 -88.54 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.23 -57.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.78 168.86 25.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 60.52 -173.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.6 p -109.57 162.38 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.535 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.437 HD13 HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.602 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -92.13 -161.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.44 31.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.65 -47.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.373 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.6 161.55 17.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.003 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.419 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.46 88.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.437 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.75 -69.0 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.532 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.601 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.645 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.477 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.548 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.7 mm -85.89 116.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 48' ' ' GLY . 6.4 m -156.67 34.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.858 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -62.84 -145.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.709 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.87 24.68 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.729 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.76 -79.1 1.88 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.6 m -63.64 -30.11 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.2 m -127.1 -172.08 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.24 97.92 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.281 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.2 p90 -138.8 1.9 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 -113.07 -72.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.596 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.601 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.4 -19.81 49.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.662 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.04 -103.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.737 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.0 p 163.94 42.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.33 0.394 . . . . 0.0 111.712 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -17.89 95.41 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.798 0.439 . . . . 0.0 111.518 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.08 125.78 9.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.186 0.517 . . . . 0.0 110.304 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.89 36.42 6.06 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 56' ' ' ASN . 25.6 p-10 -134.46 109.19 8.57 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.835 0.454 . . . . 0.0 110.329 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.4 mt -59.29 131.05 49.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HG3' ' HZ ' ' A' ' 11' ' ' PHE . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.436 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 64' ' ' LYS . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD12 HG21 ' A' ' 35' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.475 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.637 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.637 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.564 ' CA ' HD12 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.454 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 96.4 m -149.78 89.54 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 2.5 pp20? -105.38 163.8 12.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.245 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.05 -104.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.345 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -102.19 -48.35 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.39 -20.69 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.89 146.09 7.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.412 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 48.9 p -59.65 96.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 139.15 31.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.964 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 -124.49 125.35 44.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -148.62 132.25 16.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -148.63 166.67 14.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.166 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 18.9 Cg_endo -60.42 -53.14 3.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.535 2.157 . . . . 0.0 112.941 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -28.45 65.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.32 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.8 -83.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 111.054 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.0 29.85 1.14 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.258 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.6 t -127.94 170.04 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.63 116.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.71 -61.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.39 42.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.673 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t 59.85 31.11 20.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.789 0.328 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.3 66.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -103.06 -41.29 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.24 161.26 14.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -107.25 -171.81 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.16 160.63 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.606 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.537 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.51 -163.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.669 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 80.81 13.86 0.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -112.85 -41.17 3.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 161.47 24.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.512 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.484 ' CA ' HG22 ' A' ' 62' ' ' ILE . . . 48.94 49.65 18.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.295 0.569 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.26 -70.6 0.19 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.795 -178.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.707 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.49 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.555 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.5 mm -87.65 108.47 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -122.37 -36.2 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.06 -147.97 23.06 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.47 -70.28 0.31 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.533 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.55 -84.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.902 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' GLY . 85.1 m -121.79 11.93 10.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 171.44 -63.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.011 0.434 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 157.99 115.6 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.774 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CD1' ' HG3' ' A' ' 46' ' ' GLN . 1.0 OUTLIER -142.45 0.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 23.9 mt-30 -109.3 -78.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.102 -0.374 . . . . 0.0 111.591 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.02 -13.68 58.61 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' C ' ' CG2' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -68.99 -107.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -163.84 -60.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.215 0.531 . . . . 0.0 111.352 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 2.3 m-80 82.47 83.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -48.77 131.94 18.04 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.28 37.6 24.12 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.39 110.77 8.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.364 -0.418 . . . . 0.0 109.9 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.3 mt -60.97 152.15 28.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.601 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.816 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.707 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.512 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.671 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.707 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.707 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.589 ' CA ' HD12 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.572 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 84.8 m -150.1 89.84 1.63 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.2 pm0 -101.37 163.23 12.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.0 117.46 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.854 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.44 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.273 . . . . 0.0 111.31 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.11 -24.41 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 111.256 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.64 144.52 8.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.318 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 35.1 p -59.85 103.34 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -105.89 160.01 15.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.07 179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 -133.54 134.76 43.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.56 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -150.46 131.14 14.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -140.33 167.64 17.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.762 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 38.2 Cg_endo -66.81 -44.39 5.73 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.49 2.126 . . . . 0.0 112.705 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.854 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.72 -33.04 46.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.261 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.6 p -92.08 148.98 21.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.726 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.68 -42.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 74.56 -63.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.7 p -137.41 34.62 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.28 18.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.676 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -49.2 5.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.31 109.13 1.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.33 118.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.996 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.8 p -132.64 149.54 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 60.12 -170.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.1 p -68.29 -164.94 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.449 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.499 HG23 HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.589 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.439 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -97.34 -161.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER 83.5 16.31 0.28 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.73 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -109.12 -41.34 4.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.469 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.94 161.44 33.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.14 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 59.63 91.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.631 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -128.85 -71.79 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.536 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 12' ' ' THR . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.517 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.411 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.49 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.565 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.813 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.471 HD11 ' CG ' ' A' ' 78' ' ' TYR . 25.2 mm -91.65 108.42 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -118.94 -38.01 3.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.407 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 44.18 -168.92 0.02 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.276 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.71 21.52 42.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.32 2.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.288 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -108.11 -29.64 8.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.48 -164.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.55 95.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.3 p90 -138.91 1.1 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 -109.44 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.423 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.556 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.03 -17.7 62.01 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.637 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.36 -100.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.637 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.5 p 161.95 -19.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 56' ' ' ASN . 1.9 m-80 48.69 90.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -52.99 14.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.8 52.9 4.76 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.227 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 9.4 t70 -147.41 114.51 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt -59.95 136.94 58.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.539 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.568 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.779 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.422 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.649 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.649 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.563 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.439 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 90.5 m -148.84 89.48 1.68 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 51.4 mt-10 -89.51 164.34 14.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.92 -140.87 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.608 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.14 -48.97 25.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -57.92 -21.52 44.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.859 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.59 154.15 9.83 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.385 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 77.9 p -59.66 89.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.833 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.28 138.21 32.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.08 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 -128.5 130.99 48.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 83' ' ' THR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -134.08 152.77 51.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 1.0 OUTLIER 176.7 167.4 0.44 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.366 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 3.6 Cg_endo -47.4 -35.8 22.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.822 2.348 . . . . 0.0 112.996 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -47.36 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.65 0.262 . . . . 0.0 111.129 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.62 -75.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.273 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.3 p 49.76 41.18 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.054 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -74.93 -44.44 48.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.971 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.6 p 56.74 -168.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.02 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.3 m -96.01 41.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.48 16.82 63.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.3 p -115.15 177.46 4.65 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.16 -77.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.42 ' HA ' ' CE2' ' A' ' 112' ' ' PHE . 78.4 p -98.83 32.24 2.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.6 m -103.57 41.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.107 0.48 . . . . 0.0 110.83 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 110' ' ' SER . 47.2 m-85 -67.45 -170.94 0.15 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -145.98 160.36 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.513 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.843 0.354 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.89 -161.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -36.15 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -43.49 -42.25 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.224 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.543 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 21.7 mmt -46.48 172.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.488 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . 73.96 68.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.876 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -88.15 -67.32 0.15 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.542 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 51' ' ' PHE . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.639 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.731 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 HD11 ' CG ' ' A' ' 78' ' ' TYR . 24.4 mm -91.75 110.04 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -122.22 -36.35 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.87 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 41.94 -159.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.032 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.08 -82.71 0.14 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.634 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.38 33.48 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.627 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.97 -46.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.743 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -175.0 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.64 89.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.364 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 97' ' ' VAL . 10.0 p90 -120.51 -4.08 9.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 -106.48 -64.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.592 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.42 -20.94 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HG2' ' CG ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -55.06 -100.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.306 -0.246 . . . . 0.0 111.343 -178.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -164.37 -63.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 111.47 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 1.0 OUTLIER 69.83 72.01 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.88 -30.83 2.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.542 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.34 47.89 1.93 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -150.28 110.6 4.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 4.4 mt -59.3 150.25 26.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.44 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.657 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.657 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.662 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.521 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.578 ' CA ' HD12 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.573 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m -150.35 89.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 0.8 OUTLIER -99.59 163.72 12.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.125 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.48 108.33 0.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.879 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 63.14 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.429 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -50.71 -25.34 4.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.304 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.59 143.86 8.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.557 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 92.7 p -59.78 90.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.04 143.76 27.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.761 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.66 133.34 53.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 3.1 p30 174.32 163.77 0.34 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.585 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 23.4 Cg_endo -61.93 -41.28 38.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.925 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -38.36 83.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.096 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -95.98 -73.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.283 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.4 p -79.49 141.97 36.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -148.68 -60.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -137.32 109.9 7.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.9 m -139.68 93.51 2.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.97 17.65 13.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.596 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.68 -31.55 11.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.66 65.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -111.83 33.28 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.04 154.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -102.84 -171.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -141.23 160.58 39.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.65 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.465 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.791 0.329 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -95.69 -159.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.003 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 2.4 t0 87.81 8.35 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.891 0.476 . . . . 0.0 111.094 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -109.36 -43.37 4.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.14 160.96 39.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . 59.22 80.24 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -104.81 -69.2 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.221 -178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.563 HD12 ' CA ' ' A' ' 83' ' ' THR . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.671 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' CE ' ' A' ' 64' ' ' LYS . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.417 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.783 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.508 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.6 mm -92.38 117.43 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 3.3 m -128.85 -45.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 38.24 -162.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.949 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 -80.54 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.334 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.23 -42.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.363 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.4 m -85.15 81.16 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 100' ' ' PRO . 0.5 OUTLIER 63.43 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.43 122.68 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.7 p90 -143.49 6.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 -113.31 -73.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.592 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.478 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.591 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.16 -22.48 48.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.1 -100.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.776 -179.03 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.11 -65.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 111.53 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 85.28 84.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.338 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.77 135.76 14.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.117 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.16 40.61 49.8 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -133.99 110.25 9.55 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 122.734 0.414 . . . . 0.0 110.062 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 60' ' ' LEU . 1.2 mt -59.73 139.36 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 11' ' ' PHE . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.507 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.718 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.718 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.592 ' O ' HG12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.548 ' HA3' ' ND2' ' A' ' 99' ' ' ASN . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.563 ' CA ' HD12 ' A' ' 9' ' ' LEU . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.525 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.5 m -148.17 89.36 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 33.5 mt-10 -90.03 164.87 14.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.957 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.06 -147.53 15.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.667 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.39 -54.13 50.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.038 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.75 -17.76 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.61 157.71 18.88 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.535 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 73.6 p -59.66 89.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.51 144.56 27.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.502 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 -132.4 126.67 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 -122.19 162.39 21.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.652 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 72.51 104.58 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 99' ' ' ASN . 12.9 Cg_endo -58.02 -33.7 97.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.878 1.719 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER 175.05 30.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.634 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 61.24 82.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -153.94 139.96 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.5 p -58.17 146.82 32.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -134.34 143.76 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.94 89.83 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.01 -15.33 16.59 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.74 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 93.6 m 63.12 -79.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.774 0.321 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.34 170.83 33.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.2 m -114.85 82.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.73 95.32 4.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.759 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 60.15 -168.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -88.78 -165.92 1.46 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.464 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.472 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.39 -162.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.6 -62.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.722 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -78.95 -54.93 5.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.0 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.515 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 26.0 mmt -71.65 175.41 5.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.978 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . . . 65.63 60.42 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.13 -68.65 0.23 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.487 -178.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.639 ' CE2' ' O ' ' A' ' 12' ' ' THR . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG11 HG23 ' A' ' 23' ' ' ILE . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.557 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.415 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.607 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.636 HG21 HD12 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD11 ' CG ' ' A' ' 78' ' ' TYR . 21.7 mm -88.94 111.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 m -145.18 28.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.462 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -162.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.146 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.06 -58.69 5.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.843 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.8 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.62 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 110.307 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.13 -149.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.79 107.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.584 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.9 p90 -138.9 -3.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 19.9 mt-30 -108.84 -75.27 0.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.461 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE1' ' CG2' ' A' ' 35' ' ' VAL . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.46 -28.56 62.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.61 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -52.51 -93.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.017 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 11.3 p 163.27 -20.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 2.0 m-80 48.29 91.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -46.97 -45.99 21.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.382 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 55.3 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.209 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.44 116.65 3.95 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.639 0.258 . . . . 0.0 110.748 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.6 mt -59.03 163.2 3.7 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.607 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD13 HG21 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.468 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.461 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.483 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.648 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.465 ' CG ' HD11 ' A' ' 37' ' ' ILE . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.572 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.6 m -150.18 89.88 1.62 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 165.16 13.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.37 164.42 35.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.1 mp 64.82 -73.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.642 0.258 . . . . 0.0 111.241 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.49 -24.85 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.181 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.12 161.49 10.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.372 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.8 t -61.91 90.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 0.0 111.103 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.08 152.5 20.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.047 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -129.62 134.87 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.356 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 45' ' ' PHE . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 -134.08 153.66 51.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.67 164.55 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.54 -49.89 7.97 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.619 2.212 . . . . 0.0 112.71 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.67 -37.37 68.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.086 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.69 -25.78 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.461 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.1 p 51.53 35.51 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -172.67 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.3 p -136.43 87.08 2.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 84.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -106.03 9.63 43.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.78 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.0 -171.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.864 0.364 . . . . 0.0 110.959 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.71 105.47 0.5 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 124.95 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.9 m -140.42 137.67 34.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 8.2 m-85 -124.66 -171.24 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.5 m -138.87 160.73 39.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.56 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.807 0.337 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -97.93 -162.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 6.5 t0 88.35 -45.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -76.08 -41.96 48.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.47 ' HE1' ' HA ' ' A' ' 5' ' ' MET . 10.5 mmt -58.31 164.36 2.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 57.85 48.02 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.25 -71.52 0.18 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.114 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.528 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.679 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.628 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.62 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 HD11 ' CG ' ' A' ' 78' ' ' TYR . 20.7 mm -89.95 108.73 19.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 m -124.91 -32.42 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.793 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -109.07 179.87 21.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.613 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 110.84 76.71 0.86 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.324 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.44 -22.31 56.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.426 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.99 -36.54 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.716 0.293 . . . . 0.0 110.762 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.16 -75.77 0.54 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.366 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 157.27 125.12 0.84 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.269 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.8 p90 -145.56 2.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 34.5 mt-30 -117.23 -74.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.444 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.552 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.62 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.481 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -83.22 -22.4 33.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -48.36 -93.4 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.582 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 8.6 p 166.87 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 1.8 m-80 36.17 95.75 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.969 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.24 -41.76 13.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.704 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.05 61.22 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.616 ' OD1' ' O ' ' A' ' 59' ' ' ASP . 1.4 p-10 -140.09 111.33 7.09 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 112.189 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' A' ' 76' ' ' LEU . 3.0 mt -69.19 125.07 25.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.687 ' HB2' HG22 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.431 HD12 ' HB2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.683 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.683 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.583 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.542 ' CA ' HD12 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.679 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 92.0 m -149.52 89.59 1.65 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 1.2 mt-10 -93.65 163.47 13.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.93 -132.71 2.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.44 -53.78 6.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.74 -18.37 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.726 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 153.7 11.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 54.3 p -59.85 89.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.973 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.41 139.33 31.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.688 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -125.93 131.35 52.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 -136.98 156.85 47.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.441 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -179.96 166.42 0.81 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 16.3 Cg_endo -57.65 -46.7 25.28 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.653 2.235 . . . . 0.0 112.556 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -37.81 76.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -63.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.1 p -124.16 -74.9 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.058 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.9 p -159.19 163.99 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.69 170.17 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.0 t -175.08 140.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.69 -16.01 2.22 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.655 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.87 -178.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 111.032 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.12 -58.15 5.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.418 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -135.72 -175.74 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.02 112.59 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 110' ' ' SER . 42.5 m-85 -118.01 -170.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.8 m -146.02 160.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.743 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -118.97 -171.05 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.737 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.84 -41.67 0.21 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.891 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.95 -46.82 22.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.404 ' CE ' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -116.68 -146.03 0.4 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' HA ' HG13 ' A' ' 2' ' ' ILE . . . -158.31 -36.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.737 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -137.65 -78.47 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.737 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' TYR . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.646 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.555 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.786 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.625 HG21 HD12 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.3 mm -89.53 110.69 22.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.1 m -126.42 -30.29 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.934 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.753 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -125.27 -176.96 14.71 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.068 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 132.58 -64.24 0.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.36 -66.07 0.39 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.691 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.6 m -105.72 -24.08 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.1 m -149.91 -90.72 0.07 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.031 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 172.68 119.92 0.54 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.7 p90 -148.66 1.36 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.753 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 14.1 mt-30 -112.24 -79.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.932 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.495 HG23 ' HB3' ' A' ' 34' ' ' ARG . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.582 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.29 -23.53 40.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -55.54 -99.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.3 -178.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.84 -67.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.242 0.544 . . . . 0.0 111.571 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.5 m120 84.98 83.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.839 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -48.47 135.76 13.7 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.846 0.355 . . . . 0.0 110.378 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 72.12 39.34 58.45 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.914 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.04 106.48 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.291 0.236 . . . . 0.0 110.518 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.3 mt -60.03 149.76 31.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.656 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.464 ' O ' HD11 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.625 ' CD2' ' HG3' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' HG3' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD11 ' A' ' 37' ' ' ILE . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.617 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.627 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' ND2' ' A' ' 99' ' ' ASN . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.564 ' CA ' HD12 ' A' ' 9' ' ' LEU . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.575 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.481 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 89.5 m -150.38 89.66 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 6.8 pm0 -99.12 162.57 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.051 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.68 -79.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.75 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.447 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 21.0 tp -49.14 -96.92 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 4.9 mm-40 -75.69 -18.22 59.69 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.173 -0.329 . . . . 0.0 111.299 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.22 164.96 10.11 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.271 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.503 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 79.0 p -59.89 89.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.872 0.368 . . . . 0.0 111.495 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -93.35 164.53 13.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 -137.8 133.69 34.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 45' ' ' PHE . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 83' ' ' THR . 30.4 m-80 -122.75 172.17 8.63 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 66.57 106.62 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.65 -37.33 74.67 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.778 1.652 . . . . 0.0 110.738 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.487 ' CA ' HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER 167.34 31.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.987 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 62.35 61.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.8 p -148.84 -47.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.637 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -151.05 78.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.775 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.31 151.66 19.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.994 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.1 p -144.85 119.74 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.49 -20.24 1.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.654 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 51.5 m 59.39 31.43 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.31 136.51 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 -48.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.09 -173.04 2.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 60.28 -169.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.051 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.2 p -80.62 -165.33 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.451 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.266 -0.874 . . . . 0.0 111.492 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 mmm . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.57 -162.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.765 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.47 -38.17 0.01 OUTLIER 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.752 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.24 -66.66 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.488 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 27.2 mmt -58.58 168.53 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.155 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 65.95 52.14 1.27 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.238 0.542 . . . . 0.0 109.799 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.62 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -70.92 -68.05 0.53 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.416 -177.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.71 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.544 ' O ' ' CG1' ' A' ' 23' ' ' ILE . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.796 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.474 HD11 ' CG ' ' A' ' 78' ' ' TYR . 18.1 mm -85.93 117.29 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.0 m -158.71 38.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.608 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -61.81 -144.34 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.627 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 -69.48 1.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 -106.06 0.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.328 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.1 m -59.03 -28.25 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.789 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.07 -165.7 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.11 114.66 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.091 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.6 p90 -143.73 2.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 -110.51 -71.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.791 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.542 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.69 -18.33 54.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -62.54 -103.47 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.195 -178.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -163.15 -65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 0.0 111.268 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.9 m120 84.82 84.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.845 -178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.72 132.48 17.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.488 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.46 39.02 27.11 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.835 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -133.64 107.24 7.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' CD1' HD11 ' A' ' 76' ' ' LEU . 3.4 mt -62.16 156.34 21.99 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HG2' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' A' ' 11' ' ' PHE . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' CG2' ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.659 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.659 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.522 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.562 ' CA ' HD12 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.405 ' HB ' ' NE ' ' A' ' 94' ' ' ARG . 86.9 m -150.12 89.49 1.6 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 16.6 mt-10 -90.24 164.4 14.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.4 -75.05 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.461 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mp -52.37 -75.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.03 26.69 2.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.63 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 92.09 -86.21 1.24 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.175 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.9 p -150.99 89.72 1.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.612 0.244 . . . . 0.0 110.444 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.405 ' NE ' ' HB ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -96.72 142.91 28.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.82 134.89 53.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.905 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 45' ' ' PHE . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -148.65 129.86 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.6 166.91 14.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.308 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.21 -43.04 20.04 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.386 2.057 . . . . 0.0 112.412 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.26 0.12 38.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.646 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -91.36 39.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.778 0.323 . . . . 0.0 111.35 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 30.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -114.98 147.43 40.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.2 p -119.58 81.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 29.0 t -84.25 89.65 7.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -111.35 -17.59 8.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.638 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 58.4 m -68.22 124.43 23.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.39 156.16 8.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -156.94 135.57 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.69 162.94 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.85 -171.59 1.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -130.67 160.73 33.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.685 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 HG22 HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.578 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.66 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -162.59 24.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -123.32 -45.21 2.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 110.595 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.411 ' HE3' ' CB ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -137.09 177.4 7.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.134 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 58.53 79.47 0.21 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.332 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.37 -68.13 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.106 -178.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.549 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.711 ' HB2' HG23 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' C ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' H ' HG13 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 29' ' ' THR . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 68' ' ' GLN . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.558 HD12 ' CD2' ' A' ' 49' ' ' PHE . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD11 ' CG ' ' A' ' 78' ' ' TYR . 16.7 mm -87.22 111.28 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 m -147.08 31.72 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.647 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -58.7 -154.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.067 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.97 26.32 10.08 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.875 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.28 -84.95 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.531 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -27.38 64.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.67 -168.24 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.64 102.14 0.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.229 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.8 p90 -138.39 -1.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 22.9 mt-30 -107.13 -71.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.558 ' CD2' HD12 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.488 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.557 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.91 -24.2 60.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.613 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -49.76 -94.38 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 14.7 p 156.57 -20.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 124.128 0.893 . . . . 0.0 111.587 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 1.9 m-80 47.07 91.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.5 . . . . 0.0 110.178 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -47.06 -43.21 19.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.403 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.73 53.68 3.71 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.237 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.54 113.13 3.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 110.568 -179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 76' ' ' LEU . 4.7 mt -59.61 139.43 57.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 62' ' ' ILE . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.668 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.575 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.711 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.9 m -150.05 89.44 1.6 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -62.55 163.59 8.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.62 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.69 -131.5 2.58 Favored Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.0 91.58 8.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.819 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 51.41 25.63 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -154.06 66.06 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.649 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 88.1 p -59.43 118.1 5.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 111.147 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 154.83 22.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.483 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.487 ' CE1' HG22 ' A' ' 84' ' ' VAL . 4.1 t80 -139.14 132.88 30.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -143.46 148.0 35.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.561 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.2 p30 -175.44 164.9 2.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.53 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 18.1 Cg_endo -58.82 -36.74 96.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.655 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -68.89 -31.03 69.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.828 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' OD1' ' A' ' 99' ' ' ASN . . . -77.45 61.49 2.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.26 -30.64 11.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 p 58.1 164.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.1 125.34 5.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 4.6 m -103.83 102.54 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.14 -18.13 1.73 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.2 m -81.02 -54.2 5.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 -165.23 24.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.549 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m 62.35 117.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -154.78 115.26 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -77.3 -173.78 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 110.953 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.7 p -114.65 162.83 16.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.505 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.968 0.413 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.54 -174.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.006 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 174.14 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.97 -48.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.414 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 0.2 OUTLIER 52.07 -171.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 75.29 71.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.447 . . . . 0.0 110.262 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.587 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -86.72 -63.12 0.23 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.453 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.529 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB1' ' CE2' ' A' ' 11' ' ' PHE . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE2' ' CE2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' CE1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.588 ' CD1' ' CZ ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.487 ' CB ' ' O ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.692 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.798 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.47 HG12 ' HG2' ' A' ' 74' ' ' MET . 12.0 mm -78.58 118.93 26.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 m -162.59 49.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.451 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.04 -132.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.22 -77.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.621 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.9 130.35 2.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.817 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.1 m 54.97 26.21 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 p -177.55 -174.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.968 0.413 . . . . 0.0 111.047 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.58 105.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.069 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.6 p90 -135.46 1.07 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 29.9 mt-30 -112.7 -71.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CD2' ' CD1' ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 34' ' ' ARG . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.588 ' CZ ' ' CD1' ' A' ' 22' ' ' LEU . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.01 -23.44 41.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.48 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.71 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.54 -66.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.219 0.533 . . . . 0.0 111.502 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.65 84.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.347 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -48.48 135.19 14.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.216 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.6 39.78 40.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.777 -178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -135.95 110.04 8.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.72 0.408 . . . . 0.0 110.51 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 76' ' ' LEU . 1.4 mt -60.57 140.33 57.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.557 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.798 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.684 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.684 ' NE2' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.626 ' O ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD23 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.582 ' CA ' HD12 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.443 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 85.9 m -149.01 89.53 1.68 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 11.4 mt-10 -93.12 164.73 13.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.672 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 91' ' ' GLU . . . 113.11 144.11 8.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.5 tp 63.65 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.603 0.239 . . . . 0.0 110.519 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 89' ' ' GLY . 30.3 mm-40 -74.81 -8.81 57.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.787 0.327 . . . . 0.0 110.577 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 112.94 -95.53 0.77 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.626 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 59.8 p -150.52 89.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.634 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -88.22 140.84 29.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 -124.39 137.4 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 45' ' ' PHE . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -141.09 131.6 25.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.39 166.35 15.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.365 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.85 -55.59 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.455 2.103 . . . . 0.0 112.716 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -23.24 48.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.34 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -70.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 p -98.73 129.28 45.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.1 p -176.56 -46.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.4 159.76 31.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 31.99 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.68 27.06 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t -139.13 160.04 40.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.14 -138.23 2.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m 63.0 -79.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.01 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.82 120.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -78.21 -168.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -96.09 -165.38 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.53 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.639 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.724 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.866 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.79 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.668 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.675 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.595 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.94 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 HD11 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.4 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.411 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.3 mt-30 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.642 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.927 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.94 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.621 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG23 ' HD3' ' A' ' 64' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 35' ' ' VAL . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.547 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.93 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.998 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.998 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.559 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.724 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.439 ' CA ' HD11 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.604 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.746 0.308 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.676 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.748 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.717 HG13 ' HD1' ' A' ' 51' ' ' PHE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.869 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 24' ' ' SER . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.673 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.645 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.606 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 75' ' ' SER . 11.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 32.8 mt-30 . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.668 ' HD2' HG21 ' A' ' 97' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.879 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.911 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.717 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 76' ' ' LEU . 2.9 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CD1' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.712 HG12 ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.552 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.937 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.996 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.996 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.748 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.425 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.0 t80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.872 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.676 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.699 ' N ' HD13 ' A' ' 33' ' ' LEU . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 75' ' ' SER . 13.7 mm . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 16.8 mt-30 . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.494 0.187 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.517 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.848 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.918 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.748 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 60' ' ' LEU . 2.6 mt . . . . . 0 CA--C 1.521 -0.167 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.703 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.985 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.568 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' HG12 ' A' ' 97' ' ' VAL . 68.8 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.632 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.595 ' N ' HD12 ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.932 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.719 HG22 HD23 ' A' ' 33' ' ' LEU . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' CB ' HD22 ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.64 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.581 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.662 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.893 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.618 HG22 ' CE1' ' A' ' 49' ' ' PHE . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.6 mm . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.412 0.149 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HD2' HG21 ' A' ' 97' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.887 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.2 mt . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.596 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.893 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.484 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.916 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.971 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.0 mp0 -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.463 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.499 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 6.3 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 97' ' ' VAL . 16.6 m-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.857 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.803 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.915 ' HD2' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.915 HG23 ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.881 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CB ' HD22 ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.665 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.616 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG23 HD11 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 28.2 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.895 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.734 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 70' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.927 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.538 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.903 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.962 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.706 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.483 ' CA ' HD11 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.694 0.283 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 97' ' ' VAL . 34.3 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.663 ' N ' HD12 ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.979 ' HB2' HG22 ' A' ' 84' ' ' VAL . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.915 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.763 HG13 ' HD1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.661 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' CB ' HD22 ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.653 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.2 mm . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.654 ' CD2' HG21 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.92 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.763 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 76' ' ' LEU . 2.5 mt . . . . . 0 CA--C 1.524 -0.057 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.549 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.863 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.662 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.9 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.53 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.979 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 . . . . . 0 CA--C 1.522 -0.133 0 CA-C-O 120.649 0.262 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.824 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.618 ' H ' HG12 ' A' ' 97' ' ' VAL . 63.9 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.749 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.863 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.749 HG13 ' HD1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.649 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.571 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.572 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 75' ' ' SER . 9.3 mm . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' A' ' 97' ' ' VAL . 24.8 mt-30 . . . . . 0 CA--C 1.522 -0.098 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.8 mt . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.593 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.572 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.973 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.556 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.982 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.567 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.76 0.314 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 ' HD2' ' A' ' 47' ' ' TYR . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.608 ' N ' HD12 ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.832 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.822 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.774 HG13 ' HD1' ' A' ' 51' ' ' PHE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.402 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CB ' HD22 ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.943 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.77 ' N ' HD13 ' A' ' 33' ' ' LEU . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD13 ' HD1' ' A' ' 47' ' ' TYR . 18.6 mm . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 11.9 mt-30 . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.686 0.279 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HD2' HG21 ' A' ' 97' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.943 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.774 ' HD1' HG13 ' A' ' 19' ' ' VAL . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 HD12 ' A' ' 76' ' ' LEU . 5.2 mt . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.665 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.869 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.894 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.003 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 1.003 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.475 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.832 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.449 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.5 m-80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.612 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.895 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 33' ' ' LEU . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.864 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.697 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.544 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.895 HD12 HD13 ' A' ' 69' ' ' LEU . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 25.3 mt-30 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.852 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.877 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 HD12 ' A' ' 76' ' ' LEU . 3.8 mt . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.871 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.876 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.62 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.7 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.737 0.303 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.8 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.859 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.745 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.806 HG13 ' HD1' ' A' ' 51' ' ' PHE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 24' ' ' SER . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.681 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.683 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.683 HD23 ' CG ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG23 HD11 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 . . . . . 0 C--O 1.228 -0.074 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HD2' HG21 ' A' ' 97' ' ' VAL . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.919 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.897 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.806 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HG2' HG22 ' A' ' 67' ' ' VAL . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 20' ' ' LYS . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' N ' ' A' ' 68' ' ' GLN . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.888 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.664 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.535 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.925 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 13.0 mp0 -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.925 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 97' ' ' VAL . 31.7 m-80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.823 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.769 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.879 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.672 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' CB ' HD22 ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.623 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.925 HG23 HD11 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.5 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 23.9 mt-30 . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 97' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.962 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.769 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt . . . . . 0 C--O 1.227 -0.086 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.937 HD13 HD12 ' A' ' 33' ' ' LEU . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.913 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.56 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.935 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.0 mp0 -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.49 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' H ' HG12 ' A' ' 97' ' ' VAL . 22.5 m-80 . . . . . 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.631 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.861 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.734 HG13 ' HD1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.854 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.706 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.818 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 75' ' ' SER . 25.2 mm . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.579 0.228 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.634 ' HD2' HG21 ' A' ' 97' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.929 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.734 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.567 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.818 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.903 HD11 HG23 ' A' ' 35' ' ' VAL . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.67 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.507 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.99 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.595 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.685 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.876 0.369 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.634 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.4 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.848 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HD1' ' A' ' 51' ' ' PHE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 24' ' ' SER . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.588 ' CB ' HD22 ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.658 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.773 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 75' ' ' SER . 24.4 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 . . . . . 0 CA--C 1.522 -0.127 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.547 ' HD1' HG21 ' A' ' 97' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.922 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.753 HD11 HD12 ' A' ' 76' ' ' LEU . 4.4 mt . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.729 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.656 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.855 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.51 ' O ' ' CD1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.687 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.479 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 ' HD1' ' A' ' 47' ' ' TYR . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.0 m-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.577 ' N ' HD12 ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.705 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.705 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.869 HG23 HD11 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.6 mm . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 . . . . . 0 CA--C 1.525 0.006 0 CA-C-O 120.572 0.225 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HD2' HG21 ' A' ' 97' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.89 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.778 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.2 mt . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.581 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' H ' ' A' ' 67' ' ' VAL . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.907 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.58 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.984 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.762 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' ASN . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.762 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.627 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.849 ' HA ' HG13 ' A' ' 84' ' ' VAL . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HD23 ' A' ' 33' ' ' LEU . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.662 ' N ' HD12 ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.657 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.597 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.715 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.824 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.7 mm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 19.9 mt-30 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 37' ' ' ILE . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.904 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.6 mt . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.576 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.639 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.72 HG13 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.464 ' CG ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.934 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 12.0 mp0 -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.711 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.6 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.641 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HD2' ' HB3' ' A' ' 15' ' ' ALA . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.878 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.816 HG13 ' HD1' ' A' ' 51' ' ' PHE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.844 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.631 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.685 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.917 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.471 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 75' ' ' SER . 20.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' A' ' 97' ' ' VAL . 34.5 mt-30 . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.705 ' HD2' HG21 ' A' ' 97' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.917 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.896 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 HD12 ' A' ' 76' ' ' LEU . 3.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.651 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.843 ' HD3' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG23 ' HD3' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.556 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.817 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.529 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.431 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.611 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.877 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.792 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' A' ' 51' ' ' PHE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.859 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.677 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.538 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.658 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 50' ' ' THR . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.44 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.1 mt-30 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.649 0.261 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HD2' HG21 ' A' ' 97' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.907 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.725 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 35' ' ' VAL . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.524 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.519 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.911 ' O ' HD13 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.968 ' N ' HD23 ' A' ' 76' ' ' LEU . 15.4 mp0 -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ASN . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.877 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HD2' ' A' ' 47' ' ' TYR . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.4 m-80 . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.698 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.611 ' N ' HD12 ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 HD23 ' A' ' 33' ' ' LEU . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.874 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.705 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.667 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.641 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.604 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.1 mm . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 . . . . . 0 C--O 1.228 -0.077 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HD2' HG21 ' A' ' 97' ' ' VAL . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.866 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.726 ' HD1' HG13 ' A' ' 19' ' ' VAL . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 76' ' ' LEU . 3.4 mt . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.575 ' C ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.899 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.457 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.0 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.617 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.624 ' CD ' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.765 HG13 ' HD1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.884 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.616 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.946 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 22.9 mt-30 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.635 ' HD2' HG21 ' A' ' 97' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.908 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.944 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.765 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 76' ' ' LEU . 4.7 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 68' ' ' GLN . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.946 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.529 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.889 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.995 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.677 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.496 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 46' ' ' GLN . 4.1 t80 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.685 0.279 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.447 ' N ' HG12 ' A' ' 97' ' ' VAL . 65.5 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.602 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.862 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.78 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.87 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.652 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.931 HG23 HD11 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.0 mm . . . . . 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' HA ' HG23 ' A' ' 97' ' ' VAL . 29.9 mt-30 . . . . . 0 C--O 1.227 -0.112 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.626 ' HD2' HG21 ' A' ' 97' ' ' VAL . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.935 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.78 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.671 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.931 HD11 HG23 ' A' ' 35' ' ' VAL . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.531 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.993 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.862 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.69 0.281 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG13 ' CB ' ' A' ' 84' ' ' VAL . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' THR . 71.8 m-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mmm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.559 0.219 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.01 -161.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.709 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -166.29 27.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -52.04 1.12 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.334 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.449 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -76.25 162.37 27.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.028 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 60.46 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.639 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -133.02 -71.2 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.724 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.866 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.79 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.868 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.668 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.675 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.595 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.94 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 HD11 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.4 mm -87.44 113.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 38' ' ' THR . 7.1 m -145.89 17.56 1.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.335 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.638 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -55.17 -158.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.181 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.88 -85.76 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.528 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.52 -159.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.32 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.759 0.314 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.3 m -77.68 -70.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.51 133.32 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.259 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -148.92 6.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.638 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 2.3 mt-30 -114.37 -77.77 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.642 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.927 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.94 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.06 -23.67 41.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.5 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.707 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.21 -66.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.231 0.539 . . . . 0.0 111.605 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.19 84.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.561 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.5 134.72 15.11 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.38 40.13 41.03 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.94 108.65 7.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.302 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.49 146.36 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG23 ' HD3' ' A' ' 64' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 35' ' ' VAL . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.547 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.93 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.998 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.998 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.724 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.439 ' CA ' HD11 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.604 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 88.8 m -147.57 89.52 1.78 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 45.4 mt-10 -98.1 162.65 13.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.003 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.87 -129.96 2.2 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.623 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.87 -53.31 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.983 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.65 -18.71 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 151.22 11.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.677 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 22.2 p -59.94 91.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.048 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -91.11 140.92 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.691 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 -123.82 136.53 54.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -139.34 128.58 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.38 167.58 13.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.261 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 14.4 Cg_endo -57.31 -42.12 65.74 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.447 2.098 . . . . 0.0 112.721 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -28.73 68.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.74 -68.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.2 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.9 p -57.35 -44.42 84.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.042 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t 60.52 -173.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 m -113.88 136.74 52.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.6 p -113.65 -40.5 3.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 15.05 11.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.649 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m 58.74 92.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.56 75.85 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.445 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.2 m 60.68 157.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.786 0.327 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.11 116.1 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -147.45 -80.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -162.35 -161.77 0.76 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 113' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.506 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' HD13 ' A' ' 2' ' ' ILE . 1.6 mmt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.59 -162.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.72 14.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.475 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -131.55 -50.32 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.142 0.496 . . . . 0.0 110.408 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.422 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -156.08 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.993 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.767 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -165.27 -27.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.676 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -144.64 -72.08 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.748 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.717 HG13 ' HD1' ' A' ' 51' ' ' PHE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.869 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 24' ' ' SER . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.673 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.645 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.606 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 75' ' ' SER . 11.7 mm -82.68 119.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 m -158.94 37.45 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.069 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -62.39 -142.35 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.713 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 25.86 21.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.644 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.08 -76.0 2.0 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.2 p -75.48 -29.31 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -116.73 -168.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.57 101.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.13 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -142.27 3.06 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 75.5 mt-30 -116.56 -73.34 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.696 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.668 ' HD2' HG21 ' A' ' 97' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.879 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.911 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.717 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.3 -24.57 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.49 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.39 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.18 -67.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.723 0.773 . . . . 0.0 111.633 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.8 m120 84.59 84.74 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.811 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.85 133.12 18.03 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 78.87 38.97 21.99 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -138.36 110.31 7.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 76' ' ' LEU . 2.9 mt -62.52 156.5 22.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.133 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CD1' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.712 HG12 ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.552 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.937 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.996 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.996 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.748 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.425 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 96.6 m -148.79 89.64 1.7 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 30.6 mt-10 -99.79 164.95 11.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.77 -110.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.277 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.33 88.3 4.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.528 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.19 25.7 9.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.712 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.35 38.69 2.16 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 2.9 p -59.79 89.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.435 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -89.5 158.23 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.265 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.0 t80 -136.48 137.64 40.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -140.48 132.48 27.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -148.81 167.51 12.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.195 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 11.2 Cg_endo -55.29 -49.07 17.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.455 2.103 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -42.39 93.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 111.071 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.16 60.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.26 56.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -90.13 53.46 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 58.63 1.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.791 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.95 22.3 16.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 3.44 47.75 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.002 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.8 m 59.03 -170.58 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.46 174.33 31.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.9 p -120.19 -168.17 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.28 172.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 59.91 -169.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.4 p -76.36 -165.3 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.442 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.476 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.58 -161.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -107.66 -48.75 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.815 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.78 -45.27 94.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.462 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mmt 52.78 173.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.819 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . -179.21 91.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.176 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t -94.26 -60.3 0.19 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.676 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.699 ' N ' HD13 ' A' ' 33' ' ' LEU . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 75' ' ' SER . 13.7 mm -84.91 118.05 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -158.72 37.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -62.69 -143.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.644 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.62 -77.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.687 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.74 139.35 5.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.52 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m 54.45 24.76 5.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB2' ' HB1' ' A' ' 102' ' ' ALA . 13.2 p -177.24 -160.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.2 108.34 0.35 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.007 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -139.07 1.48 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 16.8 mt-30 -111.12 -72.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.4 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.517 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.848 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.918 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.748 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.01 -23.63 48.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.36 -99.51 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.491 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.55 -67.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.281 0.562 . . . . 0.0 111.182 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' HG3' ' A' ' 34' ' ' ARG . 2.7 m120 83.84 83.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.766 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.47 133.66 16.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.811 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.35 37.99 30.21 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 120.249 -0.976 . . . . 0.0 111.114 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 70' ' ' VAL . 15.1 t0 -131.88 105.72 7.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.525 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.6 mt -59.27 139.22 57.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.88 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.985 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.475 HG22 ' HD3' ' A' ' 94' ' ' ARG . 88.0 m -142.6 89.49 2.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 24.4 mt-10 -105.49 162.89 13.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.1 -76.2 0.33 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.042 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 4.1 tp -50.64 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 5.3 mt-10 -75.72 -4.85 42.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.992 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.77 -79.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.115 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 86.9 p -150.36 89.94 1.62 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.805 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HD3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -87.1 139.27 30.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -134.88 130.33 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' HG12 ' A' ' 97' ' ' VAL . 68.8 m-20 -143.54 159.47 42.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 102' ' ' ALA . 1.0 OUTLIER -178.77 160.62 1.07 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 103' ' ' THR . 59.4 Cg_endo -72.43 -41.56 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.661 2.241 . . . . 0.0 112.813 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -58.98 -25.34 63.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.618 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 43' ' ' SER . . . -118.76 45.98 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.423 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 100' ' ' PRO . 5.1 p -148.57 74.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.775 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -148.74 152.86 37.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 81.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.4 t -111.75 94.44 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.09 17.33 37.99 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -176.77 95.66 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.52 -137.98 4.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.76 119.32 31.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.78 160.1 16.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 60.23 -171.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.969 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.2 m -132.33 160.33 36.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.526 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.907 0.384 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -100.15 -162.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -132.75 -23.43 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.473 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -77.56 -45.2 26.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.012 0.434 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.537 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 56.15 -171.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.023 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 73.8 66.61 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 110.101 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -84.6 -65.55 0.21 Allowed Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.751 -178.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.595 ' N ' HD12 ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.932 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.719 HG22 HD23 ' A' ' 33' ' ' LEU . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' CB ' HD22 ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.64 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.581 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.662 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.893 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.618 HG22 ' CE1' ' A' ' 49' ' ' PHE . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.6 mm -89.62 109.68 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 m -124.32 -33.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.25 -147.65 22.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.509 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.08 -70.99 0.3 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.582 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.98 -85.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.884 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 40' ' ' GLY . 3.8 t -119.35 9.39 11.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.65 0.262 . . . . 0.0 110.711 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.26 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.049 0.452 . . . . 0.0 110.822 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 165.14 115.94 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.726 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -144.64 1.31 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 20.3 mt-30 -110.03 -79.42 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.371 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HD2' HG21 ' A' ' 97' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.887 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.627 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -54.26 -95.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.827 -178.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 7.2 p 168.89 -20.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 5.4 m120 47.13 91.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.477 0.656 . . . . 0.0 110.072 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.315 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.25 53.72 4.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.257 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 56' ' ' ASN . 9.6 t70 -146.81 113.68 6.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.192 0.197 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.2 mt -62.54 160.73 13.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.893 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.484 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.916 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.971 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.0 mp0 -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.463 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.499 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 88.5 m -149.81 89.62 1.63 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -96.78 163.49 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.258 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.12 -36.15 4.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.936 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.35 104.2 16.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.512 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.38 12.46 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.457 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.42 156.56 15.3 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.975 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 40.8 t -59.59 98.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.628 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.33 153.78 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.781 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 6.3 t80 -136.12 132.32 35.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 97' ' ' VAL . 16.6 m-80 -149.57 128.77 12.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -142.91 168.1 14.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.6 Cg_endo -54.44 -60.5 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.497 2.132 . . . . 0.0 112.74 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.666 ' O ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -55.7 -30.85 61.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.218 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 99' ' ' ASN . . . -54.54 -32.3 57.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 101' ' ' ASN . 30.6 p 53.18 100.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 111.1 17.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -131.78 -174.98 3.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 105' ' ' THR . 55.8 m -106.89 106.91 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.45 -18.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 164.49 26.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.65 114.5 4.42 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -154.1 79.61 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -131.45 149.5 52.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -129.33 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.975 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.1 m -135.39 160.97 36.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.303 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' C ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.4 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.69 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.11 9.19 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.54 -41.88 3.2 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.794 ' CE ' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -103.19 -164.27 1.06 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.392 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.794 ' HB2' ' CE ' ' A' ' 5' ' ' MET . . . 69.33 46.21 0.79 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.277 0.561 . . . . 0.0 110.158 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -55.49 -67.75 0.66 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.263 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.857 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.803 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.915 ' HD2' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.915 HG23 ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.881 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CB ' HD22 ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.665 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.616 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG23 HD11 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.9 mm -84.68 116.81 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -152.67 33.24 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.884 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -60.89 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.82 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.9 28.55 9.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.713 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.43 -96.16 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 36.4 m -73.41 -29.43 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 105' ' ' THR . 6.0 m -96.18 -167.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -155.49 93.86 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.286 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.6 p90 -133.28 -2.91 3.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 56.6 mt-30 -109.14 -74.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.895 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.79 -14.25 56.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.01 -107.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.29 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.9 t -162.49 -55.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.4 m120 65.73 72.77 0.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -46.53 -28.83 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.893 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.59 48.7 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -153.73 112.57 3.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.377 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -58.81 149.26 27.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.734 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.713 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 70' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.927 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.538 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.903 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.962 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.706 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.483 ' CA ' HD11 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 85.1 m -150.36 89.55 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.0 pp20? -99.01 163.54 12.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.074 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.36 -111.52 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.737 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.77 -53.9 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 110.83 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -56.97 -22.34 37.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.943 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.53 148.63 8.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.345 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.531 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 42.1 p -59.61 103.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.318 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.85 179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 -122.78 128.87 51.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.269 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 97' ' ' VAL . 34.3 m-20 -147.8 127.65 13.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' ND2' ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -143.22 166.93 17.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.363 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 18.6 Cg_endo -60.43 -47.98 12.71 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.47 2.113 . . . . 0.0 112.782 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -71.67 -13.3 61.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.99 35.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 99' ' ' ASN . 73.7 p -124.1 134.87 53.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m 59.8 100.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.442 HG21 ' OG ' ' A' ' 43' ' ' SER . 3.7 m -153.52 77.48 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 8.0 p -147.49 38.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.769 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.43 -32.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.849 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.63 84.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.086 0.443 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.73 110.87 0.66 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.8 168.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 82.5 p -130.19 -170.95 2.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 60.67 -172.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.8 p -100.96 161.45 13.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.601 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' C ' HD13 ' A' ' 2' ' ' ILE . 3.3 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.25 -162.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.234 0.54 . . . . 0.0 110.851 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.08 -56.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.578 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.65 -67.68 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 5' ' ' MET . 23.3 mmt -82.01 -176.3 6.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.81 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 61.07 37.93 17.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -42.14 -77.34 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.663 ' N ' HD12 ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.979 ' HB2' HG22 ' A' ' 84' ' ' VAL . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.915 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.763 HG13 ' HD1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.661 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' CB ' HD22 ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.653 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.2 mm -88.15 117.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 15.2 m -115.84 -50.03 2.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.355 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 43' ' ' SER . . . -71.83 -114.53 0.05 OUTLIER Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.781 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.585 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . 80.29 97.16 0.35 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.415 -0.392 . . . . 0.0 113.431 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 102.68 0.87 Allowed Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.68 20.49 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.842 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 7.8 p -173.53 -3.13 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.323 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.585 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . -59.66 68.19 0.01 OUTLIER Glycine 0 C--N 1.349 1.28 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.19 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.842 ' CZ ' ' HA ' ' A' ' 43' ' ' SER . 1.3 p90 179.23 16.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 -106.69 -72.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.998 -0.439 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.654 ' CD2' HG21 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.92 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.763 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.77 -21.04 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.49 -100.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.872 0.306 . . . . 0.0 111.153 -178.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.86 -66.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 111.703 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 86.18 84.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.243 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.51 135.59 14.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.04 40.41 51.27 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.304 -0.95 . . . . 0.0 110.863 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.38 108.11 7.99 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.942 0.436 . . . . 0.0 110.56 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 76' ' ' LEU . 2.5 mt -60.12 144.18 50.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.549 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.863 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.662 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.9 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.53 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.979 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 95.2 m -145.51 89.45 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -81.52 172.38 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.79 -46.94 1.1 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mp -85.72 105.89 16.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 67.41 12.44 8.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.54 -94.81 0.6 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.353 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 91.8 p -150.37 93.64 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.383 0.273 . . . . 0.0 110.911 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.4 147.41 26.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 110.384 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 -136.53 129.05 30.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.415 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.824 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.618 ' H ' HG12 ' A' ' 97' ' ' VAL . 63.9 m-80 -138.01 133.99 34.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.812 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 18.1 p30 -175.84 175.91 0.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.337 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.812 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 40.1 Cg_endo -72.38 -37.69 4.16 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.067 1.845 . . . . 0.0 112.41 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -18.09 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.413 ' HB1' ' HD2' ' A' ' 45' ' ' PHE . . . -78.11 9.7 3.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 61.09 94.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.46 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 p -100.79 -79.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.7 t -178.31 38.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.4 -14.01 77.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t 61.58 79.64 0.25 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.46 -160.6 13.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.07 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.729 0.299 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.5 p -125.82 154.07 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -71.41 -171.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -125.19 160.42 29.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.659 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.705 0.288 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.689 HG21 ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -95.09 -161.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.23 -30.76 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.798 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -103.06 -49.38 3.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.689 ' HE3' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -128.15 -156.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.74 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.861 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -172.61 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.749 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -131.81 -78.51 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.863 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.749 HG13 ' HD1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.86 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.649 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.571 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.572 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 75' ' ' SER . 9.3 mm -77.84 118.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' THR . 11.2 m -158.75 40.08 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.762 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.35 -140.89 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.79 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.62 27.33 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.52 -73.6 2.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.329 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.6 m -68.72 -29.19 67.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 t -130.59 179.87 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.63 104.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.276 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.2 p90 -145.37 3.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' A' ' 97' ' ' VAL . 42.1 mt-30 -117.12 -72.18 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.852 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' CG ' ' A' ' 54' ' ' LYS . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.02 -26.4 59.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -51.6 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.035 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.7 p 169.46 -19.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 5.2 m120 60.09 83.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.531 0.205 . . . . 0.0 110.705 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -49.93 125.61 12.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.39 40.17 10.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.323 -0.942 . . . . 0.0 110.945 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -143.75 115.46 8.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.8 mt -59.53 158.68 9.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.593 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.572 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.973 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 59' ' ' ASP . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.556 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.982 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 88.5 m -150.12 89.48 1.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 1.2 pm0 -99.24 162.75 12.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.66 -109.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.431 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.69 -54.13 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.66 -23.03 38.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.46 148.4 7.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.415 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.516 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 89.1 p -59.61 91.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.366 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.02 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 -123.49 129.26 50.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.17 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 ' HD2' ' A' ' 47' ' ' TYR . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -136.92 128.81 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.501 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.98 168.77 10.46 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.197 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.8 Cg_endo -54.7 -57.27 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.069 . . . . 0.0 112.566 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -60.24 -22.79 63.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 99' ' ' ASN . . . -81.72 9.93 7.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 p 50.25 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.427 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 m -80.41 126.77 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 175.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.71 123.34 17.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.43 17.48 3.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.631 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 56.9 m -115.65 31.47 6.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.3 -117.51 5.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.428 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.25 170.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.873 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.61 173.67 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.98 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 77.1 p -111.92 162.55 15.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.606 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.548 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mmm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.792 0.33 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.863 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 1.8 t70 89.86 -9.56 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.218 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.89 -42.99 4.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.233 0.54 . . . . 0.0 110.017 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.0 -151.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.908 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.809 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -166.32 -33.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.45 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -136.97 -77.11 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.608 ' N ' HD12 ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.832 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.822 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.774 HG13 ' HD1' ' A' ' 51' ' ' PHE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.402 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.866 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' CB ' HD22 ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.943 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.77 ' N ' HD13 ' A' ' 33' ' ' LEU . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD13 ' HD1' ' A' ' 47' ' ' TYR . 18.6 mm -87.35 110.73 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.2 m -127.45 -33.31 2.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.944 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.37 168.3 12.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.677 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . 127.34 -56.99 0.71 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.004 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 -59.86 2.58 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.652 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -120.51 -6.18 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.488 0.185 . . . . 0.0 111.171 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.2 m -148.93 -83.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.342 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA2' ' HA3' ' A' ' 40' ' ' GLY . . . 145.89 117.23 1.06 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.626 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLN . 2.7 p90 -142.86 -1.79 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.457 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 11.9 mt-30 -113.55 -73.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.175 -0.328 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HD2' HG21 ' A' ' 97' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.943 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.774 ' HD1' HG13 ' A' ' 19' ' ' VAL . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.01 -28.45 60.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.65 -96.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.09 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.1 p 167.76 -19.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 56' ' ' ASN . 2.0 m-80 48.71 92.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -46.97 -44.16 19.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.0 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.07 53.66 4.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.35 -0.929 . . . . 0.0 110.964 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.33 114.12 2.7 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 122.457 0.303 . . . . 0.0 110.445 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 HD12 ' A' ' 76' ' ' LEU . 5.2 mt -59.06 151.57 22.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.809 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.869 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.517 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.894 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.003 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 1.003 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.475 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.832 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 92.2 m -150.29 89.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 7.3 pt-20 -103.14 165.22 11.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.673 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.71 -111.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.72 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.52 -68.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.779 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -59.25 -19.84 49.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.972 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.09 157.03 22.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.168 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.546 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 7.9 t -59.6 89.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.049 0.452 . . . . 0.0 110.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -104.26 133.71 48.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 -112.56 132.85 54.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.322 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.449 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.5 m-80 -149.25 158.31 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 4.1 p30 -175.59 166.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.543 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 9.2 Cg_endo -53.41 -35.22 74.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.786 2.324 . . . . 0.0 113.05 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -77.81 -31.52 51.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.346 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' ' OD1' ' A' ' 99' ' ' ASN . . . -92.75 46.94 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.287 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p -99.9 71.79 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -93.19 -47.79 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.038 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -121.37 128.21 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.2 p -118.38 30.38 7.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.13 17.18 6.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.618 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.39 136.25 34.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.855 0.359 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.56 -71.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.66 102.42 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -145.11 116.79 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 60.42 -171.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.2 m -142.26 160.19 40.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.494 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.555 0.217 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.71 -160.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 110.681 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -169.48 -38.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.186 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.43 -49.76 76.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 2.8 mmt 48.51 -173.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.178 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 74.65 72.82 0.1 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.418 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -87.56 -64.98 0.2 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.223 -179.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.612 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.895 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 33' ' ' LEU . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.864 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.697 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.544 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.895 HD12 HD13 ' A' ' 69' ' ' LEU . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm -87.82 113.23 24.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 38' ' ' THR . 15.9 m -150.55 32.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.249 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.83 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.076 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.88 65.19 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.573 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . 162.38 51.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 5.0 m 66.62 -64.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.723 0.297 . . . . 0.0 111.282 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLY . 1.0 OUTLIER -71.94 -66.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.149 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.78 135.72 4.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.144 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -146.62 3.02 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 42.7 mt-30 -109.14 -73.11 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.455 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.852 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.877 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.64 -21.05 45.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.58 -101.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.588 -178.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -163.48 -62.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.046 0.45 . . . . 0.0 112.151 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 1.2 m120 71.39 72.52 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -47.01 -29.6 2.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.606 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.47 47.66 1.73 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -150.99 111.53 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 HD12 ' A' ' 76' ' ' LEU . 3.8 mt -59.2 147.09 36.73 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.871 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.876 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.62 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.411 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 98.7 m -148.1 89.86 1.77 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 28.8 mt-10 -51.23 159.36 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.457 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.48 27.67 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.327 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.15 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.303 . . . . 0.0 111.177 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -59.23 -23.25 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 109.64 0.26 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.396 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 16.2 m -60.0 122.33 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.091 0.472 . . . . 0.0 111.18 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -82.46 144.41 30.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.883 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 -132.35 133.64 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.8 m-20 -145.2 158.21 43.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.532 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.7 p30 -178.87 164.1 1.04 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 19.2 Cg_endo -60.35 -40.54 57.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.639 2.226 . . . . 0.0 112.594 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -35.92 77.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . . . -95.92 37.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -151.15 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.18 123.86 33.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.818 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -149.54 129.95 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 2.6 t -170.91 34.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.96 11.61 3.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.76 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 56.02 30.29 15.94 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.735 0.303 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.04 -88.54 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.23 -57.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.78 168.86 25.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 60.52 -173.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.6 p -109.57 162.38 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.535 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.602 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -92.13 -161.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.44 31.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.65 -47.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.373 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.432 ' HE1' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -113.6 161.55 17.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.003 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.46 88.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.437 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.75 -69.0 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.859 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.745 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.806 HG13 ' HD1' ' A' ' 51' ' ' PHE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.858 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 24' ' ' SER . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.681 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.683 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.683 HD23 ' CG ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG23 HD11 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm -85.89 116.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 38' ' ' THR . 6.4 m -156.67 34.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.858 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.84 -145.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.709 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.87 24.68 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.729 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.76 -79.1 1.88 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.6 m -63.64 -30.11 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.2 m -127.1 -172.08 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' C ' ' HH ' ' A' ' 47' ' ' TYR . . . -140.24 97.92 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.281 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.2 p90 -138.8 1.9 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 -113.07 -72.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.596 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HD2' HG21 ' A' ' 97' ' ' VAL . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.919 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.897 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.806 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.4 -19.81 49.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.667 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.04 -103.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.737 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.0 p 163.94 42.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.33 0.394 . . . . 0.0 111.712 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -17.89 95.41 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.798 0.439 . . . . 0.0 111.518 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.08 125.78 9.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.186 0.517 . . . . 0.0 110.304 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.89 36.42 6.06 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 56' ' ' ASN . 25.6 p-10 -134.46 109.19 8.57 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.835 0.454 . . . . 0.0 110.329 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.29 131.05 49.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HG2' HG22 ' A' ' 67' ' ' VAL . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 20' ' ' LYS . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' N ' ' A' ' 68' ' ' GLN . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.888 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.664 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.535 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.925 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 13.0 mp0 -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.925 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.565 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' A' ' 94' ' ' ARG . 96.4 m -149.78 89.54 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 2.5 pp20? -105.38 163.8 12.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.245 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.05 -104.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.345 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -102.19 -48.35 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.39 -20.69 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.89 146.09 7.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.412 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 48.9 p -59.65 96.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HD3' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 139.15 31.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.964 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 -124.49 125.35 44.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 97' ' ' VAL . 31.7 m-80 -148.62 132.25 16.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -148.63 166.67 14.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.166 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 18.9 Cg_endo -60.42 -53.14 3.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.535 2.157 . . . . 0.0 112.941 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.78 -28.45 65.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.32 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.8 -83.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 111.054 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.0 29.85 1.14 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.258 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' THR . 19.6 t -127.94 170.04 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 104' ' ' SER . 0.6 OUTLIER -162.63 116.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.71 -61.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.39 42.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.673 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t 59.85 31.11 20.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.789 0.328 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.3 66.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -103.06 -41.29 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.24 161.26 14.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -107.25 -171.81 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.16 160.63 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.606 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.537 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' C ' HD13 ' A' ' 2' ' ' ILE . 10.7 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.51 -163.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.669 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 80.81 13.86 0.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -112.85 -41.17 3.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 161.47 24.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.512 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 48.94 49.65 18.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.295 0.569 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.26 -70.6 0.19 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.795 -178.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.823 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.769 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.879 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.672 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' CB ' HD22 ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.623 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.925 HG23 HD11 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.5 mm -87.65 108.47 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -122.37 -36.2 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.06 -147.97 23.06 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.554 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.47 -70.28 0.31 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.533 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.55 -84.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.902 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' GLY . 85.1 m -121.79 11.93 10.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 171.44 -63.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.011 0.434 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.554 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 157.99 115.6 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.774 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -142.45 0.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.439 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 23.9 mt-30 -109.3 -78.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.102 -0.374 . . . . 0.0 111.591 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 97' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.962 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.769 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.02 -13.68 58.61 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -68.99 -107.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -163.84 -60.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.215 0.531 . . . . 0.0 111.352 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 5.1 m120 82.47 83.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -48.77 131.94 18.04 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.28 37.6 24.12 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.39 110.77 8.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.364 -0.418 . . . . 0.0 109.9 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt -60.97 152.15 28.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.937 HD13 HD12 ' A' ' 33' ' ' LEU . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.913 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.56 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.935 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.0 mp0 -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.49 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 84.8 m -150.1 89.84 1.63 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.2 pm0 -101.37 163.23 12.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.0 117.46 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.854 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.44 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.273 . . . . 0.0 111.31 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.11 -24.41 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 111.256 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.64 144.52 8.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.318 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 35.1 p -59.85 103.34 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.479 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -105.89 160.01 15.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.07 179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 -133.54 134.76 43.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.56 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' H ' HG12 ' A' ' 97' ' ' VAL . 22.5 m-80 -150.46 131.14 14.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -140.33 167.64 17.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.762 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 38.2 Cg_endo -66.81 -44.39 5.73 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.49 2.126 . . . . 0.0 112.705 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.854 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.72 -33.04 46.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.261 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.6 p -92.08 148.98 21.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.726 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.68 -42.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 74.56 -63.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.7 p -137.41 34.62 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.28 18.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.676 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -49.2 5.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.31 109.13 1.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.33 118.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.996 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.8 p -132.64 149.54 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 60.12 -170.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.1 p -68.29 -164.94 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.449 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.589 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.34 -161.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER 83.5 16.31 0.28 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.73 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -109.12 -41.34 4.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.469 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.583 ' O ' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -131.94 161.44 33.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.14 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.639 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.63 91.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -128.85 -71.79 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.631 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.861 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.734 HG13 ' HD1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.854 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' CB ' HD22 ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.706 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.818 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 75' ' ' SER . 25.2 mm -91.65 108.42 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -118.94 -38.01 3.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.407 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 44.18 -168.92 0.02 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.276 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.71 21.52 42.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.32 2.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.288 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -108.11 -29.64 8.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.48 -164.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.55 95.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.3 p90 -138.91 1.1 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 -109.44 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.423 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.634 ' HD2' HG21 ' A' ' 97' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.929 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.734 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -72.03 -17.7 62.01 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.36 -100.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.5 p 161.95 -19.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 5.5 m120 48.69 90.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -52.99 14.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.8 52.9 4.76 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.227 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 9.4 t70 -147.41 114.51 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.95 136.94 58.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.567 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.818 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.903 HD11 HG23 ' A' ' 35' ' ' VAL . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.67 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.507 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.99 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.685 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 90.5 m -148.84 89.48 1.68 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 51.4 mt-10 -89.51 164.34 14.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.92 -140.87 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.608 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.14 -48.97 25.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -57.92 -21.52 44.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.859 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.59 154.15 9.83 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.385 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 77.9 p -59.66 89.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.833 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.28 138.21 32.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.08 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 -128.5 130.99 48.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.634 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.4 m-20 -134.08 152.77 51.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.522 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 1.0 OUTLIER 176.7 167.4 0.44 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.366 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 3.6 Cg_endo -47.4 -35.8 22.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.822 2.348 . . . . 0.0 112.996 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -47.36 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.65 0.262 . . . . 0.0 111.129 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.62 -75.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.273 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 99' ' ' ASN . 3.3 p 49.76 41.18 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.054 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -74.93 -44.44 48.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.971 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.6 p 56.74 -168.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.02 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.3 m -96.01 41.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.48 16.82 63.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.3 p -115.15 177.46 4.65 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.16 -77.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 112' ' ' PHE . 78.4 p -98.83 32.24 2.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.6 m -103.57 41.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.107 0.48 . . . . 0.0 110.83 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 110' ' ' SER . 47.2 m-85 -67.45 -170.94 0.15 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -145.98 160.36 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.513 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.843 0.354 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.89 -161.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -36.15 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -43.49 -42.25 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.224 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 21.7 mmt -46.48 172.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.831 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 73.96 68.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.876 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -88.15 -67.32 0.15 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.848 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HD1' ' A' ' 51' ' ' PHE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.86 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 24' ' ' SER . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.588 ' CB ' HD22 ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.658 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.773 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 75' ' ' SER . 24.4 mm -91.75 110.04 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -122.22 -36.35 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.87 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 41.94 -159.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.032 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.08 -82.71 0.14 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.634 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.38 33.48 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.627 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.97 -46.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.743 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -175.0 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . -179.64 89.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.364 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 97' ' ' VAL . 10.0 p90 -120.51 -4.08 9.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 -106.48 -64.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.592 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.547 ' HD1' HG21 ' A' ' 97' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.922 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.42 -20.94 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -55.06 -100.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.306 -0.246 . . . . 0.0 111.343 -178.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -164.37 -63.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 111.47 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 1.0 OUTLIER 69.83 72.01 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.88 -30.83 2.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.542 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.34 47.89 1.93 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -150.28 110.6 4.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.753 HD11 HD12 ' A' ' 76' ' ' LEU . 4.4 mt -59.3 150.25 26.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.729 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.855 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.51 ' O ' ' CD1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.687 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.479 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m -150.35 89.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 0.8 OUTLIER -99.59 163.72 12.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.125 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.48 108.33 0.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.879 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 63.14 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.429 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -50.71 -25.34 4.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.304 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.59 143.86 8.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 92.7 p -59.78 90.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.04 143.76 27.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.761 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.66 133.34 53.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 ' HD1' ' A' ' 47' ' ' TYR . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.0 m-20 -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.656 ' OD1' ' HB3' ' A' ' 102' ' ' ALA . 3.1 p30 174.32 163.77 0.34 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.585 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 23.4 Cg_endo -61.93 -41.28 38.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.925 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -38.36 83.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.096 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . . . -95.98 -73.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.283 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.4 p -79.49 141.97 36.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -148.68 -60.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -137.32 109.9 7.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.9 m -139.68 93.51 2.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.97 17.65 13.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.596 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.68 -31.55 11.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.66 65.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -111.83 33.28 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.04 154.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -102.84 -171.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -141.23 160.58 39.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.65 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.465 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.791 0.329 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -95.69 -159.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.003 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 2.4 t0 87.81 8.35 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.891 0.476 . . . . 0.0 111.094 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -109.36 -43.37 4.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -142.14 160.96 39.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.428 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.22 80.24 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -104.81 -69.2 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.221 -178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.577 ' N ' HD12 ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.858 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.705 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.705 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.869 HG23 HD11 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.6 mm -92.38 117.43 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 3.3 m -128.85 -45.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 38.24 -162.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.949 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 -80.54 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.334 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.23 -42.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.363 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.4 m -85.15 81.16 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 100' ' ' PRO . 0.5 OUTLIER 63.43 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.43 122.68 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.7 p90 -143.49 6.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 -113.31 -73.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.592 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HD2' HG21 ' A' ' 97' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.89 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.778 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.16 -22.48 48.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.1 -100.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.776 -179.03 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.11 -65.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 111.53 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 85.28 84.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.338 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.77 135.76 14.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.117 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.16 40.61 49.8 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -133.99 110.25 9.55 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 122.734 0.414 . . . . 0.0 110.062 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.2 mt -59.73 139.36 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.581 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' H ' ' A' ' 67' ' ' VAL . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.907 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.58 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.984 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.762 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' ASN . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.5 m -148.17 89.36 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 33.5 mt-10 -90.03 164.87 14.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.957 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.06 -147.53 15.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.667 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.39 -54.13 50.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.038 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.75 -17.76 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.61 157.71 18.88 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.535 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 73.6 p -59.66 89.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.51 144.56 27.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.502 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 -132.4 126.67 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.762 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 -122.19 162.39 21.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.652 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 72.51 104.58 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 99' ' ' ASN . 12.9 Cg_endo -58.02 -33.7 97.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.878 1.719 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.832 ' CA ' HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER 175.05 30.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.634 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 61.24 82.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -153.94 139.96 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.5 p -58.17 146.82 32.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -134.34 143.76 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.94 89.83 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.01 -15.33 16.59 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.74 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 93.6 m 63.12 -79.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.774 0.321 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.34 170.83 33.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.2 m -114.85 82.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.73 95.32 4.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.759 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 60.15 -168.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -88.78 -165.92 1.46 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.464 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.472 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.39 -162.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.6 -62.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.722 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -78.95 -54.93 5.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.0 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.515 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 26.0 mmt -71.65 175.41 5.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.978 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 65.63 60.42 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.627 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.13 -68.65 0.23 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.487 -178.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.849 ' HA ' HG13 ' A' ' 84' ' ' VAL . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HD23 ' A' ' 33' ' ' LEU . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.85 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.662 ' N ' HD12 ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.657 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.597 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.715 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.824 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.7 mm -88.94 111.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 38' ' ' THR . 20.2 m -145.18 28.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.462 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -162.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.146 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.06 -58.69 5.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.843 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.8 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.62 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 110.307 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.13 -149.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.79 107.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.584 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.9 p90 -138.9 -3.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 42.8 mt-30 -108.84 -75.27 0.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 37' ' ' ILE . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.904 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -73.46 -28.56 62.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.639 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -52.51 -93.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.017 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 11.3 p 163.27 -20.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 2.0 m-80 48.29 91.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -46.97 -45.99 21.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.382 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 55.3 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.209 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.44 116.65 3.95 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.639 0.258 . . . . 0.0 110.748 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mt -59.03 163.2 3.7 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.576 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.639 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.72 HG13 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.464 ' CG ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.934 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 12.0 mp0 -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.711 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.6 m -150.18 89.88 1.62 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -92.85 165.16 13.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.37 164.42 35.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.1 mp 64.82 -73.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.642 0.258 . . . . 0.0 111.241 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.49 -24.85 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.181 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.12 161.49 10.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.372 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 28.8 t -61.91 90.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 0.0 111.103 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.08 152.5 20.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.047 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -129.62 134.87 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.356 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 -134.08 153.66 51.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.687 ' OD1' ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 178.67 164.55 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.54 -49.89 7.97 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.619 2.212 . . . . 0.0 112.71 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.655 ' O ' HG23 ' A' ' 103' ' ' THR . 3.3 p-10 -55.67 -37.37 68.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.687 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -54.69 -25.78 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.461 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 101' ' ' ASN . 44.1 p 51.53 35.51 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.087 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -172.67 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.3 p -136.43 87.08 2.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 84.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -106.03 9.63 43.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.78 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.0 -171.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.864 0.364 . . . . 0.0 110.959 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.71 105.47 0.5 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 124.95 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.9 m -140.42 137.67 34.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 8.2 m-85 -124.66 -171.24 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.5 m -138.87 160.73 39.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.56 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.807 0.337 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.93 -162.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 6.5 t0 88.35 -45.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 69.8 m-20 -76.08 -41.96 48.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.438 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.477 ' HE2' ' HA ' ' A' ' 5' ' ' MET . 10.5 mmt -58.31 164.36 2.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 57.85 48.02 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.25 -71.52 0.18 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.114 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.641 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HD2' ' HB3' ' A' ' 15' ' ' ALA . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.878 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.816 HG13 ' HD1' ' A' ' 51' ' ' PHE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.844 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.631 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.685 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.917 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.471 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 75' ' ' SER . 20.7 mm -89.95 108.73 19.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 m -124.91 -32.42 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.793 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -109.07 179.87 21.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.613 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 110.84 76.71 0.86 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.324 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.44 -22.31 56.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.426 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.99 -36.54 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.716 0.293 . . . . 0.0 110.762 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.16 -75.77 0.54 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.366 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 157.27 125.12 0.84 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.269 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.58 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.8 p90 -145.56 2.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' CZ ' ' A' ' 45' ' ' PHE . 61.7 mt-30 -117.23 -74.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.444 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.705 ' HD2' HG21 ' A' ' 97' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.917 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.896 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -83.22 -22.4 33.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -48.36 -93.4 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.582 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 8.6 p 166.87 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 1.8 m-80 36.17 95.75 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.969 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.24 -41.76 13.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.704 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.05 61.22 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.616 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.4 p-10 -140.09 111.33 7.09 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 112.189 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 HD12 ' A' ' 76' ' ' LEU . 3.0 mt -69.19 125.07 25.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.651 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.843 ' HD3' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG23 ' HD3' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.556 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.817 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.529 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.431 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.611 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 92.0 m -149.52 89.59 1.65 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 1.2 mt-10 -93.65 163.47 13.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.93 -132.71 2.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.44 -53.78 6.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.74 -18.37 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.726 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 153.7 11.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 54.3 p -59.85 89.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.973 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.41 139.33 31.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.688 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -125.93 131.35 52.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 -136.98 156.85 47.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -179.96 166.42 0.81 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 16.3 Cg_endo -57.65 -46.7 25.28 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.653 2.235 . . . . 0.0 112.556 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -37.81 76.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -64.18 -63.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.1 p -124.16 -74.9 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.058 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.9 p -159.19 163.99 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.69 170.17 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.0 t -175.08 140.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.69 -16.01 2.22 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.655 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.87 -178.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 111.032 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.12 -58.15 5.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -135.72 -175.74 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.02 112.59 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 110' ' ' SER . 42.5 m-85 -118.01 -170.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.8 m -146.02 160.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.743 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.52 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.639 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -118.97 -171.05 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.737 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.84 -41.67 0.21 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.891 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.95 -46.82 22.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -116.68 -146.03 0.4 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.662 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -158.31 -36.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -137.65 -78.47 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.877 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.792 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' A' ' 51' ' ' PHE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.677 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.538 ' CB ' HD22 ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.658 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 50' ' ' THR . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.3 mm -89.53 110.69 22.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.1 m -126.42 -30.29 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.934 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.768 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -125.27 -176.96 14.71 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.068 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 132.58 -64.24 0.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.36 -66.07 0.39 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.691 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.6 m -105.72 -24.08 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 70.1 m -149.91 -90.72 0.07 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.031 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 172.68 119.92 0.54 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.7 p90 -148.66 1.36 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.768 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 14.1 mt-30 -112.24 -79.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.932 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HD2' HG21 ' A' ' 97' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.907 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.725 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.29 -23.53 40.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -55.54 -99.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.3 -178.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.84 -67.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.242 0.544 . . . . 0.0 111.571 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.5 m120 84.98 83.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.839 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -48.47 135.76 13.7 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.846 0.355 . . . . 0.0 110.378 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 72.12 39.34 58.45 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.914 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.04 106.48 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.291 0.236 . . . . 0.0 110.518 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt -60.03 149.76 31.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 35' ' ' VAL . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.524 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.519 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.911 ' O ' HD13 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.968 ' N ' HD23 ' A' ' 76' ' ' LEU . 15.4 mp0 -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.886 HD11 ' CA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ASN . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.877 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 89.5 m -150.38 89.66 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 6.8 pm0 -99.12 162.57 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.051 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.68 -79.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.75 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 21.0 tp -49.14 -96.92 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 4.9 mm-40 -75.69 -18.22 59.69 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.173 -0.329 . . . . 0.0 111.299 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.22 164.96 10.11 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.271 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.508 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 79.0 p -59.89 89.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.872 0.368 . . . . 0.0 111.495 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -93.35 164.53 13.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 -137.8 133.69 34.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HD2' ' A' ' 47' ' ' TYR . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.4 m-80 -122.75 172.17 8.63 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 66.57 106.62 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 43' ' ' SER . 10.3 Cg_endo -52.65 -37.33 74.67 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.778 1.652 . . . . 0.0 110.738 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.886 ' CA ' HD11 ' A' ' 80' ' ' ILE . 2.8 p30 167.34 31.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.987 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 62.35 61.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.8 p -148.84 -47.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.637 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -151.05 78.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.775 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.31 151.66 19.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.994 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.1 p -144.85 119.74 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.49 -20.24 1.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.654 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 51.5 m 59.39 31.43 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.31 136.51 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 -48.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.09 -173.04 2.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 60.28 -169.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.051 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.2 p -80.62 -165.33 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.451 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.266 -0.874 . . . . 0.0 111.492 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 mmm . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.57 -162.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.765 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.47 -38.17 0.01 OUTLIER 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.752 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.24 -66.66 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.498 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 27.2 mmt -58.58 168.53 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.155 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 65.95 52.14 1.27 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.238 0.542 . . . . 0.0 109.799 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -70.92 -68.05 0.53 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.416 -177.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.698 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.611 ' N ' HD12 ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 HD23 ' A' ' 33' ' ' LEU . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.874 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.705 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.667 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.641 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.604 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.1 mm -85.93 117.29 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' THR . 21.0 m -158.71 38.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.81 -144.34 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.627 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 -69.48 1.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 -106.06 0.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.328 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.1 m -59.03 -28.25 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.789 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.07 -165.7 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.11 114.66 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.091 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.6 p90 -143.73 2.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 -110.51 -71.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.791 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HD2' HG21 ' A' ' 97' ' ' VAL . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.866 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.726 ' HD1' HG13 ' A' ' 19' ' ' VAL . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.69 -18.33 54.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -62.54 -103.47 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.195 -178.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -163.15 -65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 0.0 111.268 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.9 m120 84.82 84.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.845 -178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.72 132.48 17.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.488 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.46 39.02 27.11 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.835 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -133.64 107.24 7.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 76' ' ' LEU . 3.4 mt -62.16 156.34 21.99 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.575 ' C ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.899 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.457 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 86.9 m -150.12 89.49 1.6 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 16.6 mt-10 -90.24 164.4 14.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.4 -75.05 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.461 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mp -52.37 -75.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.03 26.69 2.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.63 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 92.09 -86.21 1.24 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.175 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.9 p -150.99 89.72 1.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.612 0.244 . . . . 0.0 110.444 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.447 ' H ' ' HG3' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -96.72 142.91 28.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.82 134.89 53.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.905 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.0 m-80 -148.65 129.86 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -147.6 166.91 14.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.308 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 99' ' ' ASN . 29.6 Cg_endo -63.21 -43.04 20.04 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.386 2.057 . . . . 0.0 112.412 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.26 0.12 38.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.646 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . . . -91.36 39.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.778 0.323 . . . . 0.0 111.35 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 30.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -114.98 147.43 40.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.2 p -119.58 81.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 29.0 t -84.25 89.65 7.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -111.35 -17.59 8.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.638 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 58.4 m -68.22 124.43 23.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.39 156.16 8.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -156.94 135.57 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.69 162.94 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.85 -171.59 1.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -130.67 160.73 33.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.685 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.578 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.66 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -162.59 24.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -123.32 -45.21 2.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 110.595 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.58 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -137.09 177.4 7.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.134 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 62' ' ' ILE . . . 58.53 79.47 0.21 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.332 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.617 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.37 -68.13 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.106 -178.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.624 ' CD ' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.765 HG13 ' HD1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.884 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.616 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.946 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm -87.22 111.28 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 38' ' ' THR . 22.5 m -147.08 31.72 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -58.7 -154.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.067 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.97 26.32 10.08 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.875 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.28 -84.95 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.531 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -27.38 64.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.67 -168.24 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.64 102.14 0.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.229 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 2.8 p90 -138.39 -1.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 41.6 mt-30 -107.13 -71.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.635 ' HD2' HG21 ' A' ' 97' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.908 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.944 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.765 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.91 -24.2 60.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.63 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -49.76 -94.38 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 14.7 p 156.57 -20.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 124.128 0.893 . . . . 0.0 111.587 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 5.5 m120 47.07 91.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.5 . . . . 0.0 110.178 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -47.06 -43.21 19.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.403 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.73 53.68 3.71 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.237 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.54 113.13 3.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 110.568 -179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 76' ' ' LEU . 4.7 mt -59.61 139.43 57.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 68' ' ' GLN . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.946 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.529 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.889 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.995 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.677 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.496 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 88.9 m -150.05 89.44 1.6 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -62.55 163.59 8.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.62 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.69 -131.5 2.58 Favored Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.0 91.58 8.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.819 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 51.41 25.63 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -154.06 66.06 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.649 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 88.1 p -59.43 118.1 5.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 111.147 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -84.62 154.83 22.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.483 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 46' ' ' GLN . 4.1 t80 -139.14 132.88 30.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.447 ' N ' HG12 ' A' ' 97' ' ' VAL . 65.5 m-20 -143.46 148.0 35.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.578 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.2 p30 -175.44 164.9 2.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.53 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 18.1 Cg_endo -58.82 -36.74 96.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.655 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -68.89 -31.03 69.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.828 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -77.45 61.49 2.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.26 -30.64 11.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 p 58.1 164.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.1 125.34 5.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 4.6 m -103.83 102.54 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.14 -18.13 1.73 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.2 m -81.02 -54.2 5.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 -165.23 24.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.549 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m 62.35 117.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -154.78 115.26 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -77.3 -173.78 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 110.953 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.7 p -114.65 162.83 16.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.505 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.968 0.413 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.54 -174.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.006 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 174.14 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.97 -48.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER 52.07 -171.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 75.29 71.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.447 . . . . 0.0 110.262 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.602 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -86.72 -63.12 0.23 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.453 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.862 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.78 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.87 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' CB ' HD22 ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.652 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.931 HG23 HD11 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.0 mm -78.58 118.93 26.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 2.6 m -162.59 49.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.451 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.04 -132.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.22 -77.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.621 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.9 130.35 2.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.817 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.1 m 54.97 26.21 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 p -177.55 -174.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.968 0.413 . . . . 0.0 111.047 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.58 105.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.069 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 2.6 p90 -135.46 1.07 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' NE2' ' CZ ' ' A' ' 45' ' ' PHE . 50.3 mt-30 -112.7 -71.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.626 ' HD2' HG21 ' A' ' 97' ' ' VAL . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.935 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.78 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.01 -23.44 41.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.48 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.71 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.54 -66.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.219 0.533 . . . . 0.0 111.502 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.65 84.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.347 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -48.48 135.19 14.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.216 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.6 39.78 40.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.777 -178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 70' ' ' VAL . 9.8 t70 -135.95 110.04 8.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.72 0.408 . . . . 0.0 110.51 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.671 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -60.57 140.33 57.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.931 HD11 HG23 ' A' ' 35' ' ' VAL . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.531 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.993 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.862 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.443 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 85.9 m -149.01 89.53 1.68 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 11.4 mt-10 -93.12 164.73 13.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.672 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 91' ' ' GLU . . . 113.11 144.11 8.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.5 tp 63.65 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.603 0.239 . . . . 0.0 110.519 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 89' ' ' GLY . 30.3 mm-40 -74.81 -8.81 57.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.787 0.327 . . . . 0.0 110.577 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 112.94 -95.53 0.77 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.626 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 59.8 p -150.52 89.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.634 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -88.22 140.84 29.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 -124.39 137.4 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG13 ' CB ' ' A' ' 84' ' ' VAL . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' THR . 71.8 m-20 -141.09 131.6 25.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -149.39 166.35 15.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.365 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 24.2 Cg_endo -61.85 -55.59 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.455 2.103 . . . . 0.0 112.716 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.39 -23.24 48.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.34 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -70.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 p -98.73 129.28 45.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 105' ' ' THR . 78.1 p -176.56 -46.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -160.4 159.76 31.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 31.99 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.68 27.06 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t -139.13 160.04 40.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.14 -138.23 2.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m 63.0 -79.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.01 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.82 120.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -78.21 -168.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -96.09 -165.38 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.53 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.639 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.724 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.866 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.79 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.668 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.694 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.595 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.94 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 HD11 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.4 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.411 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 2.3 mt-30 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.642 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.927 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.94 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.621 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG23 ' HD3' ' A' ' 64' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 35' ' ' VAL . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.696 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.93 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.998 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.998 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.559 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.724 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.439 ' CA ' HD11 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.604 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.8 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.746 0.308 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.676 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.748 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.717 HG13 ' HD1' ' A' ' 51' ' ' PHE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.869 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 24' ' ' SER . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.673 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.606 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.679 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 75' ' ' SER . 11.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 32.8 mt-30 . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.668 ' HD2' HG21 ' A' ' 97' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.879 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.911 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.717 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 76' ' ' LEU . 2.9 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.624 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CD1' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.712 HG12 ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.703 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.937 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.996 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.996 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.748 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.425 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.0 t80 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.872 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.518 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.702 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.702 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.699 ' N ' HD13 ' A' ' 33' ' ' LEU . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 75' ' ' SER . 13.7 mm . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.423 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 16.8 mt-30 . . . . . 0 C--O 1.227 -0.081 0 CA-C-O 120.494 0.187 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.517 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.848 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.918 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.748 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 60' ' ' LEU . 2.6 mt . . . . . 0 CA--C 1.521 -0.167 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.703 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.667 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.985 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.568 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.819 0.343 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' HG12 ' A' ' 97' ' ' VAL . 68.8 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.632 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.595 ' N ' HD12 ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.932 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.719 HG22 HD23 ' A' ' 33' ' ' LEU . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.581 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.675 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.893 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.618 HG22 ' CE1' ' A' ' 49' ' ' PHE . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.6 mm . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.412 0.149 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HD2' HG21 ' A' ' 97' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.887 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.2 mt . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.548 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.596 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.893 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.522 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.916 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.971 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.463 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.499 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 6.3 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 97' ' ' VAL . 16.6 m-80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.857 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.803 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.915 ' HD2' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.915 HG23 ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.881 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.715 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.616 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.715 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG23 HD11 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 28.2 mt-30 . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.895 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.734 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 70' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.927 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.689 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.903 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.962 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.706 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.483 ' CA ' HD11 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.694 0.283 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 97' ' ' VAL . 34.3 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.663 ' N ' HD12 ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.979 ' HB2' HG22 ' A' ' 84' ' ' VAL . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.915 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.763 HG13 ' HD1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.661 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.679 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.2 mm . . . . . 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.654 ' CD2' HG21 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.92 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.763 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 76' ' ' LEU . 2.5 mt . . . . . 0 CA--C 1.524 -0.057 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.549 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.863 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.662 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.9 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.685 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.979 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 . . . . . 0 CA--C 1.522 -0.133 0 CA-C-O 120.649 0.262 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.824 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.618 ' H ' HG12 ' A' ' 97' ' ' VAL . 63.9 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.749 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.863 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.749 HG13 ' HD1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.707 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.571 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.572 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 75' ' ' SER . 9.3 mm . . . . . 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' A' ' 97' ' ' VAL . 24.8 mt-30 . . . . . 0 CA--C 1.522 -0.098 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' N ' HD12 ' A' ' 31' ' ' LEU . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.8 mt . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.593 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.572 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.973 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.706 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.982 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.567 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.76 0.314 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 ' HD2' ' A' ' 47' ' ' TYR . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.608 ' N ' HD12 ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.832 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.822 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.774 HG13 ' HD1' ' A' ' 51' ' ' PHE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.402 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.713 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.713 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.943 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.77 ' N ' HD13 ' A' ' 33' ' ' LEU . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD13 ' HD1' ' A' ' 47' ' ' TYR . 18.6 mm . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 11.9 mt-30 . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.686 0.279 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HD2' HG21 ' A' ' 97' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.943 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.774 ' HD1' HG13 ' A' ' 19' ' ' VAL . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' N ' HD12 ' A' ' 31' ' ' LEU . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 HD12 ' A' ' 76' ' ' LEU . 5.2 mt . . . . . 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.665 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.869 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.671 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.894 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.003 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 1.003 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.475 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.832 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.789 0.328 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.449 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.5 m-80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.612 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.895 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 33' ' ' LEU . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.864 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.697 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.703 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.895 HD12 HD13 ' A' ' 69' ' ' LEU . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 25.3 mt-30 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.714 0.292 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.852 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.877 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 HD12 ' A' ' 76' ' ' LEU . 3.8 mt . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.871 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.876 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.598 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.778 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.7 m . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.737 0.303 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.8 m-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.859 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.745 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.806 HG13 ' HD1' ' A' ' 51' ' ' PHE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 24' ' ' SER . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.681 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.683 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.683 HD23 ' CG ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.818 HG23 HD11 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 . . . . . 0 C--O 1.228 -0.074 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HD2' HG21 ' A' ' 97' ' ' VAL . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.919 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.897 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.806 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HG2' HG22 ' A' ' 67' ' ' VAL . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 20' ' ' LYS . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' N ' ' A' ' 68' ' ' GLN . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.888 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.664 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.535 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.925 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.925 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.4 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 97' ' ' VAL . 31.7 m-80 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.823 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.769 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.879 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.672 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.623 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.925 HG23 HD11 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.5 mm . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 23.9 mt-30 . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 97' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.962 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.769 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt . . . . . 0 C--O 1.227 -0.086 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.937 HD13 HD12 ' A' ' 33' ' ' LEU . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.913 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.707 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.935 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.703 0.287 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' H ' HG12 ' A' ' 97' ' ' VAL . 22.5 m-80 . . . . . 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.631 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.861 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.734 HG13 ' HD1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.854 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.712 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.818 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 75' ' ' SER . 25.2 mm . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.579 0.228 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.634 ' HD2' HG21 ' A' ' 97' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.929 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.734 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.567 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.818 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.903 HD11 HG23 ' A' ' 35' ' ' VAL . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.67 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.649 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.99 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.595 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.685 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.876 0.369 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.634 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.4 m-20 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.848 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HD1' ' A' ' 51' ' ' PHE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 24' ' ' SER . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.684 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.773 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 75' ' ' SER . 24.4 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 . . . . . 0 CA--C 1.522 -0.127 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.547 ' HD1' HG21 ' A' ' 97' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.922 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.753 HD11 HD12 ' A' ' 76' ' ' LEU . 4.4 mt . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.729 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.656 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.855 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.657 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.57 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.687 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.479 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 ' HD1' ' A' ' 47' ' ' TYR . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.0 m-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.577 ' N ' HD12 ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.858 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.705 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.705 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.869 HG23 HD11 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.6 mm . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 . . . . . 0 CA--C 1.525 0.006 0 CA-C-O 120.572 0.225 . . . . 0.0 111.592 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HD2' HG21 ' A' ' 97' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.89 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.778 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.2 mt . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.581 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' H ' ' A' ' 67' ' ' VAL . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.907 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.718 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.984 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.762 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' ASN . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.722 0.296 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.762 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.627 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.849 ' HA ' HG13 ' A' ' 84' ' ' VAL . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HD23 ' A' ' 33' ' ' LEU . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.662 ' N ' HD12 ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.696 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.597 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.715 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.824 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.7 mm . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 19.9 mt-30 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 37' ' ' ILE . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.904 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.6 mt . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.576 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.639 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.72 HG13 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.537 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.934 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.711 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.6 m . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.641 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HD2' ' HB3' ' A' ' 15' ' ' ALA . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.878 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.816 HG13 ' HD1' ' A' ' 51' ' ' PHE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.844 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.631 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.685 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.917 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.471 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 75' ' ' SER . 20.7 mm . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' A' ' 97' ' ' VAL . 34.5 mt-30 . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.705 ' HD2' HG21 ' A' ' 97' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.917 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.896 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 HD12 ' A' ' 76' ' ' LEU . 3.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.651 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.843 ' HD3' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG23 ' HD3' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.556 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.817 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.683 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.633 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.431 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.611 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 120.818 0.342 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.877 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.792 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' A' ' 51' ' ' PHE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.859 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.677 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.695 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.695 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 50' ' ' THR . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.44 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.1 mt-30 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.649 0.261 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HD2' HG21 ' A' ' 97' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.907 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.725 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.424 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 35' ' ' VAL . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.524 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.533 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.911 ' O ' HD13 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.968 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.875 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ASN . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.877 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HD2' ' A' ' 47' ' ' TYR . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.4 m-80 . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.698 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.611 ' N ' HD12 ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 HD23 ' A' ' 33' ' ' LEU . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.874 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.705 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.667 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.604 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.1 mm . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 . . . . . 0 C--O 1.228 -0.077 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HD2' HG21 ' A' ' 97' ' ' VAL . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.866 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.726 ' HD1' HG13 ' A' ' 19' ' ' VAL . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 76' ' ' LEU . 3.4 mt . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.575 ' C ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.575 HD13 ' C ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.899 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.659 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.457 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.0 m-80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.617 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.624 ' CD ' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.765 HG13 ' HD1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.884 HD22 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.694 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.694 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.946 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 22.9 mt-30 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.635 ' HD2' HG21 ' A' ' 97' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.908 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.944 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.765 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 76' ' ' LEU . 4.7 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.649 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 68' ' ' GLN . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.946 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.668 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.889 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.995 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 ' N ' HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.677 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.496 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.9 m . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 46' ' ' GLN . 4.1 t80 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.685 0.279 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.447 ' H ' HG12 ' A' ' 97' ' ' VAL . 65.5 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.602 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.862 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.78 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.87 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.518 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.702 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.931 HG23 HD11 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.0 mm . . . . . 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' HA ' HG23 ' A' ' 97' ' ' VAL . 29.9 mt-30 . . . . . 0 C--O 1.227 -0.112 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.626 ' HD2' HG21 ' A' ' 97' ' ' VAL . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.935 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.78 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.671 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.931 HD11 HG23 ' A' ' 35' ' ' VAL . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.684 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.993 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.862 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.9 m . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.69 0.281 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.636 HG13 ' CB ' ' A' ' 84' ' ' VAL . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' THR . 71.8 m-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mmm . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.559 0.219 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.01 -161.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.919 0.39 . . . . 0.0 110.709 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -166.29 27.63 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.13 -52.04 1.12 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.334 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.449 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -76.25 162.37 27.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.028 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 60.46 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.639 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -133.02 -71.2 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -104.97 -120.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.786 2.324 . . . . 0.0 113.24 -178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.724 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.73 126.51 27.86 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.26 0.624 . . . . 0.0 112.508 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.537 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 26.8 m -99.34 121.45 41.12 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.866 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.9 p90 -88.16 -179.62 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.355 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.649 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.14 -160.56 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.272 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 72.1 m-20 -91.61 -42.67 10.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.191 0.519 . . . . 0.0 110.865 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.99 89.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.631 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.79 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.94 -32.85 55.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -70.67 -43.27 69.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.203 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -57.26 -43.54 83.13 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.748 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -59.06 -30.72 68.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.7 t -81.73 -68.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.633 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.25 -19.35 3.08 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.9 m -85.85 -46.38 10.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.868 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.81 -25.4 32.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.655 -179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.4 -48.48 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.193 0.52 . . . . 0.0 109.738 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.668 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -59.62 -23.43 62.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.279 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.62 -19.92 40.82 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.546 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.52 -18.93 47.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.15 0.5 . . . . 0.0 110.084 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.71 11.61 0.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.44 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.694 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.82 -70.66 0.11 Allowed 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.595 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.87 -45.33 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.638 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.74 67.74 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.9 153.79 16.55 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.924 -177.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.5 mtpt -116.03 123.84 48.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.454 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.94 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.13 145.96 40.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 0.0 110.999 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -139.43 97.48 3.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.379 0.609 . . . . 0.0 110.026 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 HD11 ' A' ' 69' ' ' LEU . 11.9 t -73.4 154.87 6.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.81 6.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.738 178.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.4 mm -87.44 113.6 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.128 0.49 . . . . 0.0 111.218 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 38' ' ' THR . 7.1 m -145.89 17.56 1.43 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.335 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.638 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -55.17 -158.63 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 113.181 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.88 -85.76 1.24 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.528 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.52 -159.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.32 56.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.759 0.314 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.3 m -77.68 -70.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.095 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.51 133.32 4.94 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.259 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -148.92 6.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.638 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 2.3 mt-30 -114.37 -77.77 0.58 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.642 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.3 m-85 75.33 114.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.104 0.478 . . . . 0.0 110.773 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.66 133.18 27.37 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.208 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.927 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.54 134.6 48.38 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.94 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.8 t -131.24 166.67 20.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.62 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.6 m-85 -107.74 98.95 8.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.46 0.648 . . . . 0.0 110.06 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.59 105.78 11.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.568 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.06 -23.67 41.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.492 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.584 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.5 -99.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.707 -178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.21 -66.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.231 0.539 . . . . 0.0 111.605 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.19 84.37 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.561 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.5 134.72 15.11 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.497 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.38 40.13 41.03 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.94 108.65 7.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.08 -0.56 . . . . 0.0 110.302 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.49 146.36 40.67 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -130.55 126.26 36.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.55 126.09 73.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.994 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -59.57 152.97 20.81 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.917 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 15.4 mtpt -115.77 169.45 9.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -48.63 -41.82 32.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.854 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.61 8.12 4.94 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.822 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG23 ' HD3' ' A' ' 64' ' ' LYS . 14.0 m -154.64 -148.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.769 0.284 . . . . 0.0 110.8 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -133.13 135.5 45.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 35' ' ' VAL . 2.3 tp -102.17 135.56 43.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -140.55 112.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.922 0.392 . . . . 0.0 109.969 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.667 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.39 157.92 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.241 0.544 . . . . 0.0 112.105 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -83.08 144.55 47.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.279 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 96.3 Cg_exo -43.68 -37.49 8.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.568 2.845 . . . . 0.0 113.009 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.696 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.62 -46.24 84.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.564 0.697 . . . . 0.0 109.608 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.93 ' O ' HD13 ' A' ' 79' ' ' LEU . 91.9 p -74.34 -33.04 63.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.644 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.998 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -44.79 -46.06 10.38 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.853 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.998 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -78.43 -19.75 52.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.063 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.9 m-85 -84.97 -39.05 18.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 111.395 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.66 28.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.23 123.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.46 31.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.336 -1.302 . . . . 0.0 115.429 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.724 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.57 -151.11 18.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.708 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.439 ' CA ' HD11 ' A' ' 9' ' ' LEU . 42.2 m -150.1 132.25 15.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.733 0.301 . . . . 0.0 110.634 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.866 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -124.69 150.96 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.516 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.604 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 142.96 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.137 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.36 147.68 37.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.088 0.471 . . . . 0.0 111.46 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 94' ' ' ARG . 88.8 m -147.57 89.52 1.78 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.467 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 45.4 mt-10 -98.1 162.65 13.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.003 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.87 -129.96 2.2 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.623 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.3 tp -80.87 -53.31 6.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 110.983 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -54.65 -18.71 4.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.781 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 151.22 11.09 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.677 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 22.2 p -59.94 91.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 111.048 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -91.11 140.92 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.691 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.6 t80 -123.82 136.53 54.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.24 130.7 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.039 0.447 . . . . 0.0 111.718 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.3 t -129.67 157.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.336 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.1 m-20 -139.34 128.58 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.982 0.42 . . . . 0.0 111.52 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.505 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.38 167.58 13.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.261 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 14.4 Cg_endo -57.31 -42.12 65.74 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.447 2.098 . . . . 0.0 112.721 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -28.73 68.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.74 -68.4 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.2 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.9 p -57.35 -44.42 84.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.042 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 t 60.52 -173.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 m -113.88 136.74 52.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 5.6 p -113.65 -40.5 3.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 15.05 11.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.649 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m 58.74 92.19 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.833 0.349 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.56 75.85 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.445 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.2 m 60.68 157.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.786 0.327 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.11 116.1 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -147.45 -80.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -162.35 -161.77 0.76 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.578 HD13 ' HB3' ' A' ' 113' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.506 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' HD13 ' A' ' 2' ' ' ILE . 1.6 mmt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.99 0.424 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.59 -162.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -146.72 14.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.475 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -131.55 -50.32 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.142 0.496 . . . . 0.0 110.408 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.422 ' HB3' ' OG1' ' A' ' 10' ' ' THR . 0.0 OUTLIER -156.08 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.993 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.767 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -165.27 -27.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.676 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -144.64 -72.08 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.676 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -110.31 -121.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.668 2.245 . . . . 0.0 114.911 -176.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.748 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.08 127.93 34.65 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.746 0.818 . . . . 0.0 112.771 -178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.539 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 52.7 m -101.36 121.46 41.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.196 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.98 ' HB2' HG22 ' A' ' 84' ' ' VAL . 31.6 p90 -88.69 -179.56 6.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.801 0.334 . . . . 0.0 110.977 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.623 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.18 -162.39 0.6 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.207 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.3 m-20 -90.97 -41.57 11.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.127 0.489 . . . . 0.0 110.887 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.07 -41.37 96.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.506 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.55 -33.24 44.78 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.63 -43.01 66.91 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.823 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.06 -51.12 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.2 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.664 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -55.36 -30.32 60.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.225 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.717 HG13 ' HD1' ' A' ' 51' ' ' PHE . 96.8 t -77.62 -69.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.515 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.26 -20.08 6.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.275 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 41.5 t -87.02 -45.36 10.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.869 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.9 33.08 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.47 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.673 HD12 ' N ' ' A' ' 24' ' ' SER . 2.5 pp -73.78 -48.06 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.673 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.1 m -58.03 -24.37 58.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.55 -19.67 41.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.937 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -79.78 -18.97 49.7 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 82.14 10.78 0.7 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.612 -178.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.83 -72.2 0.08 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.606 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 160.15 -46.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.587 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 172.99 68.03 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.679 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.05 153.43 17.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.33 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 19.9 mtpt -115.87 122.31 44.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.087 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.32 143.76 48.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.913 0.387 . . . . 0.0 110.709 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.708 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -134.64 92.31 2.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.229 0.538 . . . . 0.0 109.772 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.4 t -70.73 154.54 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.75 178.79 7.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.91 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 75' ' ' SER . 11.7 mm -82.68 119.89 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.113 0.483 . . . . 0.0 111.217 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 m -158.94 37.45 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.069 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -62.39 -142.35 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.713 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 25.86 21.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.644 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.08 -76.0 2.0 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.2 p -75.48 -29.31 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -116.73 -168.32 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.57 101.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.13 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -142.27 3.06 1.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 32.8 mt-30 -116.56 -73.34 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.696 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.668 ' HD2' HG21 ' A' ' 97' ' ' VAL . 22.9 m-85 74.96 119.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 110.763 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.33 131.04 21.96 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.966 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.879 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.45 133.31 49.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.911 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.61 163.25 27.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.533 177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.717 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.9 m-85 -106.75 98.02 7.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.527 0.68 . . . . 0.0 110.047 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.8 t70 -119.08 106.79 12.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.142 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.3 -24.57 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.266 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.49 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.39 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.18 -67.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-O 121.723 0.773 . . . . 0.0 111.633 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.8 m120 84.59 84.74 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.811 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.85 133.12 18.03 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 78.87 38.97 21.99 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -138.36 110.31 7.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 76' ' ' LEU . 2.9 mt -62.52 156.5 22.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.133 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.712 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -135.88 129.28 32.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.767 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -127.03 91.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.409 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 29.0 tt0 -59.78 157.43 12.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.509 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -165.08 -164.83 0.81 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.476 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 4.6 -71.26 0.0 OUTLIER 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.78 21.76 1.02 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 119.705 -1.236 . . . . 0.0 114.18 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 m -156.77 -167.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.183 0.491 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -113.26 120.72 42.16 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CD1' HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -96.86 101.0 12.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.712 HG12 ' HB ' ' A' ' 61' ' ' THR . 1.0 OUTLIER -105.36 154.15 6.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.476 179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -147.03 162.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.958 0.409 . . . . 0.0 110.939 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -86.52 143.36 36.09 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.859 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.3 Cg_exo -45.29 -40.81 17.07 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.254 2.636 . . . . 0.0 113.018 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.703 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -54.52 -42.41 70.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.706 0.765 . . . . 0.0 109.392 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.937 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.6 t -75.1 -32.88 61.53 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.707 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.996 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.25 -45.72 8.69 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.815 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.996 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -79.02 -19.81 50.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.095 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.4 m-85 -84.46 -39.96 18.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.32 29.39 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.566 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.01 122.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.11 32.77 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 114.22 -1.354 . . . . 0.0 115.512 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.748 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.8 -150.41 19.57 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.625 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.425 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.3 m -150.04 134.29 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.848 0.324 . . . . 0.0 110.776 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.27 153.6 34.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.063 0.458 . . . . 0.0 111.375 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.13 144.89 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.693 178.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -117.88 145.19 44.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 96.6 m -148.79 89.64 1.7 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 30.6 mt-10 -99.79 164.95 11.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.77 -110.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.277 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.33 88.3 4.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 110.528 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.19 25.7 9.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.712 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.35 38.69 2.16 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 2.9 p -59.79 89.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.863 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.435 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -89.5 158.23 17.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.265 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.0 t80 -136.48 137.64 40.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.91 133.68 27.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.048 0.451 . . . . 0.0 111.736 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.668 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.5 t -131.1 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.476 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -140.48 132.48 27.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 111.467 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.557 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.2 OUTLIER -148.81 167.51 12.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.195 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 11.2 Cg_endo -55.29 -49.07 17.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.455 2.103 . . . . 0.0 112.87 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.78 -42.39 93.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 111.071 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.16 60.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.329 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.26 56.23 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -90.13 53.46 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.99 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 58.63 1.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.791 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.95 22.3 16.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 3.44 47.75 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.002 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 34.8 m 59.03 -170.58 0.12 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.46 174.33 31.37 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.9 p -120.19 -168.17 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.28 172.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 59.91 -169.98 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.4 p -76.36 -165.3 0.48 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.442 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.476 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.992 0.425 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.58 -161.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -107.66 -48.75 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.815 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.78 -45.27 94.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.462 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 mmt 52.78 173.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.819 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.88 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . -179.21 91.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.176 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.725 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.8 t -94.26 -60.3 0.19 Allowed Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -110.85 -130.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 123.295 2.663 . . . . 0.0 114.216 -176.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.76 127.68 33.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.762 0.825 . . . . 0.0 112.925 -178.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.634 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -102.27 122.74 44.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.148 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HB2' HG22 ' A' ' 84' ' ' VAL . 32.4 p90 -88.01 -179.92 6.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.785 0.326 . . . . 0.0 111.292 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.8 t -82.76 -159.8 0.35 Allowed 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 15.9 t0 -91.18 -43.55 9.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.656 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.24 -41.36 92.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.339 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.838 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -53.04 -31.02 39.13 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.57 -44.08 65.16 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.9 m-80 -55.83 -49.09 74.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.512 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -52.99 -30.83 37.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.273 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.2 t -83.02 -69.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.229 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.14 -20.46 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 69.6 m -84.97 -46.6 11.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.39 -25.23 31.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.612 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.76 -47.88 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -59.38 -24.14 63.17 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.59 -19.58 41.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.457 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.518 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.24 -18.96 47.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.941 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.39 11.36 0.79 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.568 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.702 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.92 -71.53 0.09 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.373 0.606 . . . . 0.0 109.437 179.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.579 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.62 -45.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.165 -179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.2 69.83 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.702 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.91 155.02 14.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.935 -177.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 5.4 mtpt -116.34 118.98 34.24 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.495 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.918 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.45 142.33 52.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.699 ' N ' HD13 ' A' ' 33' ' ' LEU . 6.8 tmm_? -133.82 95.11 3.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.899 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.616 HG22 ' CE1' ' A' ' 49' ' ' PHE . 30.9 t -72.31 153.47 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.393 -0.822 . . . . 0.0 113.13 -178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.3 -179.82 6.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.827 178.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.749 HD11 ' HA ' ' A' ' 75' ' ' SER . 13.7 mm -84.91 118.05 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.088 0.47 . . . . 0.0 111.072 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.8 m -158.72 37.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 46' ' ' GLN . . . -62.69 -143.73 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.644 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.62 -77.42 1.04 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.687 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.74 139.35 5.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.52 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m 54.45 24.76 5.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB2' ' HB1' ' A' ' 102' ' ' ALA . 13.2 p -177.24 -160.63 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.65 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.2 108.34 0.35 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.007 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.9 p90 -139.07 1.48 2.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.427 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 16.8 mt-30 -111.12 -72.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.4 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.517 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.6 m-85 70.48 132.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -84.3 130.54 9.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.53 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.848 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.71 133.39 48.8 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.918 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.5 t -131.03 162.12 30.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.924 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.748 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -105.66 99.45 9.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -118.03 104.66 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.388 -178.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.01 -23.63 48.19 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.566 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.36 -99.51 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.491 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.55 -67.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.281 0.562 . . . . 0.0 111.182 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' HG3' ' A' ' 34' ' ' ARG . 2.7 m120 83.84 83.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.766 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.47 133.66 16.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.811 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.35 37.99 30.21 Favored Glycine 0 C--O 1.222 -0.645 0 C-N-CA 120.249 -0.976 . . . . 0.0 111.114 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 70' ' ' VAL . 15.1 t0 -131.88 105.72 7.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.525 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.6 mt -59.27 139.22 57.19 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -123.94 129.84 51.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.524 0.678 . . . . 0.0 112.377 -178.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.88 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.63 92.7 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.398 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 31.0 tt0 -59.66 157.27 12.11 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.508 0.194 . . . . 0.0 111.185 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 11' ' ' PHE . 1.4 mtpt -165.42 -168.79 1.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.485 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 6.32 -72.79 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.869 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -145.53 17.07 1.85 Allowed Glycine 0 CA--C 1.518 0.27 0 C-N-CA 119.768 -1.206 . . . . 0.0 114.406 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.423 ' CG1' ' HB3' ' A' ' 20' ' ' LYS . 9.7 m -152.31 -165.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 117.263 0.531 . . . . 0.0 110.353 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -117.52 115.51 25.29 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.38 140.53 29.37 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -144.72 151.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.707 0.289 . . . . 0.0 110.318 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -145.22 160.11 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -87.83 143.44 33.47 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.024 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.625 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 83.3 Cg_exo -41.81 -37.16 3.88 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.562 2.841 . . . . 0.0 113.131 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.667 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -57.75 -44.52 86.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.743 0.783 . . . . 0.0 109.498 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.25 -31.62 58.42 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.935 178.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.64 -44.95 4.47 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.817 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.985 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.74 -20.16 36.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.381 -179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.71 -39.54 20.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.3 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.45 -16.05 29.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.7 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.61 32.73 0.01 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-N 113.852 -1.522 . . . . 0.0 115.906 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.35 -150.05 10.95 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.613 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.0 m -150.09 134.63 17.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.817 0.309 . . . . 0.0 110.198 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.05 154.88 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.284 0.564 . . . . 0.0 111.919 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -150.94 144.99 25.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.808 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -113.15 145.66 40.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.098 0.475 . . . . 0.0 111.5 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.475 HG22 ' HD3' ' A' ' 94' ' ' ARG . 88.0 m -142.6 89.49 2.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.167 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 24.4 mt-10 -105.49 162.89 13.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.1 -76.2 0.33 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.042 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 4.1 tp -50.64 -83.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 5.3 mt-10 -75.72 -4.85 42.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.743 0.306 . . . . 0.0 110.992 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.77 -79.8 0.37 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.115 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 86.9 p -150.36 89.94 1.62 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.687 0.28 . . . . 0.0 110.805 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.475 ' HD3' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -87.1 139.27 30.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -134.88 130.33 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.83 124.47 14.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.429 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.8 t -119.3 168.07 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.556 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' H ' HG12 ' A' ' 97' ' ' VAL . 68.8 m-20 -143.54 159.47 42.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.948 0.404 . . . . 0.0 111.135 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' A' ' 102' ' ' ALA . 1.0 OUTLIER -178.77 160.62 1.07 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.827 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' ' OG1' ' A' ' 103' ' ' THR . 59.4 Cg_endo -72.43 -41.56 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.661 2.241 . . . . 0.0 112.813 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.98 -25.34 63.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 43' ' ' SER . . . -118.76 45.98 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.423 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 100' ' ' PRO . 5.1 p -148.57 74.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.775 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -148.74 152.86 37.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 81.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.4 t -111.75 94.44 4.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.09 17.33 37.99 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.625 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -176.77 95.66 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 169.52 -137.98 4.81 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.476 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.76 119.32 31.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 0.0 110.966 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.78 160.1 16.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 60.23 -171.56 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.969 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 72.2 m -132.33 160.33 36.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.75 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.526 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.907 0.384 . . . . 0.0 111.18 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -100.15 -162.61 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.798 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -132.75 -23.43 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.473 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -77.56 -45.2 26.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.012 0.434 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.537 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.5 OUTLIER 56.15 -171.13 0.08 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.023 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 73.8 66.61 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.095 0.474 . . . . 0.0 110.101 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.632 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -84.6 -65.55 0.21 Allowed Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.751 -178.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.4 Cg_endo -109.71 -126.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.235 2.623 . . . . 0.0 113.877 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.36 126.34 27.27 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.406 0.682 . . . . 0.0 112.379 -179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.595 ' N ' HD12 ' A' ' 9' ' ' LEU . 33.6 m -99.66 121.25 40.96 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.293 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.932 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.0 p90 -88.4 -179.5 6.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.899 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.607 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.19 -161.96 0.56 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 120.945 0.402 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 m-20 -91.33 -41.93 10.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.207 0.527 . . . . 0.0 110.915 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.64 -41.97 96.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.492 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.797 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.01 -33.38 38.12 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.81 -42.52 66.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.997 177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.5 m-80 -55.2 -49.72 71.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.701 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -57.03 -30.55 64.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.203 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.719 HG22 HD23 ' A' ' 33' ' ' LEU . 90.8 t -76.2 -69.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.266 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.19 -19.84 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.236 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.3 t -87.71 -46.0 9.87 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.872 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.14 -25.55 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.716 -179.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.63 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.1 m -57.21 -24.87 57.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -19.63 47.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.239 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 62.3 mt-10 -80.61 -18.53 47.91 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 110.005 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 7.8 tt0 80.84 11.53 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.757 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.34 -70.99 0.1 Allowed 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.581 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.7 -46.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.177 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 173.28 67.68 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.675 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.86 154.53 14.88 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.07 -177.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 4.1 mtpt -118.15 122.34 42.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.951 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.893 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.3 tm? -59.18 142.84 50.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.085 0.469 . . . . 0.0 111.043 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 2.7 tmm_? -134.32 95.26 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.946 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.618 HG22 ' CE1' ' A' ' 49' ' ' PHE . 19.9 t -72.6 153.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.033 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -144.48 -179.83 6.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.341 178.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.6 mm -89.62 109.68 20.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 m -124.32 -33.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.66 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.25 -147.65 22.97 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.509 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.08 -70.99 0.3 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.582 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.98 -85.15 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.884 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 40' ' ' GLY . 3.8 t -119.35 9.39 11.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.65 0.262 . . . . 0.0 110.711 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.26 -67.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.049 0.452 . . . . 0.0 110.822 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 165.14 115.94 0.34 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.726 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -144.64 1.31 1.03 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 20.3 mt-30 -110.03 -79.42 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.371 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HD2' HG21 ' A' ' 97' ' ' VAL . 13.7 m-85 75.14 123.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -77.54 131.33 11.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.484 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -103.99 134.28 47.52 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.887 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.9 t -131.57 163.27 28.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.743 178.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.725 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 8.7 m-85 -105.98 97.57 7.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.645 0.736 . . . . 0.0 109.909 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.1 t70 -115.4 106.0 13.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.495 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -76.08 -23.1 55.0 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.627 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -54.26 -95.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.827 -178.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 7.2 p 168.89 -20.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' N ' HD22 ' A' ' 56' ' ' ASN . 1.9 m-80 47.13 91.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.477 0.656 . . . . 0.0 110.072 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.315 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -86.25 53.72 4.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.257 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 56' ' ' ASN . 9.6 t70 -146.81 113.68 6.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.192 0.197 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' N ' HD23 ' A' ' 60' ' ' LEU . 2.2 mt -62.54 160.73 13.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -142.21 151.2 41.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.769 0.795 . . . . 0.0 112.503 -178.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.774 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -143.05 93.86 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.07 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 33.4 tt0 -59.48 153.69 18.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.668 0.27 . . . . 0.0 111.064 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 4.8 mmmt -161.09 -169.75 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.454 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 5.57 -72.5 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -148.63 14.06 1.2 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 119.568 -1.301 . . . . 0.0 114.086 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.5 m -143.84 -153.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.57 0.685 . . . . 0.0 110.8 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.54 119.11 16.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.988 0.423 . . . . 0.0 109.958 179.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.893 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -90.42 100.11 13.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.612 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -107.16 115.91 49.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.863 0.363 . . . . 0.0 110.23 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -112.94 157.27 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.255 0.55 . . . . 0.0 111.863 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.9 t70 -80.62 144.61 56.91 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.801 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -48.65 -35.37 29.55 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.164 2.576 . . . . 0.0 112.96 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.522 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.7 OUTLIER -54.91 -46.44 74.87 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 122.015 0.912 . . . . 0.0 109.584 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.916 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.8 OUTLIER -74.47 -30.43 61.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.167 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.3 -45.76 12.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.295 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.971 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.82 -25.0 60.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 110.552 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.67 -39.43 20.22 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.57 -15.91 29.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.577 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.54 120.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.15 34.86 0.01 OUTLIER Glycine 0 CA--C 1.523 0.578 0 CA-C-N 114.061 -1.427 . . . . 0.0 115.835 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.36 -149.16 15.3 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 119.951 -1.118 . . . . 0.0 111.695 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.463 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.1 m -150.01 134.34 17.28 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.875 0.338 . . . . 0.0 110.262 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.932 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.47 155.22 41.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.715 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.586 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.2 p-10 -151.27 145.88 25.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.772 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.499 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -119.56 142.7 48.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.743 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 88.5 m -149.81 89.62 1.63 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.876 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -96.78 163.49 12.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.258 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.12 -36.15 4.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.936 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -99.35 104.2 16.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.512 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.38 12.46 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.457 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.42 156.56 15.3 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.975 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 40.8 t -59.59 98.69 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.628 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -91.33 153.78 19.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.781 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.473 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 6.3 t80 -136.12 132.32 35.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.741 0.305 . . . . 0.0 111.268 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.57 134.97 31.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.128 0.489 . . . . 0.0 111.547 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.2 t -127.47 166.23 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.459 ' H ' HG12 ' A' ' 97' ' ' VAL . 16.6 m-80 -149.57 128.77 12.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.931 0.396 . . . . 0.0 111.288 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -142.91 168.1 14.15 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.289 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.6 Cg_endo -54.44 -60.5 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.497 2.132 . . . . 0.0 112.74 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.666 ' O ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -55.7 -30.85 61.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.218 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 99' ' ' ASN . . . -54.54 -32.3 57.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.347 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 101' ' ' ASN . 30.6 p 53.18 100.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.224 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.64 111.1 17.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.858 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 106' ' ' CYS . 0.2 OUTLIER -131.78 -174.98 3.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 105' ' ' THR . 55.8 m -106.89 106.91 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.45 -18.89 1.69 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.66 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.68 164.49 26.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.65 114.5 4.42 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -154.1 79.61 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.1 t -131.45 149.5 52.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -129.33 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.975 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.1 m -135.39 160.97 36.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.303 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' C ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.041 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.4 -161.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.69 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -140.11 9.19 2.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.28 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.54 -41.88 3.2 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.547 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.794 ' CE ' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -103.19 -164.27 1.06 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.392 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.794 ' HB2' ' CE ' ' A' ' 5' ' ' MET . . . 69.33 46.21 0.79 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.277 0.561 . . . . 0.0 110.158 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -55.49 -67.75 0.66 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.263 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.38 -119.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.056 2.504 . . . . 0.0 114.003 -177.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.59 126.81 29.09 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.519 0.727 . . . . 0.0 112.294 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.593 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.4 m -98.45 121.11 39.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.857 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.7 p90 -88.11 -179.76 6.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.979 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.8 t -85.27 -160.24 0.49 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.352 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.5 -42.78 10.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.178 0.513 . . . . 0.0 110.638 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -59.76 -41.39 90.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.806 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.803 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.77 -32.59 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.56 -42.79 64.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.075 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.4 m-80 -54.78 -49.26 71.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.332 -1.304 . . . . 0.0 112.165 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.915 ' HD2' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -59.7 -29.09 67.86 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.255 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.915 HG23 ' HD2' ' A' ' 18' ' ' LYS . 97.5 t -74.54 -68.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.21 0.529 . . . . 0.0 110.056 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.51 -19.38 9.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.428 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 67.0 m -86.67 -45.88 10.58 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.881 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.88 -26.2 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.435 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.25 -48.32 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.414 0.626 . . . . 0.0 109.955 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 m -57.95 -24.35 57.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.69 -20.02 43.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 54.4 mt-10 -79.82 -19.18 49.09 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.77 11.57 0.92 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.479 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.715 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.1 -71.04 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.555 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.616 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.48 -45.51 0.0 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 124.189 0.931 . . . . 0.0 112.354 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 172.46 67.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.715 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.95 153.38 17.56 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.016 -177.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 24.9 mtpt -115.35 122.9 47.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.424 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -59.51 149.05 30.94 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.873 0.368 . . . . 0.0 111.291 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 48.6 ttt180 -142.5 97.99 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.337 0.589 . . . . 0.0 110.107 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG23 HD11 ' A' ' 69' ' ' LEU . 19.9 t -74.51 153.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.006 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -139.6 -179.84 6.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.771 178.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.768 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.9 mm -84.68 116.81 28.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.928 0.394 . . . . 0.0 111.211 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 m -152.67 33.24 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.884 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -60.89 -150.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.82 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.9 28.55 9.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.713 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.43 -96.16 1.3 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.463 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 36.4 m -73.41 -29.43 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 105' ' ' THR . 6.0 m -96.18 -167.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' C ' ' HH ' ' A' ' 47' ' ' TYR . . . -155.49 93.86 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.286 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 97' ' ' VAL . 4.6 p90 -133.28 -2.91 3.09 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 28.2 mt-30 -109.14 -74.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 111.506 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 34.5 m-85 72.19 119.0 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.37 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -73.23 134.98 20.51 Favored Glycine 0 N--CA 1.454 -0.131 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.197 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.895 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.49 134.43 48.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.0 t -128.76 163.72 24.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.28 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 6.1 m-85 -109.98 100.31 9.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 5.2 p-10 -117.41 111.26 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.79 -14.25 56.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.063 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.462 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -64.01 -107.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.29 -179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.9 t -162.49 -55.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 54' ' ' LYS . 2.6 m-80 65.73 72.77 0.4 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -46.53 -28.83 1.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.893 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.59 48.7 1.66 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -153.73 112.57 3.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.377 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD12 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -58.81 149.26 27.07 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.734 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.5 p -128.27 130.15 47.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.713 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.68 125.05 70.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.637 178.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -59.51 153.12 20.24 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.082 -0.386 . . . . 0.0 111.57 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 16.5 mtpp -114.23 170.8 8.02 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.83 -41.36 44.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.172 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.1 8.03 5.11 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.394 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.5 m -154.73 -150.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 O-C-N 122.475 -0.427 . . . . 0.0 110.814 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.71 134.32 46.81 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.802 0.334 . . . . 0.0 110.967 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 70' ' ' VAL . 2.5 tp -104.43 136.74 43.44 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.687 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.927 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -138.91 109.33 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 121.17 0.509 . . . . 0.0 110.061 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.565 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -99.9 166.31 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 112.324 -178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -86.5 144.83 38.37 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.261 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -47.23 -43.01 26.68 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.078 2.519 . . . . 0.0 112.628 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.689 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -56.83 -41.55 78.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.467 0.651 . . . . 0.0 109.749 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.903 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -76.28 -33.22 59.11 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.27 -44.15 7.82 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.517 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.962 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.1 -19.55 39.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.156 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.45 -40.42 19.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.964 0.411 . . . . 0.0 111.269 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.33 -16.3 29.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.99 123.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -177.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.49 31.2 0.01 OUTLIER Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.06 -1.427 . . . . 0.0 115.714 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.706 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.22 -149.57 10.18 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.589 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.483 ' CA ' HD11 ' A' ' 9' ' ' LEU . 11.9 m -150.12 134.2 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.97 0.385 . . . . 0.0 110.422 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -129.35 152.44 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.603 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.1 p-10 -151.2 143.02 23.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.783 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.62 140.65 49.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.782 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 85.1 m -150.36 89.55 1.58 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.118 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.0 pp20? -99.01 163.54 12.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.396 . . . . 0.0 111.074 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.36 -111.52 0.32 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.737 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.77 -53.9 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 110.83 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -56.97 -22.34 37.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.943 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.53 148.63 8.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.345 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.531 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 42.1 p -59.61 103.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 111.318 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -98.51 143.62 28.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.85 179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 3.9 t80 -122.78 128.87 51.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.269 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.29 125.62 26.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 111.502 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -123.41 165.05 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.378 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 97' ' ' VAL . 34.3 m-20 -147.8 127.65 13.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.003 0.43 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.22 166.93 17.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.363 179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 18.6 Cg_endo -60.43 -47.98 12.71 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.47 2.113 . . . . 0.0 112.782 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -13.3 61.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.99 35.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 99' ' ' ASN . 73.7 p -124.1 134.87 53.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m 59.8 100.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.442 HG21 ' OG ' ' A' ' 43' ' ' SER . 3.7 m -153.52 77.48 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 8.0 p -147.49 38.24 0.94 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.769 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.43 -32.2 0.02 OUTLIER Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.849 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.63 84.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.086 0.443 . . . . 0.0 110.838 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.73 110.87 0.66 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.8 168.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 82.5 p -130.19 -170.95 2.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 60.67 -172.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 89.8 p -100.96 161.45 13.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.542 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.601 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' C ' HD13 ' A' ' 2' ' ' ILE . 3.3 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.613 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.25 -162.17 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.234 0.54 . . . . 0.0 110.851 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.08 -56.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.578 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.65 -67.68 0.67 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.701 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.547 ' HE2' ' HA ' ' A' ' 5' ' ' MET . 23.3 mmt -82.01 -176.3 6.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.81 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 61.07 37.93 17.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG23 HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -42.14 -77.34 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.66 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.51 -119.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.61 2.206 . . . . 0.0 113.578 -178.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.22 126.94 29.71 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.206 0.602 . . . . 0.0 112.41 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.663 ' N ' HD12 ' A' ' 9' ' ' LEU . 47.7 m -102.82 120.87 41.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.18 177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.979 ' HB2' HG22 ' A' ' 84' ' ' VAL . 40.9 p90 -86.67 -179.81 6.65 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.813 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.2 t -79.48 -162.27 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.147 0.498 . . . . 0.0 111.655 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 28.1 t0 -90.32 -43.01 10.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.539 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -58.26 -44.76 88.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.915 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.54 -31.47 35.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.43 -43.77 66.09 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -58.3 -45.63 87.62 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.244 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.09 -30.16 59.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.203 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.763 HG13 ' HD1' ' A' ' 51' ' ' PHE . 63.7 t -85.08 -68.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.432 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.661 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.81 -20.32 3.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.558 -179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 13.3 t -87.95 -46.27 9.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -80.99 -25.55 37.19 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.501 -179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.98 -48.83 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.09 0.471 . . . . 0.0 109.747 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -58.31 -23.63 57.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.86 -19.86 43.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.399 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 50.6 mt-10 -80.51 -18.65 47.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.989 0.424 . . . . 0.0 110.089 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER 80.39 11.28 1.06 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.805 -178.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.679 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.3 -70.45 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.74 -45.92 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.266 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.12 69.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.703 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.07 154.67 15.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.941 -1.482 . . . . 0.0 113.677 -177.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 11.7 mtpt -116.74 119.28 34.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 113.885 -1.507 . . . . 0.0 109.111 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.57 142.94 51.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.96 0.409 . . . . 0.0 110.665 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 11.6 ttt180 -134.98 94.56 3.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.484 0.659 . . . . 0.0 109.835 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.599 HG22 ' CE1' ' A' ' 49' ' ' PHE . 12.0 t -72.21 153.8 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.32 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -139.73 174.26 10.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.49 177.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.2 mm -88.15 117.74 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 15.2 m -115.84 -50.03 2.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.355 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 43' ' ' SER . . . -71.83 -114.53 0.05 OUTLIER Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.781 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.585 ' H ' ' HA2' ' A' ' 44' ' ' GLY . . . 80.29 97.16 0.35 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.415 -0.392 . . . . 0.0 113.431 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 102.68 0.87 Allowed Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.68 20.49 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.842 ' HA ' ' CZ ' ' A' ' 45' ' ' PHE . 7.8 p -173.53 -3.13 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.323 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.585 ' HA2' ' H ' ' A' ' 40' ' ' GLY . . . -59.66 68.19 0.01 OUTLIER Glycine 0 C--N 1.349 1.28 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.19 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.842 ' CZ ' ' HA ' ' A' ' 43' ' ' SER . 1.3 p90 179.23 16.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 27.4 mt-30 -106.69 -72.23 0.73 Allowed 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.998 -0.439 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.654 ' CD2' HG21 ' A' ' 97' ' ' VAL . 5.7 m-85 69.09 127.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.028 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -81.49 138.06 18.45 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.193 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.51 135.26 49.28 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.92 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -131.88 158.95 40.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.375 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.763 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.9 m-85 -103.28 96.73 6.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.511 0.672 . . . . 0.0 109.7 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -117.53 104.84 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.989 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.77 -21.04 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.49 -100.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.872 0.306 . . . . 0.0 111.153 -178.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.86 -66.78 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 111.703 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 86.18 84.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.243 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.51 135.59 14.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.588 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.04 40.41 51.27 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.304 -0.95 . . . . 0.0 110.863 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.38 108.11 7.99 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.942 0.436 . . . . 0.0 110.56 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 76' ' ' LEU . 2.5 mt -60.12 144.18 50.4 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.549 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.2 p -127.78 142.98 51.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.282 0.563 . . . . 0.0 112.412 -178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -135.29 102.21 3.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.014 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 3.7 tt0 -59.54 155.07 16.0 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.863 ' HG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.6 tptt -147.68 166.93 25.94 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.662 ' N ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -16.88 -55.82 0.01 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.685 -1.598 . . . . 0.0 115.027 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.82 0.42 7.84 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 119.489 -1.339 . . . . 0.0 115.31 -176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 20' ' ' LYS . 6.4 m -153.68 -156.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.746 0.773 . . . . 0.0 111.337 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -136.38 123.7 21.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.114 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.9 ' CD1' HD12 ' A' ' 33' ' ' LEU . 1.8 mm? -87.01 144.19 27.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.716 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 1.0 OUTLIER -147.95 106.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.491 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -110.25 159.55 9.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.313 0.577 . . . . 0.0 111.919 -178.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -80.57 144.93 57.66 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.755 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 80.7 Cg_exo -45.43 -34.58 10.81 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.158 2.572 . . . . 0.0 112.952 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.685 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -56.65 -40.75 76.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.683 0.754 . . . . 0.0 109.633 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 51.8 p -76.06 -32.82 59.49 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.903 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.54 -44.53 4.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.792 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.12 -19.95 35.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.482 -179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.5 m-85 -83.56 -40.43 19.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.52 -15.75 30.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.583 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.21 123.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.46 36.12 0.01 OUTLIER Glycine 0 CA--C 1.519 0.334 0 CA-C-N 113.609 -1.632 . . . . 0.0 115.803 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -90.11 -152.65 27.36 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.027 -1.083 . . . . 0.0 111.885 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.3 m -148.8 135.27 19.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.979 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.79 159.26 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.321 0.581 . . . . 0.0 112.264 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.0 p30 -151.45 147.14 26.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.967 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.75 137.67 53.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.518 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 95.2 m -145.51 89.45 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.11 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -81.52 172.38 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.425 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.79 -46.94 1.1 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mp -85.72 105.89 16.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 67.41 12.44 8.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.54 -94.81 0.6 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.353 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 91.8 p -150.37 93.64 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.383 0.273 . . . . 0.0 110.911 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.4 147.41 26.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.74 0.305 . . . . 0.0 110.384 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 14.0 t80 -136.53 129.05 30.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.415 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m -143.65 143.53 31.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.172 0.511 . . . . 0.0 111.306 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.824 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.1 t -125.47 172.7 12.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.618 ' H ' HG12 ' A' ' 97' ' ' VAL . 63.9 m-80 -138.01 133.99 34.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.611 0.243 . . . . 0.0 110.788 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.812 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 18.1 p30 -175.84 175.91 0.66 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.337 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.812 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 40.1 Cg_endo -72.38 -37.69 4.16 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.067 1.845 . . . . 0.0 112.41 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -18.09 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.413 ' HB1' ' HD2' ' A' ' 45' ' ' PHE . . . -78.11 9.7 3.51 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 61.09 94.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.908 0.385 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -178.46 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.2 p -100.79 -79.03 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.7 t -178.31 38.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.4 -14.01 77.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t 61.58 79.64 0.25 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.46 -160.6 13.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.07 -41.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.729 0.299 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.5 p -125.82 154.07 43.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -71.41 -171.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.7 m -125.19 160.42 29.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.659 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.546 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.705 0.288 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.689 HG21 ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -95.09 -161.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -135.23 -30.76 1.02 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.798 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -103.06 -49.38 3.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.191 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.689 ' HE3' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -128.15 -156.01 0.73 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.74 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.861 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -172.61 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.749 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -131.81 -78.51 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.749 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -107.29 -114.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 122.247 1.965 . . . . 0.0 114.595 -177.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.13 127.64 33.19 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.514 0.725 . . . . 0.0 112.669 -178.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 9' ' ' LEU . 59.1 m -98.94 121.83 41.41 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.514 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.863 ' HB2' HG22 ' A' ' 84' ' ' VAL . 23.4 p90 -88.62 -179.71 6.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.647 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.32 -160.24 0.54 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 120.798 0.333 . . . . 0.0 111.218 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.3 m-20 -91.49 -42.9 10.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.289 0.566 . . . . 0.0 110.811 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.27 -40.55 90.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.447 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.831 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.45 -31.15 44.18 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.38 -42.21 59.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.334 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.7 m-80 -55.45 -50.79 68.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.806 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.14 -34.59 63.89 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.904 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.749 HG13 ' HD1' ' A' ' 51' ' ' PHE . 47.8 t -71.39 -70.55 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.874 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.44 -19.42 5.64 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.2 t -86.56 -45.2 11.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.86 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.24 -25.69 29.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.656 -179.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.713 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.58 -48.62 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.4 m -60.05 -23.09 63.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.95 -19.46 37.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.052 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.5 mm-40 -80.16 -19.06 48.04 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 81.88 11.01 0.73 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.241 -179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.707 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.73 -70.16 0.13 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.571 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.78 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.427 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 171.86 68.25 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.713 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.1 157.13 10.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.149 -1.387 . . . . 0.0 113.026 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.572 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 13.3 mtpt -118.13 121.73 41.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.546 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.14 144.35 46.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.808 0.337 . . . . 0.0 110.478 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -139.27 96.17 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.361 0.6 . . . . 0.0 110.223 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.973 HG23 HD11 ' A' ' 69' ' ' LEU . 10.5 t -72.27 155.16 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.08 171.0 14.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.481 177.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD11 ' HA ' ' A' ' 75' ' ' SER . 9.3 mm -77.84 118.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.148 0.499 . . . . 0.0 111.296 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' THR . 11.2 m -158.75 40.08 0.23 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.762 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.35 -140.89 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.79 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.62 27.33 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.544 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.52 -73.6 2.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.329 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 71.6 m -68.72 -29.19 67.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.858 0.361 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 t -130.59 179.87 5.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.826 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.63 104.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.276 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.2 p90 -145.37 3.76 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' A' ' 97' ' ' VAL . 24.8 mt-30 -117.12 -72.18 0.7 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.852 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' HD2' HG21 ' A' ' 97' ' ' VAL . 20.5 m-85 75.21 129.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.998 0.428 . . . . 0.0 110.807 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -79.44 133.82 12.95 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.051 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.69 135.03 47.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.86 164.91 24.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.515 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.749 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.9 m-85 -108.53 96.46 6.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.466 0.651 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' OD1' ' CG ' ' A' ' 54' ' ' LYS . 8.9 t70 -120.5 107.43 12.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.617 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.02 -26.4 59.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.745 -178.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -51.6 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.035 -179.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.7 p 169.46 -19.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.5 m-80 60.09 83.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.531 0.205 . . . . 0.0 110.705 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -49.93 125.61 12.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.39 40.17 10.3 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.323 -0.942 . . . . 0.0 110.945 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -143.75 115.46 8.2 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.661 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.8 mt -59.53 158.68 9.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.955 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.593 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.5 131.5 24.59 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 122.047 0.927 . . . . 0.0 113.404 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -118.55 125.62 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.543 178.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.63 152.69 21.73 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.697 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.1 mtpp -114.78 170.54 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.157 0.503 . . . . 0.0 111.328 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.03 -41.62 47.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.763 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.3 8.05 5.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.569 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 12.0 m -154.58 -151.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 122.652 -0.322 . . . . 0.0 110.399 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.572 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -134.2 130.55 37.4 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.777 0.322 . . . . 0.0 110.362 179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.973 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -96.84 138.37 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.375 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.24 112.8 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.2 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -109.34 174.42 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.419 ' HA ' ' CG ' ' A' ' 59' ' ' ASP . 8.3 t70 -95.34 143.78 26.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.145 -178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.6 Cg_exo -46.2 -37.3 18.18 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.082 2.521 . . . . 0.0 112.772 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.706 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -57.0 -42.88 81.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.709 0.766 . . . . 0.0 109.523 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.928 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.9 t -75.49 -32.32 60.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.803 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.96 -45.1 7.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.743 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.982 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.79 -19.78 44.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.035 -179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.9 m-85 -83.48 -40.17 19.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.914 0.387 . . . . 0.0 111.216 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.928 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.65 28.75 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 -178.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.07 123.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.9 32.72 0.01 OUTLIER Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.269 -1.332 . . . . 0.0 115.616 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.19 -151.08 19.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.69 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 20.8 m -150.25 130.21 13.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.916 0.358 . . . . 0.0 110.704 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.04 152.43 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.263 0.554 . . . . 0.0 111.605 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.25 142.76 23.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.485 178.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -117.07 141.58 48.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.016 0.436 . . . . 0.0 110.956 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.416 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 88.5 m -150.12 89.48 1.59 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.516 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 1.2 pm0 -99.24 162.75 12.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.66 -109.68 0.27 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.431 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.69 -54.13 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.66 -23.03 38.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.46 148.4 7.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.415 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.516 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 89.1 p -59.61 91.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.366 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.02 141.42 30.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.5 t80 -123.49 129.26 50.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.17 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 128.74 32.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.123 0.487 . . . . 0.0 111.76 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 ' HD2' ' A' ' 47' ' ' TYR . 1.8 t -125.98 158.98 34.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -136.92 128.81 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.977 0.418 . . . . 0.0 111.505 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.501 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -147.98 168.77 10.46 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.197 179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 10.8 Cg_endo -54.7 -57.27 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.069 . . . . 0.0 112.566 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -22.79 63.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 99' ' ' ASN . . . -81.72 9.93 7.01 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.3 p 50.25 98.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.84 0.352 . . . . 0.0 111.427 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 m -80.41 126.77 31.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.55 175.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.71 123.34 17.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.43 17.48 3.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.631 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 56.9 m -115.65 31.47 6.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.819 0.342 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.3 -117.51 5.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.428 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.25 170.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 110.873 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.61 173.67 2.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -103.98 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 77.1 p -111.92 162.55 15.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.606 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.548 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mmm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.792 0.33 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.62 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.863 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 1.8 t70 89.86 -9.56 0.37 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.218 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.89 -42.99 4.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.233 0.54 . . . . 0.0 110.017 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.0 -151.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.908 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.809 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -166.32 -33.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.45 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -136.97 -77.11 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -108.95 -114.72 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.198 1.932 . . . . 0.0 114.79 -176.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.04 127.42 32.13 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.533 0.733 . . . . 0.0 112.832 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.608 ' N ' HD12 ' A' ' 9' ' ' LEU . 45.8 m -100.14 122.43 42.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.389 177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.832 ' HB2' HG22 ' A' ' 84' ' ' VAL . 22.7 p90 -89.57 -179.68 5.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.815 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.35 -160.31 0.55 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.226 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 m-20 -91.58 -42.62 10.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.3 0.571 . . . . 0.0 110.773 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -41.02 93.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.54 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.822 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.89 -31.01 37.35 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.12 -42.06 60.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.185 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -54.69 -50.61 67.84 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.381 -1.281 . . . . 0.0 112.485 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.72 -32.44 65.53 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.063 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.774 HG13 ' HD1' ' A' ' 51' ' ' PHE . 50.7 t -72.48 -70.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.96 -19.77 5.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.665 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.402 ' N ' ' HE3' ' A' ' 20' ' ' LYS . 35.1 t -86.13 -46.97 9.93 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.866 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.49 -25.34 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.83 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.709 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -71.96 -47.91 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.713 0.768 . . . . 0.0 109.964 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.4 m -58.49 -23.96 59.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.125 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -19.93 43.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.164 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 46.2 mt-10 -80.14 -18.37 49.99 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.365 0.602 . . . . 0.0 110.442 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER 80.5 11.41 1.01 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.526 -178.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.713 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.12 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.573 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.73 -46.55 0.0 OUTLIER 'General case' 0 C--O 1.231 0.096 0 O-C-N 124.063 0.852 . . . . 0.0 112.382 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 173.36 66.79 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.713 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.2 154.98 15.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.743 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HG3' ' HA ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -118.63 126.78 52.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.317 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.943 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.22 146.4 39.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.172 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.77 ' N ' HD13 ' A' ' 33' ' ' LEU . 8.9 ttt-85 -141.85 97.21 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.359 0.6 . . . . 0.0 109.855 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 69' ' ' LEU . 6.7 t -74.37 156.45 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -144.85 176.46 9.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.806 178.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD13 ' HD1' ' A' ' 47' ' ' TYR . 18.6 mm -87.35 110.73 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.876 0.369 . . . . 0.0 110.837 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.2 m -127.45 -33.31 2.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.944 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -117.37 168.3 12.87 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.677 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . 127.34 -56.99 0.71 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.004 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 -59.86 2.58 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.652 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -120.51 -6.18 9.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.488 0.185 . . . . 0.0 111.171 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.2 m -148.93 -83.5 0.1 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.601 0.239 . . . . 0.0 111.342 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA2' ' HA3' ' A' ' 40' ' ' GLY . . . 145.89 117.23 1.06 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.626 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 46' ' ' GLN . 2.7 p90 -142.86 -1.79 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.457 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 11.9 mt-30 -113.55 -73.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.175 -0.328 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HD2' HG21 ' A' ' 97' ' ' VAL . 11.6 m-85 72.49 119.95 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.899 0.381 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -74.04 131.85 14.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.628 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.91 134.51 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.943 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.1 t -127.94 169.79 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.186 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.774 ' HD1' HG13 ' A' ' 19' ' ' VAL . 11.1 m-85 -112.2 99.16 7.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.578 0.704 . . . . 0.0 110.127 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 2.7 t70 -114.83 108.66 17.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.444 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.553 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -75.01 -28.45 60.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.358 -178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.65 -96.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.09 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 12.1 p 167.76 -19.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 56' ' ' ASN . 2.0 m-80 48.71 92.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.105 0.479 . . . . 0.0 110.478 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -46.97 -44.16 19.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.0 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.07 53.66 4.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.35 -0.929 . . . . 0.0 110.964 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.33 114.12 2.7 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 122.457 0.303 . . . . 0.0 110.445 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD11 HD12 ' A' ' 76' ' ' LEU . 5.2 mt -59.06 151.57 22.01 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -135.63 128.6 31.42 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.809 HG22 ' N ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -116.55 127.39 74.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.536 177.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -59.75 152.89 21.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 21.8 mtpp -114.08 171.08 7.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.165 0.507 . . . . 0.0 111.42 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -42.15 39.79 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.733 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -133.91 9.15 4.85 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.874 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.83 -146.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.943 0.371 . . . . 0.0 110.847 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -135.14 135.45 41.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 110.977 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -103.01 137.43 41.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.769 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.869 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.2 m -143.07 108.89 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 110.833 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.78 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -101.92 171.12 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.985 0.422 . . . . 0.0 111.613 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -95.19 146.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.414 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 93.2 Cg_exo -43.54 -38.77 9.14 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.272 2.648 . . . . 0.0 112.739 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.671 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -56.79 -44.57 82.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.784 0.802 . . . . 0.0 109.435 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.894 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.0 OUTLIER -76.03 -31.04 58.68 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.045 178.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.003 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.73 -45.09 4.63 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.765 -179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 1.003 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.28 -19.72 35.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.201 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -83.21 -39.35 21.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.821 0.343 . . . . 0.0 111.403 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.894 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.48 -17.05 27.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.67 123.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -177.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.52 32.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 115.508 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.7 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.69 -151.01 18.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.852 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.475 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.9 m -150.16 134.6 17.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.849 0.325 . . . . 0.0 110.576 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.832 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -128.97 150.73 34.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.121 0.486 . . . . 0.0 111.571 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.4 OUTLIER -151.27 143.38 24.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.966 178.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.53 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.93 143.01 46.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 92.2 m -150.29 89.77 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.947 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 7.3 pt-20 -103.14 165.22 11.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.673 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.71 -111.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.72 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.52 -68.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.779 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -59.25 -19.84 49.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.972 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.09 157.03 22.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.168 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.546 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 7.9 t -59.6 89.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.049 0.452 . . . . 0.0 110.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -104.26 133.71 48.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.1 t80 -112.56 132.85 54.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.322 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.7 129.23 26.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.394 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.9 t -127.87 165.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.448 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.449 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.5 m-80 -149.25 158.31 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.908 0.385 . . . . 0.0 111.251 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.556 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 4.1 p30 -175.59 166.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.543 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 9.2 Cg_endo -53.41 -35.22 74.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.786 2.324 . . . . 0.0 113.05 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.43 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -77.81 -31.52 51.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.346 -179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' ' OD1' ' A' ' 99' ' ' ASN . . . -92.75 46.94 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.957 0.408 . . . . 0.0 111.287 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 p -99.9 71.79 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -93.19 -47.79 6.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.038 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -121.37 128.21 52.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.2 p -118.38 30.38 7.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.13 17.18 6.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.618 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.39 136.25 34.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.855 0.359 . . . . 0.0 110.855 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.56 -71.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.476 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.66 102.42 3.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -145.11 116.79 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 60.42 -171.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.2 m -142.26 160.19 40.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.771 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.494 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.225 0 CA-C-O 120.555 0.217 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.71 -160.56 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 110.681 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -169.48 -38.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.186 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.43 -49.76 76.3 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.555 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 2.8 mmt 48.51 -173.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.178 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 74.65 72.82 0.1 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.418 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -87.56 -64.98 0.2 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.223 -179.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.31 -123.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.085 2.523 . . . . 0.0 114.307 -177.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.663 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.09 128.71 38.58 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.756 0.822 . . . . 0.0 112.556 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.612 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.3 m -99.2 120.91 40.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.305 177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.895 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.1 p90 -88.86 -179.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.004 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -83.82 -160.86 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.326 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.526 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 70.4 m-20 -91.97 -42.48 9.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.264 0.554 . . . . 0.0 111.252 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.98 -40.83 90.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.09 -33.69 40.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.92 -43.71 67.67 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.009 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.3 m-80 -58.33 -43.33 88.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.22 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.82 -31.16 68.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.986 0.422 . . . . 0.0 109.977 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 33' ' ' LEU . 83.6 t -80.24 -68.6 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.229 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -53.04 -19.58 2.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.527 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 30.9 t -86.96 -45.23 10.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.864 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.55 -25.13 31.23 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.422 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.725 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 pp -72.59 -48.71 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.697 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.3 m -59.83 -23.46 63.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.08 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -81.94 -20.26 39.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.338 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.55 -18.38 48.6 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.059 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.6 tt0 80.86 11.54 0.89 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.606 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.703 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.82 -70.56 0.11 Allowed 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.86 -45.6 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.192 -179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 171.41 68.29 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 153.23 17.58 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.171 -177.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 7.5 mtpt -114.64 120.57 40.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.399 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.895 HD12 HD13 ' A' ' 69' ' ' LEU . 2.4 tm? -59.25 145.35 43.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.797 0.332 . . . . 0.0 110.716 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -140.04 96.34 3.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.283 0.563 . . . . 0.0 110.165 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -73.01 155.62 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.956 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.27 -179.91 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.135 177.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 75' ' ' SER . 15.0 mm -87.82 113.23 24.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 0.0 111.764 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 38' ' ' THR . 15.9 m -150.55 32.71 0.63 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.249 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.83 -153.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.076 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.88 65.19 0.1 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.573 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 42' ' ' CYS . . . 162.38 51.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.403 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' GLY . 5.0 m 66.62 -64.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.723 0.297 . . . . 0.0 111.282 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 41' ' ' GLY . 1.0 OUTLIER -71.94 -66.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.149 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.78 135.72 4.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.144 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -146.62 3.02 0.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 25.3 mt-30 -109.14 -73.11 0.7 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.455 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.687 ' HD2' HG21 ' A' ' 97' ' ' VAL . 18.2 m-85 72.34 111.11 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.479 . . . . 0.0 110.094 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -66.85 134.46 32.19 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.142 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.852 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -107.6 137.55 45.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 112.117 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.877 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -133.76 163.5 29.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.819 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.2 m-85 -106.66 98.05 7.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.565 0.697 . . . . 0.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.1 t70 -116.52 105.23 12.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.576 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.505 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.64 -21.05 45.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -56.58 -101.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.588 -178.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -163.48 -62.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.046 0.45 . . . . 0.0 112.151 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 1.2 m120 71.39 72.52 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -47.01 -29.6 2.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.606 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.47 47.66 1.73 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' OD1' ' HA ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -150.99 111.53 4.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD11 HD12 ' A' ' 76' ' ' LEU . 3.8 mt -59.2 147.09 36.73 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.871 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.6 p -126.46 131.25 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -122.29 130.79 74.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.975 -1.466 . . . . 0.0 107.794 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.54 152.08 22.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.672 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HG2' HG22 ' A' ' 67' ' ' VAL . 16.4 tptt -109.41 159.17 17.24 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.291 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.454 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.67 -37.6 29.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.168 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.43 9.57 4.68 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.524 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 20' ' ' LYS . 12.2 m -155.81 -149.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -131.68 129.13 40.35 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 35' ' ' VAL . 3.2 tp -98.88 139.05 35.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.953 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.876 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -143.66 110.76 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.603 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -104.87 166.15 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 5.2 t70 -84.24 145.18 45.16 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.089 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.598 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 87.9 Cg_exo -47.85 -49.22 14.15 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.015 2.477 . . . . 0.0 112.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.778 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 4.0 ptp -51.37 -34.57 34.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.698 0.761 . . . . 0.0 109.584 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 4.6 m -75.8 -36.11 59.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.401 177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -43.35 -43.2 4.93 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.67 -179.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -80.25 -21.87 42.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.617 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -85.24 -39.3 17.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.886 0.374 . . . . 0.0 111.522 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.18 29.71 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.67 120.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 29.75 35.06 0.01 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.159 -1.382 . . . . 0.0 115.718 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -86.22 -147.66 10.83 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.003 -1.094 . . . . 0.0 111.744 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 6.2 m -150.1 134.9 17.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.919 0.359 . . . . 0.0 110.389 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.895 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.95 154.31 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.126 0.488 . . . . 0.0 111.549 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.2 146.04 25.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.407 178.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.502 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.4 145.08 45.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.113 0.482 . . . . 0.0 111.34 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.411 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 98.7 m -148.1 89.86 1.77 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.542 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 28.8 mt-10 -51.23 159.36 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.457 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.48 27.67 2.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.327 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp 63.15 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.735 0.303 . . . . 0.0 111.177 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -59.23 -23.25 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 109.64 0.26 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.396 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.635 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 16.2 m -60.0 122.33 14.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.091 0.472 . . . . 0.0 111.18 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -82.46 144.41 30.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.883 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.4 t80 -132.35 133.64 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.011 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.95 130.0 23.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.275 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.687 HG21 ' HD2' ' A' ' 47' ' ' TYR . 3.1 t -128.15 165.2 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.955 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' H ' HG12 ' A' ' 97' ' ' VAL . 49.8 m-20 -145.2 158.21 43.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.956 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.532 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.7 p30 -178.87 164.1 1.04 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.856 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 19.2 Cg_endo -60.35 -40.54 57.49 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.639 2.226 . . . . 0.0 112.594 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -35.92 77.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.866 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . . . -95.92 37.29 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -151.15 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.854 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.18 123.86 33.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.818 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -149.54 129.95 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 2.6 t -170.91 34.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -137.96 11.61 3.63 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.76 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 56.02 30.29 15.94 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.735 0.303 . . . . 0.0 111.05 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.04 -88.54 1.35 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.499 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.23 -57.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.78 168.86 25.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 60.52 -173.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.6 p -109.57 162.38 14.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.535 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.602 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -92.13 -161.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -174.44 31.56 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.65 -47.67 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.373 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.432 ' HE1' HG13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -113.6 161.55 17.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.003 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.46 88.54 0.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.437 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.61 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.75 -69.0 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 7' ' ' VAL . 1.8 Cg_endo -104.95 -119.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.858 2.372 . . . . 0.0 113.204 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.57 126.67 28.52 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.02 0.528 . . . . 0.0 112.352 -179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.594 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.2 m -99.75 120.71 40.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.859 ' HB2' HG22 ' A' ' 84' ' ' VAL . 26.5 p90 -87.76 -179.63 6.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.807 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.655 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.3 t -84.52 -161.5 0.57 Allowed 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.135 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -91.74 -42.9 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.963 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.22 -41.22 88.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.716 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.745 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.6 -33.68 34.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.33 -43.42 67.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.217 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 21' ' ' SER . 5.7 m-80 -60.68 -35.44 76.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.482 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -70.47 -25.82 63.35 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.899 0.38 . . . . 0.0 110.518 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.806 HG13 ' HD1' ' A' ' 51' ' ' PHE . 97.1 t -81.8 -64.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.125 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -55.78 -19.64 12.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 112.134 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 48.1 t -88.12 -44.87 10.6 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.858 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.13 -24.76 34.93 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.387 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 24' ' ' SER . 2.4 pp -73.61 -48.91 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.681 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.71 -24.36 56.46 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.4 -20.75 46.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.113 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.5 mm-40 -79.43 -19.03 50.91 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.089 0.471 . . . . 0.0 109.884 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tp10 82.15 11.41 0.66 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.604 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.683 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -58.26 -71.73 0.11 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.89 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 159.87 -47.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.932 0.77 . . . . 0.0 112.392 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 174.65 66.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.683 HD23 ' CG ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.23 154.84 15.44 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.322 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 26.8 mtpt -115.2 122.99 47.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.322 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.19 146.46 38.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.899 0.381 . . . . 0.0 110.947 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.75 96.58 3.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.117 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.818 HG23 HD11 ' A' ' 69' ' ' LEU . 20.4 t -72.63 155.04 7.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.21 -179.76 6.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.846 178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.805 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm -85.89 116.47 28.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.119 0.485 . . . . 0.0 111.333 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 38' ' ' THR . 6.4 m -156.67 34.3 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.858 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.84 -145.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.709 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.87 24.68 25.23 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.729 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.76 -79.1 1.88 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.6 m -63.64 -30.11 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.731 0.3 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.2 m -127.1 -172.08 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' C ' ' HH ' ' A' ' 47' ' ' TYR . . . -140.24 97.92 0.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.281 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.2 p90 -138.8 1.9 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 13.0 mt-30 -113.07 -72.78 0.69 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.596 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HD2' HG21 ' A' ' 97' ' ' VAL . 24.9 m-85 70.75 125.14 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.025 0.44 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -78.26 131.62 11.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.789 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.919 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.06 133.66 47.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.137 0.494 . . . . 0.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.897 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -129.08 164.24 23.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.392 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.806 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.4 m-85 -107.91 98.81 8.33 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.679 0.752 . . . . 0.0 109.752 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.9 t70 -118.22 105.84 12.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.725 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -79.4 -19.81 49.14 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.667 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.04 -103.51 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.737 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.0 p 163.94 42.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.33 0.394 . . . . 0.0 111.712 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -17.89 95.41 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.798 0.439 . . . . 0.0 111.518 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.08 125.78 9.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.186 0.517 . . . . 0.0 110.304 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.89 36.42 6.06 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 56' ' ' ASN . 25.6 p-10 -134.46 109.19 8.57 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.835 0.454 . . . . 0.0 110.329 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.29 131.05 49.82 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB ' ' A' ' 70' ' ' VAL . 2.2 p -115.27 125.47 53.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -177.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -112.28 129.63 67.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.64 152.11 23.16 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.333 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HG2' HG22 ' A' ' 67' ' ' VAL . 14.4 tptt -109.08 158.96 17.26 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.431 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.459 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -49.41 -37.71 26.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.042 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 20' ' ' LYS . . . -134.76 9.49 4.57 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.98 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' N ' ' A' ' 68' ' ' GLN . 13.8 m -155.95 -148.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -130.81 130.53 43.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.688 0.28 . . . . 0.0 110.408 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.888 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.9 tp -100.29 133.58 44.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.382 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.888 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -139.02 112.45 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.1 0.476 . . . . 0.0 110.622 -179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.664 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -105.61 167.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.469 . . . . 0.0 111.983 -178.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -93.1 145.02 29.29 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.027 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.586 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 85.2 Cg_exo -46.47 -36.89 18.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.346 2.697 . . . . 0.0 112.989 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.535 ' HG2' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -55.71 -47.31 77.08 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.042 0.925 . . . . 0.0 109.637 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.925 ' O ' HD13 ' A' ' 79' ' ' LEU . 16.0 m -74.44 -30.43 61.89 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.164 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.25 -46.26 12.38 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.287 -179.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.75 -24.59 60.98 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.533 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -83.8 -39.15 20.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.925 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.36 -16.3 29.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.565 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.27 121.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 31.2 33.94 0.01 OUTLIER Glycine 0 CA--C 1.522 0.509 0 CA-C-N 114.425 -1.261 . . . . 0.0 115.689 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.89 -150.17 14.3 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.458 ' CA ' HD11 ' A' ' 9' ' ' LEU . 10.3 m -150.05 134.38 17.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.861 0.331 . . . . 0.0 110.459 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -130.36 153.17 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.151 0.501 . . . . 0.0 111.641 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.9 OUTLIER -151.19 145.01 25.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.1 144.94 45.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.976 -179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' A' ' 94' ' ' ARG . 96.4 m -149.78 89.54 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.096 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 2.5 pp20? -105.38 163.8 12.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.245 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.05 -104.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.345 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.7 mp -102.19 -48.35 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 110.721 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.39 -20.69 64.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.985 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.89 146.09 7.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.412 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 48.9 p -59.65 96.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 111.637 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HD3' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.18 139.15 31.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.964 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' HZ ' ' CZ ' ' A' ' 49' ' ' PHE . 4.5 t80 -124.49 125.35 44.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 122.45 21.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.712 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.52 166.26 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.227 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 97' ' ' VAL . 31.7 m-80 -148.62 132.25 16.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.626 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -148.63 166.67 14.89 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.166 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 18.9 Cg_endo -60.42 -53.14 3.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.535 2.157 . . . . 0.0 112.941 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -28.45 65.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.32 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.8 -83.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.765 0.317 . . . . 0.0 111.054 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.0 29.85 1.14 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.258 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' THR . 19.6 t -127.94 170.04 13.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.938 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 104' ' ' SER . 0.6 OUTLIER -162.63 116.24 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.71 -61.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.39 42.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.673 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t 59.85 31.11 20.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.789 0.328 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.3 66.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -103.06 -41.29 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.784 0.326 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.24 161.26 14.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -107.25 -171.81 1.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.16 160.63 21.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.606 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.537 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' C ' HD13 ' A' ' 2' ' ' ILE . 10.7 ptm . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.799 0.333 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -101.51 -163.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.669 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 80.81 13.86 0.74 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.8 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -112.85 -41.17 3.83 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.233 0.54 . . . . 0.0 110.427 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.59 161.47 24.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.512 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 48.94 49.65 18.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.295 0.569 . . . . 0.0 109.853 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.26 -70.6 0.19 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.795 -178.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.2 Cg_endo -105.39 -120.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.734 2.289 . . . . 0.0 113.652 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.712 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.33 125.74 24.82 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.074 0.55 . . . . 0.0 112.128 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.4 m -97.28 121.04 38.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.433 177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.823 ' HB2' HG22 ' A' ' 84' ' ' VAL . 21.7 p90 -87.2 -179.71 6.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.64 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.5 t -85.56 -161.12 0.57 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.252 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.1 m-20 -91.62 -41.97 10.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.212 0.53 . . . . 0.0 110.924 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.58 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.798 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.17 -33.41 40.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.87 -43.13 69.07 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.908 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.3 m-80 -55.94 -48.66 75.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.563 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -57.99 -28.55 64.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.445 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.769 HG13 ' HD1' ' A' ' 51' ' ' PHE . 57.5 t -78.76 -69.24 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.62 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.81 -19.4 4.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.255 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 38.0 t -87.86 -44.68 10.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.879 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.34 -25.65 31.26 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.517 -179.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.39 -48.7 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.672 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.7 m -59.27 -23.33 62.3 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.231 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.15 -20.08 42.06 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.494 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 5.4 mm-40 -80.72 -18.17 48.71 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.155 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.2 tt0 80.49 11.5 1.01 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.466 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.16 -70.76 0.1 Allowed 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.623 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.16 -46.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.428 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.78 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.8 155.27 13.28 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 114.44 -1.254 . . . . 0.0 113.095 -178.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 32.2 mtpt -118.54 124.86 48.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.381 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.962 HD22 ' O ' ' A' ' 50' ' ' THR . 2.3 tm? -59.47 147.39 36.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.086 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -141.91 96.33 2.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.925 HG23 HD11 ' A' ' 69' ' ' LEU . 9.9 t -73.05 156.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -146.25 177.66 8.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.432 -1.258 . . . . 0.0 109.017 178.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.5 mm -87.65 108.47 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.4 m -122.37 -36.2 2.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.71 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.06 -147.97 23.06 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.554 ' HA2' ' HA2' ' A' ' 44' ' ' GLY . . . 150.47 -70.28 0.31 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.533 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.55 -84.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.902 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' GLY . 85.1 m -121.79 11.93 10.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 171.44 -63.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.011 0.434 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.554 ' HA2' ' HA2' ' A' ' 40' ' ' GLY . . . 157.99 115.6 0.45 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.774 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -142.45 0.67 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.439 ' HG3' ' CD1' ' A' ' 45' ' ' PHE . 23.9 mt-30 -109.3 -78.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.102 -0.374 . . . . 0.0 111.591 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 97' ' ' VAL . 15.3 m-85 73.15 120.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 0.0 110.783 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -75.56 131.53 12.19 Favored Glycine 0 N--CA 1.454 -0.159 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.996 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.05 133.89 48.23 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.962 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.2 t -128.66 167.75 16.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.317 177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.769 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.4 m-85 -111.8 100.57 9.03 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 1.9 p-10 -115.45 113.32 23.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.277 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HG3' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.02 -13.68 58.61 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -68.99 -107.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -163.84 -60.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.215 0.531 . . . . 0.0 111.352 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 2.3 m-80 82.47 83.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.924 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -48.77 131.94 18.04 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.28 37.6 24.12 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -136.39 110.77 8.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.364 -0.418 . . . . 0.0 109.9 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.673 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt -60.97 152.15 28.53 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.58 128.75 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.984 0.897 . . . . 0.0 113.289 -177.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.42 122.88 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.615 178.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -59.55 152.62 21.57 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.05 -0.406 . . . . 0.0 111.25 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.551 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 18.9 mtpp -114.3 171.06 7.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.149 0.5 . . . . 0.0 111.211 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.73 -41.65 44.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.861 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -133.12 7.74 5.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.131 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.7 m -154.48 -149.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 O-C-N 122.487 -0.42 . . . . 0.0 110.648 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.84 134.35 45.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.924 0.393 . . . . 0.0 110.811 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.937 HD13 HD12 ' A' ' 33' ' ' LEU . 2.0 tp -102.87 134.33 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.382 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.913 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -137.24 118.03 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.745 0.307 . . . . 0.0 110.417 -179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -115.12 158.87 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.362 0.601 . . . . 0.0 111.813 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.47 144.81 46.79 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.806 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 89.7 Cg_exo -46.1 -36.55 16.6 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.237 2.625 . . . . 0.0 113.052 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.707 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -57.76 -45.22 86.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.838 0.828 . . . . 0.0 109.73 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 5.1 m -73.83 -32.78 63.86 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.401 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.39 -47.72 18.78 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.578 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.935 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.11 -24.02 63.13 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.506 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.5 m-85 -83.65 -39.59 20.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.51 -16.64 28.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.18 121.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.35 32.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.608 0 CA-C-N 114.593 -1.185 . . . . 0.0 115.587 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.712 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.28 -148.79 14.34 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.972 -1.109 . . . . 0.0 111.85 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 ' CA ' HD11 ' A' ' 9' ' ' LEU . 8.8 m -150.11 133.86 16.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.899 0.349 . . . . 0.0 110.473 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -127.89 152.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.061 0.458 . . . . 0.0 111.399 179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.37 144.37 24.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.105 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.76 143.81 45.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.471 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 84.8 m -150.1 89.84 1.63 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.9 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 3.2 pm0 -101.37 163.23 12.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.0 117.46 1.87 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.854 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 62.44 -79.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.273 . . . . 0.0 111.31 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -53.11 -24.41 10.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.774 0.321 . . . . 0.0 111.256 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.64 144.52 8.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.318 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.517 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 35.1 p -59.85 103.34 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.479 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -105.89 160.01 15.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.07 179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.535 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 6.2 t80 -133.54 134.76 43.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.56 -179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 133.28 30.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.984 0.421 . . . . 0.0 111.474 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.8 t -129.64 166.05 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.632 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' H ' HG12 ' A' ' 97' ' ' VAL . 22.5 m-80 -150.46 131.14 14.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -140.33 167.64 17.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.762 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 38.2 Cg_endo -66.81 -44.39 5.73 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.49 2.126 . . . . 0.0 112.705 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -30.34 67.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.854 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.72 -33.04 46.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.261 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 74.6 p -92.08 148.98 21.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.726 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.68 -42.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.12 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 m 74.56 -63.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.7 p -137.41 34.62 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.28 18.24 1.52 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.676 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -49.2 5.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.31 109.13 1.55 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.33 118.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.352 . . . . 0.0 110.996 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.8 p -132.64 149.54 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 60.12 -170.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.1 p -68.29 -164.94 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.449 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.589 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.34 -161.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER 83.5 16.31 0.28 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.73 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -109.12 -41.34 4.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.469 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.583 ' O ' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -131.94 161.44 33.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.14 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.639 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.63 91.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -128.85 -71.79 0.01 OUTLIER Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.647 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -105.98 -116.73 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.713 2.275 . . . . 0.0 113.22 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.68 127.14 30.5 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.268 0.627 . . . . 0.0 112.472 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.631 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.15 120.94 40.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.861 ' HB2' HG22 ' A' ' 84' ' ' VAL . 30.8 p90 -87.99 -179.84 6.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.664 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -84.46 -160.14 0.45 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.815 0.34 . . . . 0.0 111.385 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 m-20 -91.59 -42.84 9.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.167 0.508 . . . . 0.0 110.683 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.6 -40.26 91.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.505 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.761 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . . . -52.62 -32.99 44.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD ' ' A' ' 64' ' ' LYS . . . -70.89 -43.4 68.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.034 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.3 m-80 -58.25 -43.71 87.99 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.055 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.85 -30.91 62.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.269 179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.734 HG13 ' HD1' ' A' ' 51' ' ' PHE . 74.9 t -83.69 -69.31 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.83 -19.73 2.73 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 21.4 t -87.59 -45.28 10.58 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.854 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.32 -24.57 32.08 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.752 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.23 -48.69 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.732 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.67 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.86 -23.45 63.42 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.205 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.46 -19.67 41.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.214 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 3.0 mm-40 -80.96 -18.48 46.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.056 0.455 . . . . 0.0 110.194 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.8 OUTLIER 79.93 11.9 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.477 -178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.21 -70.33 0.12 Allowed 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.293 -179.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 173.6 66.04 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.712 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.89 160.34 5.99 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.367 -1.288 . . . . 0.0 112.541 -178.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.818 ' HE2' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -124.39 127.84 48.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.295 179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 50' ' ' THR . 1.9 tm? -64.55 146.63 54.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.992 0.425 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.842 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.82 96.14 2.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.473 0.654 . . . . 0.0 109.998 178.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG23 HD11 ' A' ' 69' ' ' LEU . 10.6 t -71.79 154.04 7.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.263 -178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.28 -179.74 6.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.369 -1.287 . . . . 0.0 108.801 178.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 75' ' ' SER . 25.2 mm -91.65 108.42 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.165 0.507 . . . . 0.0 111.492 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.9 m -118.94 -38.01 3.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.407 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 44.18 -168.92 0.02 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.276 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.71 21.52 42.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.441 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.97 -43.32 2.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.288 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 61.7 m -108.11 -29.64 8.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.834 0.35 . . . . 0.0 110.722 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.48 -164.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.795 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.55 95.01 0.19 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.272 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.3 p90 -138.91 1.1 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 5.9 mt-30 -109.44 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.423 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.634 ' HD2' HG21 ' A' ' 97' ' ' VAL . 40.7 m-85 72.33 115.89 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.098 0.475 . . . . 0.0 110.354 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.09 131.65 23.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.28 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.888 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.03 133.6 50.49 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.929 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.9 t -129.56 160.71 32.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.599 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.734 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -107.74 100.43 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.269 0.557 . . . . 0.0 110.009 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.7 p-10 -116.26 113.21 22.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.11 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -72.03 -17.7 62.01 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.154 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.36 -100.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 10.5 p 161.95 -19.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 56' ' ' ASN . 1.9 m-80 48.69 90.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -47.27 -52.99 14.55 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.8 52.9 4.76 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.227 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 71' ' ' ILE . 9.4 t70 -147.41 114.51 6.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -59.95 136.94 58.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -121.78 128.43 51.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.086 0.946 . . . . 0.0 113.446 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -113.86 130.25 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.168 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -59.74 151.7 24.56 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.254 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.567 ' HE2' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -111.5 156.09 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.485 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -46.61 -37.22 7.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.53 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.56 8.28 4.62 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.258 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -154.47 -146.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 122.818 -0.225 . . . . 0.0 110.765 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.818 ' HG2' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.58 125.17 29.86 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.903 HD11 HG23 ' A' ' 35' ' ' VAL . 4.6 tp -95.93 136.82 35.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.842 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.6 OUTLIER -141.63 115.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.898 0.38 . . . . 0.0 110.284 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.67 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.87 149.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.307 0.575 . . . . 0.0 111.716 -179.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -73.59 145.97 85.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.18 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.571 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.9 Cg_exo -45.63 -36.17 13.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.336 2.691 . . . . 0.0 113.059 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.649 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -56.25 -43.88 79.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.671 0.748 . . . . 0.0 109.687 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 2.0 m -76.17 -31.67 58.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.03 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.99 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.77 -44.63 3.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.887 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.99 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.25 -21.03 31.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.458 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -82.12 -39.89 22.67 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.914 0.388 . . . . 0.0 111.295 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.3 -16.7 28.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.29 122.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 33.26 31.49 0.01 OUTLIER Glycine 0 CA--C 1.521 0.449 0 CA-C-N 114.308 -1.314 . . . . 0.0 115.805 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.685 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.04 -150.85 13.12 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.516 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.478 ' CA ' HD11 ' A' ' 9' ' ' LEU . 22.7 m -150.21 130.54 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.948 0.374 . . . . 0.0 110.569 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.861 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -125.25 152.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.175 0.512 . . . . 0.0 111.639 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 2.6 p30 -151.2 143.14 23.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.325 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.504 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -116.56 142.71 46.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.924 0.392 . . . . 0.0 111.034 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.457 ' HB ' ' CD ' ' A' ' 94' ' ' ARG . 90.5 m -148.84 89.48 1.68 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.778 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 51.4 mt-10 -89.51 164.34 14.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.957 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.92 -140.87 6.39 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.608 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.4 mp -74.14 -48.97 25.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 0.0 110.703 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -57.92 -21.52 44.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.859 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.59 154.15 9.83 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.385 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 77.9 p -59.66 89.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.833 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' CD ' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -85.28 138.21 32.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.08 179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.8 t80 -128.5 130.99 48.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.52 134.45 39.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.21 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.634 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.4 t -133.31 156.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.179 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.4 m-20 -134.08 152.77 51.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 111.48 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.522 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 1.0 OUTLIER 176.7 167.4 0.44 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.366 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 3.6 Cg_endo -47.4 -35.8 22.04 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.822 2.348 . . . . 0.0 112.996 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -47.36 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.65 0.262 . . . . 0.0 111.129 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.62 -75.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.273 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 99' ' ' ASN . 3.3 p 49.76 41.18 21.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.054 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.5 t -74.93 -44.44 48.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.971 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.6 p 56.74 -168.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.02 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.3 m -96.01 41.83 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.48 16.82 63.55 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.725 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.3 p -115.15 177.46 4.65 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.16 -77.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 112' ' ' PHE . 78.4 p -98.83 32.24 2.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.6 m -103.57 41.05 1.32 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.107 0.48 . . . . 0.0 110.83 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 110' ' ' SER . 47.2 m-85 -67.45 -170.94 0.15 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.013 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -145.98 160.36 41.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.513 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.843 0.354 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.89 -161.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -36.15 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -43.49 -42.25 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.224 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 21.7 mmt -46.48 172.72 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.693 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.831 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 73.96 68.37 0.1 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.876 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -88.15 -67.32 0.15 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -109.97 -119.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.21 2.607 . . . . 0.0 113.988 -177.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.34 128.18 35.81 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.626 0.771 . . . . 0.0 112.389 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.61 ' N ' HD12 ' A' ' 9' ' ' LEU . 27.4 m -100.36 122.86 43.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.627 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.848 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.8 p90 -88.34 -179.68 6.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.644 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.6 t -86.72 -160.31 0.56 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.278 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.0 t0 -91.75 -42.7 9.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.517 . . . . 0.0 110.844 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.68 -40.85 93.68 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.674 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.811 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.01 -31.85 43.34 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . . . -72.27 -43.22 64.62 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.102 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 21' ' ' SER . 3.7 m-80 -57.13 -44.84 83.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.317 -1.311 . . . . 0.0 111.274 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -60.61 -31.65 70.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.994 0.426 . . . . 0.0 110.412 -179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.757 HG13 ' HD1' ' A' ' 51' ' ' PHE . 60.4 t -75.75 -68.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.9 OUTLIER -54.01 -19.54 4.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.285 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 36.2 t -88.6 -44.62 10.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.86 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.51 -25.33 33.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 24' ' ' SER . 2.6 pp -73.49 -48.85 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.182 0.515 . . . . 0.0 109.903 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.689 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.3 m -57.87 -24.08 55.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.962 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -19.64 45.61 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.112 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 4.5 mm-40 -81.09 -18.54 46.17 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 120.979 0.419 . . . . 0.0 110.141 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 5.0 tt0 81.37 11.26 0.8 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.735 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.684 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -56.82 -71.25 0.1 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.103 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 158.96 -46.87 0.0 OUTLIER 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.554 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.91 67.69 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.684 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.12 155.09 14.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.312 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 6.9 mtpt -116.25 122.03 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.368 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.6 145.38 44.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.918 0.389 . . . . 0.0 110.874 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.773 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -138.92 97.36 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.292 0.568 . . . . 0.0 109.793 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 69' ' ' LEU . 13.4 t -74.44 155.68 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.15 -179.74 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.169 -1.378 . . . . 0.0 108.85 178.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 75' ' ' SER . 24.4 mm -91.75 110.04 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.107 0.479 . . . . 0.0 111.407 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.5 m -122.22 -36.35 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.87 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 41.94 -159.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 113.032 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.08 -82.71 0.14 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.634 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.38 33.48 1.01 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.627 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.97 -46.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.943 0.402 . . . . 0.0 110.743 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -175.0 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.593 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . -179.64 89.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.364 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 97' ' ' VAL . 10.0 p90 -120.51 -4.08 9.85 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 7.0 mt-30 -106.48 -64.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.592 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.547 ' HD1' HG21 ' A' ' 97' ' ' VAL . 56.3 m-85 71.6 115.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.046 0.45 . . . . 0.0 110.482 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -70.96 130.39 19.59 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.083 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.922 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.02 134.31 48.35 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.3 t -130.11 163.65 26.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.371 177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.6 m-85 -108.13 99.34 8.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.588 0.709 . . . . 0.0 109.98 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.05 105.46 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.919 -178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' CG ' ' HA ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -81.42 -20.94 39.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -55.06 -100.01 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.306 -0.246 . . . . 0.0 111.343 -178.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 54' ' ' LYS . 2.6 t -164.37 -63.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 111.47 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 1.0 OUTLIER 69.83 72.01 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -177.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.88 -30.83 2.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.542 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.34 47.89 1.93 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.495 ' OD2' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -150.28 110.6 4.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.753 HD11 HD12 ' A' ' 76' ' ' LEU . 4.4 mt -59.3 150.25 26.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.729 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.2 p -130.44 136.37 48.95 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.831 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.93 125.54 68.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.427 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.53 152.62 21.49 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.922 -0.486 . . . . 0.0 111.234 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 16' ' ' ALA . 13.5 mtpt -116.56 169.7 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.197 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.48 -41.49 40.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.195 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -134.64 10.29 4.61 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.414 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HD3' ' A' ' 64' ' ' LYS . 18.2 m -154.96 -146.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 122.912 -0.169 . . . . 0.0 110.607 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -138.41 132.2 31.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 110.439 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -98.6 138.74 35.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.147 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.855 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -142.85 107.36 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.231 0.539 . . . . 0.0 110.482 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.625 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -102.33 163.44 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.155 0.502 . . . . 0.0 112.298 -178.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HA ' ' OD1' ' A' ' 59' ' ' ASP . 6.6 t70 -86.64 144.98 38.25 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.289 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.1 Cg_exo -46.05 -39.46 20.1 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.052 2.501 . . . . 0.0 112.982 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.657 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.9 OUTLIER -54.14 -43.23 70.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.372 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.879 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.2 m -76.1 -31.4 58.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.9 -45.04 3.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.706 -179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -84.24 -19.78 33.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.373 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.6 m-85 -83.5 -40.37 19.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 111.246 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.07 -16.33 29.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.57 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.04 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.26 32.6 0.01 OUTLIER Glycine 0 CA--C 1.522 0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 115.678 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.687 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -84.27 -149.63 10.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.455 178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.479 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.9 m -150.06 133.28 16.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.082 0.441 . . . . 0.0 110.674 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -126.38 150.81 32.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.085 0.469 . . . . 0.0 111.265 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -150.96 143.46 24.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.608 178.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.495 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.33 141.23 48.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m -150.35 89.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.26 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.56 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 0.8 OUTLIER -99.59 163.72 12.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.125 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.48 108.33 0.74 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.879 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 mp 63.14 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.706 0.288 . . . . 0.0 111.429 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -50.71 -25.34 4.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.304 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.59 143.86 8.07 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 92.7 p -59.78 90.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.04 143.76 27.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.761 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.66 133.34 53.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 133.55 36.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.485 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 ' HD1' ' A' ' 47' ' ' TYR . 2.4 t -132.82 160.23 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.255 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' THR . 76.0 m-20 -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.075 0.464 . . . . 0.0 111.545 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.656 ' OD1' ' HB3' ' A' ' 102' ' ' ALA . 3.1 p30 174.32 163.77 0.34 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.585 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 23.4 Cg_endo -61.93 -41.28 38.03 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.506 2.137 . . . . 0.0 112.925 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -38.36 83.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.096 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . . . -95.98 -73.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.283 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.4 p -79.49 141.97 36.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.942 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.2 m -148.68 -60.32 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.83 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -137.32 109.9 7.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 43.9 m -139.68 93.51 2.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.97 17.65 13.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.596 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.68 -31.55 11.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.815 0.34 . . . . 0.0 110.864 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.66 65.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -111.83 33.28 4.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.04 154.25 12.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -102.84 -171.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -141.23 160.58 39.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.65 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.465 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.791 0.329 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.598 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -95.69 -159.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.003 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 2.4 t0 87.81 8.35 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.891 0.476 . . . . 0.0 111.094 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -109.36 -43.37 4.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.467 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -142.14 160.96 39.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.428 179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 59.22 80.24 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.076 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -104.81 -69.2 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.221 -178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.06 -117.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.849 2.366 . . . . 0.0 113.49 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.793 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.5 127.36 31.66 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.117 0.567 . . . . 0.0 112.227 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.577 ' N ' HD12 ' A' ' 9' ' ' LEU . 31.7 m -99.5 122.56 42.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.2 p90 -88.38 -179.76 6.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.656 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.93 -160.48 0.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.329 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 32.5 t0 -91.53 -43.0 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.254 0.549 . . . . 0.0 110.743 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' N ' HG23 ' A' ' 12' ' ' THR . . . -59.94 -40.42 88.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.585 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.774 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.43 -33.63 44.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.42 -43.42 70.0 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.904 177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.8 m-80 -58.5 -42.83 88.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.579 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -58.63 -29.39 66.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.992 0.425 . . . . 0.0 110.194 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.3 t -83.95 -68.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.457 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.85 -19.95 2.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 24.0 t -87.0 -46.35 9.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.858 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -81.91 -25.1 35.25 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.7 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.28 -48.86 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.321 0.581 . . . . 0.0 109.597 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -57.89 -24.39 57.48 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -19.94 45.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.369 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 79.1 mt-10 -80.31 -18.39 49.35 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.099 0.476 . . . . 0.0 110.331 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.4 tt0 80.98 11.02 0.89 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.441 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.705 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -55.85 -70.76 0.1 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.61 -0.436 . . . . 0.0 109.917 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.627 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 159.12 -44.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.9 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 170.89 68.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.705 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.01 155.53 13.38 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.91 -177.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 41.2 mtpt -117.25 122.45 44.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.289 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.916 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -58.97 144.63 44.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.875 0.369 . . . . 0.0 110.743 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.809 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.08 97.21 3.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.38 0.61 . . . . 0.0 109.995 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.869 HG23 HD11 ' A' ' 69' ' ' LEU . 7.9 t -74.46 156.83 6.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.495 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -139.97 -179.83 6.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.537 177.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.854 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.6 mm -92.38 117.43 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.226 0.536 . . . . 0.0 112.065 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 48' ' ' GLY . 3.3 m -128.85 -45.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.073 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 38.24 -162.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 113.949 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 -80.54 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.334 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.23 -42.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.363 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.4 m -85.15 81.16 8.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 100' ' ' PRO . 0.5 OUTLIER 63.43 -86.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.43 122.68 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.423 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.7 p90 -143.49 6.23 1.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mt-30 -113.31 -73.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.592 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HD2' HG21 ' A' ' 97' ' ' VAL . 26.3 m-85 70.73 119.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -75.06 134.37 16.83 Favored Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.708 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.89 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -108.81 136.68 47.97 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.916 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.0 t -132.16 165.94 22.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.491 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.778 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.49 97.38 7.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.613 0.72 . . . . 0.0 109.833 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 3.5 t70 -118.38 105.85 12.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.736 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.16 -22.48 48.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.1 -100.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.479 -0.489 . . . . 0.0 111.776 -179.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.11 -65.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.27 0.557 . . . . 0.0 111.53 -179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.6 m120 85.28 84.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.338 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -48.77 135.76 14.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.117 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 73.16 40.61 49.8 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -133.99 110.25 9.55 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 122.734 0.414 . . . . 0.0 110.062 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.2 mt -59.73 139.36 57.32 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.581 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.8 p -123.41 120.33 32.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.094 0.95 . . . . 0.0 113.166 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD11 HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -108.02 128.09 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.002 177.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.52 152.46 21.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.389 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' H ' ' A' ' 67' ' ' VAL . 15.2 tptt -110.64 159.71 17.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.408 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -50.61 -37.27 39.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.24 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -134.47 9.31 4.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.906 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 20' ' ' LYS . 13.5 m -156.18 -150.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.22 128.15 39.34 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.03 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.907 HD12 ' N ' ' A' ' 70' ' ' VAL . 1.7 tp -96.89 132.94 42.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.907 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -137.11 114.77 13.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.901 0.382 . . . . 0.0 110.404 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.77 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -112.54 157.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.265 0.555 . . . . 0.0 111.822 -179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.406 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.5 t70 -79.66 144.68 61.13 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.677 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 86.1 Cg_exo -45.99 -34.42 12.74 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.21 2.607 . . . . 0.0 113.03 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.718 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.5 OUTLIER -56.88 -42.4 79.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.537 0.684 . . . . 0.0 109.647 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.941 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -75.18 -34.0 61.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.755 178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -44.73 -43.82 8.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.707 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.984 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -81.31 -19.38 43.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.543 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 101' ' ' ASN . 4.2 m-85 -85.3 -38.87 18.34 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.816 0.341 . . . . 0.0 111.75 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.941 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.68 -16.46 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.905 HD12 ' O ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -16.88 79.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.47 9.58 72.17 Favored Glycine 0 C--N 1.318 -0.463 0 N-CA-C 116.641 1.417 . . . . 0.0 116.641 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.762 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -70.58 -152.71 0.91 Allowed Glycine 0 C--N 1.317 -0.499 0 C-N-CA 119.559 -1.305 . . . . 0.0 112.065 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' ASN . 17.4 m -149.74 130.03 13.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.88 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -119.97 153.77 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 112.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.622 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.04 143.24 24.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.146 178.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.534 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.03 143.75 46.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 111.377 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.5 m -148.17 89.36 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.442 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 33.5 mt-10 -90.03 164.87 14.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.957 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.06 -147.53 15.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.667 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.39 -54.13 50.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.038 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -56.75 -17.76 10.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.811 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.61 157.71 18.88 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.535 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 73.6 p -59.66 89.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.898 0.38 . . . . 0.0 110.971 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.51 144.56 27.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.502 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.525 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.1 t80 -132.4 126.67 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.29 112.82 8.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.051 0.453 . . . . 0.0 111.694 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.762 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.6 t -102.65 167.22 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.556 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 83' ' ' THR . 27.9 m-80 -122.19 162.39 21.45 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.799 0.333 . . . . 0.0 110.197 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.652 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 72.51 104.58 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 99' ' ' ASN . 12.9 Cg_endo -58.02 -33.7 97.55 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.878 1.719 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.832 ' CA ' HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER 175.05 30.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.634 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 61.24 82.14 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.3 p -153.94 139.96 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.717 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.5 p -58.17 146.82 32.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -134.34 143.76 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.94 89.83 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.01 -15.33 16.59 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.74 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 93.6 m 63.12 -79.82 0.03 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.774 0.321 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.34 170.83 33.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.2 m -114.85 82.39 1.72 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.73 95.32 4.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.759 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 60.15 -168.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.9 m -88.78 -165.92 1.46 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.464 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.472 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.783 0.325 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.39 -162.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.6 -62.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.722 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -78.95 -54.93 5.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.0 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.515 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 26.0 mmt -71.65 175.41 5.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.978 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.814 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 65.63 60.42 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.627 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.13 -68.65 0.23 Allowed Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.487 -178.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 4.8 Cg_endo -108.57 -118.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.976 2.45 . . . . 0.0 113.658 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.775 HD11 HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.32 126.59 28.26 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.279 0.631 . . . . 0.0 112.223 -179.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.499 ' N ' ' CD1' ' A' ' 9' ' ' LEU . 32.2 m -99.26 121.89 41.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.849 ' HA ' HG13 ' A' ' 84' ' ' VAL . 17.2 p90 -88.81 -179.8 6.06 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.25 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.639 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 4.4 t -86.45 -160.73 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 18.2 m-20 -91.74 -42.37 10.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 110.947 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.91 -42.0 97.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.623 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.08 -32.76 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.32 -43.45 70.27 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.837 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 4.5 m-80 -56.92 -43.61 81.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.466 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -57.88 -30.9 66.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.061 0.458 . . . . 0.0 110.05 179.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HD23 ' A' ' 33' ' ' LEU . 64.4 t -82.44 -69.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.548 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.561 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -52.14 -19.96 2.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.492 -179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 47.0 t -85.89 -45.11 11.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.85 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.28 -25.47 29.3 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.611 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.715 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.72 -47.99 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 121.553 0.692 . . . . 0.0 109.75 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.662 ' N ' HD12 ' A' ' 23' ' ' ILE . 32.0 t -60.91 -23.25 65.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.168 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -19.16 36.84 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.969 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.5 mm-40 -80.47 -18.99 47.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER 80.08 12.13 1.07 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.784 -178.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.696 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.75 -69.9 0.14 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.597 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.38 -46.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.271 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.43 66.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.715 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.78 155.88 12.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 113.987 -1.46 . . . . 0.0 112.87 -178.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.1 OUTLIER -118.96 124.16 46.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.201 178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.3 tm? -59.21 146.01 40.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.747 0.308 . . . . 0.0 110.874 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -140.04 96.83 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.403 0.62 . . . . 0.0 110.168 179.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 69' ' ' LEU . 18.7 t -71.59 154.8 7.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.66 -179.93 6.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.77 177.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.824 HD11 ' HA ' ' A' ' 75' ' ' SER . 21.7 mm -88.94 111.73 23.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.076 0.465 . . . . 0.0 111.524 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 38' ' ' THR . 20.2 m -145.18 28.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.462 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.7 -162.83 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.146 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.06 -58.69 5.98 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.843 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.8 -78.61 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.62 42.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 110.307 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.13 -149.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.79 107.19 0.25 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.584 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' VAL . 2.9 p90 -138.9 -3.58 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 19.9 mt-30 -108.84 -75.27 0.63 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.425 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.532 ' HD1' HD13 ' A' ' 37' ' ' ILE . 27.5 m-85 72.79 114.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.185 0.517 . . . . 0.0 110.424 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -68.05 133.86 29.16 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.263 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.913 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -105.15 134.63 47.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.904 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.3 t -130.88 164.34 25.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.665 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HD1' HG13 ' A' ' 19' ' ' VAL . 7.7 m-85 -106.73 98.27 7.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.545 0.688 . . . . 0.0 109.92 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.6 t70 -114.03 104.92 12.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.259 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -73.46 -28.56 62.02 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.639 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -52.51 -93.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.017 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 11.3 p 163.27 -20.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 2.0 m-80 48.29 91.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -46.97 -45.99 21.27 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.382 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.93 55.3 4.06 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.209 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.44 116.65 3.95 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.639 0.258 . . . . 0.0 110.748 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.6 mt -59.03 163.2 3.7 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -142.45 132.3 24.24 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -123.73 123.33 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.624 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -59.42 153.32 19.47 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.012 -0.43 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 20.4 mtpp -115.05 171.3 7.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.61 -41.84 55.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -131.58 7.89 5.57 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.444 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.576 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.4 m -154.6 -148.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 122.773 -0.251 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.639 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -137.31 131.49 32.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.495 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 35' ' ' VAL . 3.5 tp -98.18 138.68 35.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.549 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.892 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -140.32 113.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.72 HG13 HD11 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -106.77 170.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 0.0 112.051 -178.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -93.62 143.41 26.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.245 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 81.2 Cg_exo -45.1 -35.39 10.55 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.126 2.551 . . . . 0.0 112.425 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.537 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.1 OUTLIER -58.16 -47.92 81.86 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.956 0.884 . . . . 0.0 109.586 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.934 ' O ' HD13 ' A' ' 79' ' ' LEU . 78.8 p -73.16 -31.28 64.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.089 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -45.29 -47.22 13.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.533 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.967 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -72.2 -23.65 61.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.506 178.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 74' ' ' MET . 2.8 m-85 -83.89 -39.2 20.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.32 -16.5 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -17.49 121.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.94 34.08 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-N 114.405 -1.27 . . . . 0.0 115.683 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.711 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.67 -151.08 20.88 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.932 -1.128 . . . . 0.0 111.637 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 98' ' ' ASN . 16.5 m -146.93 135.22 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.975 0.387 . . . . 0.0 110.585 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 11' ' ' PHE . 0.3 OUTLIER -129.14 151.09 35.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.102 0.477 . . . . 0.0 111.724 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.5 OUTLIER -151.58 145.25 24.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.986 178.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.529 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.54 144.54 45.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 95.6 m -150.18 89.88 1.62 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.7 OUTLIER -92.85 165.16 13.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.37 164.42 35.99 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.1 mp 64.82 -73.12 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.642 0.258 . . . . 0.0 111.241 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -98.49 -24.85 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.181 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.12 161.49 10.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.372 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 28.8 t -61.91 90.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.852 0.358 . . . . 0.0 111.103 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -102.08 152.5 20.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.047 179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.9 t80 -129.62 134.87 47.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.356 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.3 128.54 24.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.994 0.426 . . . . 0.0 111.429 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -126.77 165.88 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.587 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 70.0 m-80 -134.08 153.66 51.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.369 . . . . 0.0 111.255 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.687 ' OD1' ' HB2' ' A' ' 102' ' ' ALA . 0.3 OUTLIER 178.67 164.55 0.66 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.54 -49.89 7.97 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.619 2.212 . . . . 0.0 112.71 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.655 ' O ' HG23 ' A' ' 103' ' ' THR . 1.1 p30 -55.67 -37.37 68.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.086 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.687 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -54.69 -25.78 29.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.461 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 101' ' ' ASN . 44.1 p 51.53 35.51 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.087 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 -172.67 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.3 p -136.43 87.08 2.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.0 84.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -106.03 9.63 43.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.78 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.0 -171.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.864 0.364 . . . . 0.0 110.959 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.71 105.47 0.5 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.377 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.1 124.95 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.838 0.352 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.9 m -140.42 137.67 34.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 112' ' ' PHE . 8.2 m-85 -124.66 -171.24 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.5 m -138.87 160.73 39.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.56 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.807 0.337 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.93 -162.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.816 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 2' ' ' ILE . 6.5 t0 88.35 -45.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.547 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 69.8 m-20 -76.08 -41.96 48.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.438 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.477 ' HE2' ' HA ' ' A' ' 5' ' ' MET . 10.5 mmt -58.31 164.36 2.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 57.85 48.02 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.25 -71.52 0.18 Allowed Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.114 -177.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -107.71 -121.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.592 2.195 . . . . 0.0 114.458 -177.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 10' ' ' THR . 0.1 OUTLIER -59.13 128.21 36.03 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.783 0.833 . . . . 0.0 112.929 -178.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.641 ' N ' HD12 ' A' ' 9' ' ' LEU . 26.6 m -101.81 121.99 43.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.312 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.878 ' HD2' ' HB3' ' A' ' 15' ' ' ALA . 25.1 p90 -88.29 -179.53 6.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 85' ' ' ASP . 4.7 t -85.2 -159.31 0.43 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.299 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 71.8 m-20 -91.42 -43.85 9.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.66 -40.4 91.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.403 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.878 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.76 -29.28 39.2 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.0 -42.79 59.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.168 177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.7 m-80 -54.71 -50.54 68.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.11 -1.404 . . . . 0.0 112.232 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.687 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -54.74 -35.11 63.38 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.097 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.816 HG13 ' HD1' ' A' ' 51' ' ' PHE . 56.4 t -76.15 -68.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.522 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -54.33 -20.2 6.82 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 19.1 t -88.39 -44.58 10.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.844 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.29 -24.48 34.67 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 -179.298 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.4 pp -73.1 -48.85 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.631 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -59.57 -22.89 62.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.06 -19.54 36.65 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.093 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -80.01 -19.22 48.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 1.1 tt0 81.19 11.26 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.55 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.685 ' CG ' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.52 -70.3 0.12 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.593 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.85 -46.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.102 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.56 66.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.811 0.815 . . . . 0.0 108.838 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.86 154.49 14.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.952 -177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 28.0 mtpt -117.84 124.72 49.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.242 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.917 HD21 ' HB3' ' A' ' 49' ' ' PHE . 2.5 tm? -58.66 145.64 39.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.869 0.366 . . . . 0.0 110.812 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.799 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -140.78 100.44 3.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 69' ' ' LEU . 7.2 t -76.76 156.07 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.28 -0.873 . . . . 0.0 113.105 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.471 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -143.3 177.65 8.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.793 178.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 75' ' ' SER . 20.7 mm -89.95 108.73 19.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.928 0.394 . . . . 0.0 110.887 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.8 m -124.91 -32.42 3.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.793 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -109.07 179.87 21.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.613 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 110.84 76.71 0.86 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.324 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -59.44 -22.31 56.05 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.426 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.99 -36.54 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.716 0.293 . . . . 0.0 110.762 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.16 -75.77 0.54 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.366 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 157.27 125.12 0.84 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.269 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.58 ' O ' HG23 ' A' ' 97' ' ' VAL . 1.8 p90 -145.56 2.15 0.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' A' ' 97' ' ' VAL . 34.5 mt-30 -117.23 -74.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.444 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.705 ' HD2' HG21 ' A' ' 97' ' ' VAL . 8.5 m-85 74.21 121.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.019 0.438 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 36' ' ' TYR . . . -73.63 133.12 17.0 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.634 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.917 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -105.8 135.54 47.04 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.896 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.4 t -131.92 166.32 21.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.654 178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HD1' HG13 ' A' ' 19' ' ' VAL . 5.8 m-85 -107.36 98.46 8.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.526 0.679 . . . . 0.0 109.545 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -117.41 106.56 13.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.08 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -83.22 -22.4 33.14 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -48.36 -93.4 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.582 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 8.6 p 166.87 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.546 ' CB ' ' HB3' ' A' ' 59' ' ' ASP . 1.8 m-80 36.17 95.75 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.969 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -46.24 -41.76 13.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.704 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.05 61.22 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.616 ' O ' ' OD1' ' A' ' 59' ' ' ASP . 1.4 p-10 -140.09 111.33 7.09 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.04 0.448 . . . . 0.0 112.189 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.793 HD11 HD12 ' A' ' 76' ' ' LEU . 3.0 mt -69.19 125.07 25.55 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.651 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.4 p -111.73 136.14 51.39 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.93 125.77 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.2 178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.44 153.65 18.8 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.948 -0.47 . . . . 0.0 111.416 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.843 ' HD3' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -119.13 169.04 10.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 111.714 -178.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -47.41 -43.02 23.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.462 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -137.05 12.42 3.87 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.37 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG23 ' HD3' ' A' ' 64' ' ' LYS . 26.8 m -155.56 -139.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.556 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -142.91 136.11 28.29 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.867 0.365 . . . . 0.0 110.768 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.942 HD11 HG23 ' A' ' 35' ' ' VAL . 2.8 tp -101.67 135.17 43.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.455 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.817 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -142.89 108.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.253 0.549 . . . . 0.0 110.516 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.709 HG13 HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -104.26 170.91 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.157 0.503 . . . . 0.0 111.912 -178.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.8 t70 -93.44 144.65 28.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.659 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.549 ' O ' ' HB3' ' A' ' 76' ' ' LEU . 97.3 Cg_exo -44.05 -37.06 9.16 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.154 2.569 . . . . 0.0 112.953 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.683 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.17 -43.71 78.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.732 0.777 . . . . 0.0 109.334 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.86 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.4 m -74.19 -31.57 62.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.202 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -41.13 -45.49 2.78 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.989 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -83.85 -19.77 34.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.525 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.3 m-85 -84.1 -39.15 19.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.53 -16.52 28.68 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.573 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 123.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 28.6 35.53 0.01 OUTLIER Glycine 0 CA--C 1.522 0.51 0 CA-C-N 113.982 -1.463 . . . . 0.0 115.895 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.633 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -86.94 -151.53 20.34 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.864 -1.16 . . . . 0.0 111.514 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.431 ' CA ' HD11 ' A' ' 9' ' ' LEU . 23.2 m -150.2 129.94 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.004 0.402 . . . . 0.0 110.408 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.863 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.25 153.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.225 0.536 . . . . 0.0 111.906 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.611 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.8 OUTLIER -151.14 143.31 24.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.166 178.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -114.53 147.25 39.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.28 -179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 92.0 m -149.52 89.59 1.65 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.73 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 1.2 mt-10 -93.65 163.47 13.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.029 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.93 -132.71 2.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.44 -53.78 6.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.74 -18.37 4.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.726 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 112.77 153.7 11.66 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 54.3 p -59.85 89.85 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.973 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -86.41 139.33 31.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.688 179.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -125.93 131.35 52.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.837 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.54 124.86 19.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.035 0.445 . . . . 0.0 111.772 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HD2' ' A' ' 47' ' ' TYR . 2.0 t -121.38 159.42 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.127 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' THR . 72.3 m-20 -136.98 156.85 47.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB2' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -179.96 166.42 0.81 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 16.3 Cg_endo -57.65 -46.7 25.28 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.653 2.235 . . . . 0.0 112.556 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -37.81 76.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -64.18 -63.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.148 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 31.1 p -124.16 -74.9 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.058 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.9 p -159.19 163.99 35.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.69 170.17 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.0 t -175.08 140.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.795 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.69 -16.01 2.22 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.655 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.87 -178.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.763 0.316 . . . . 0.0 111.032 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.12 -58.15 5.05 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.375 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.434 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -135.72 -175.74 4.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 110.891 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.02 112.59 8.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 110' ' ' SER . 42.5 m-85 -118.01 -170.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.8 m -146.02 160.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.743 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.52 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.52 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.873 0.368 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.639 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -118.97 -171.05 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.737 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.84 -41.67 0.21 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.891 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.95 -46.82 22.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.406 ' CE ' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -116.68 -146.03 0.4 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.662 ' N ' HG22 ' A' ' 62' ' ' ILE . . . -158.31 -36.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.758 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -137.65 -78.47 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -109.08 -114.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 122.386 2.057 . . . . 0.0 114.9 -176.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.666 HD22 ' CA ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -58.92 126.65 28.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.591 0.757 . . . . 0.0 112.625 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.603 ' N ' HD12 ' A' ' 9' ' ' LEU . 66.9 m -98.98 122.26 42.01 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.535 177.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.877 ' HB2' HG22 ' A' ' 84' ' ' VAL . 20.7 p90 -88.24 -179.77 6.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.643 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -86.34 -160.98 0.6 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.202 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 73.1 m-20 -91.66 -42.47 10.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.211 0.529 . . . . 0.0 110.875 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.54 -41.5 94.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.541 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.792 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -51.94 -33.76 38.94 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -71.09 -43.41 67.78 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.955 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' O ' ' CB ' ' A' ' 21' ' ' SER . 4.2 m-80 -56.78 -48.33 78.12 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.7 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.639 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -57.18 -28.66 63.0 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.921 0.391 . . . . 0.0 110.51 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.725 HG13 ' HD1' ' A' ' 51' ' ' PHE . 68.2 t -79.42 -69.78 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.749 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.32 -20.29 4.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.362 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 32.0 t -86.44 -45.32 11.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -84.07 -24.4 30.42 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.604 -179.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.685 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.69 -48.6 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.353 0.597 . . . . 0.0 109.446 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.677 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -58.88 -23.89 61.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.029 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -81.87 -19.63 40.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.146 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 2.8 mm-40 -80.34 -18.27 49.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.393 0.616 . . . . 0.0 110.3 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 0.2 OUTLIER 81.22 11.06 0.85 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.756 -179.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.695 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.89 -71.22 0.1 Allowed 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.594 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER 159.71 -46.64 0.0 OUTLIER 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.987 0.805 . . . . 0.0 112.393 -179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.9 67.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.695 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -58.98 156.3 11.89 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.073 -1.421 . . . . 0.0 113.286 -177.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 68' ' ' GLN . 10.5 mtpt -117.57 122.75 44.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.214 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.907 HD22 ' O ' ' A' ' 50' ' ' THR . 2.5 tm? -59.14 144.8 44.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.744 0.307 . . . . 0.0 110.587 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.811 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 40.1 ttt-85 -138.63 96.68 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.377 0.608 . . . . 0.0 110.088 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.887 HG23 HD11 ' A' ' 69' ' ' LEU . 11.3 t -74.12 154.83 6.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.1 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -142.8 -179.83 6.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.016 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.3 mm -89.53 110.69 22.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 0.0 110.894 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.1 m -126.42 -30.29 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.934 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.768 ' HA3' ' HB2' ' A' ' 46' ' ' GLN . . . -125.27 -176.96 14.71 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.068 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' CA ' ' HA2' ' A' ' 44' ' ' GLY . . . 132.58 -64.24 0.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.721 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.36 -66.07 0.39 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.691 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.6 m -105.72 -24.08 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 70.1 m -149.91 -90.72 0.07 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.031 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' HA2' ' CA ' ' A' ' 40' ' ' GLY . . . 172.68 119.92 0.54 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.7 p90 -148.66 1.36 0.59 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.768 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 14.1 mt-30 -112.24 -79.47 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.932 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.787 ' HD2' HG21 ' A' ' 97' ' ' VAL . 9.9 m-85 72.05 121.75 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.452 . . . . 0.0 110.609 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -76.03 131.68 12.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.655 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.874 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.3 m-85 -104.85 134.83 47.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.144 0.497 . . . . 0.0 112.338 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.907 ' O ' HD22 ' A' ' 33' ' ' LEU . 6.2 t -132.04 166.02 22.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.553 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.725 ' HD1' HG13 ' A' ' 19' ' ' VAL . 9.6 m-85 -108.31 97.8 7.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.498 0.666 . . . . 0.0 109.863 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -117.18 106.52 13.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.979 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.29 -23.53 40.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -55.54 -99.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.3 -178.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -166.84 -67.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.242 0.544 . . . . 0.0 111.571 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.5 m120 84.98 83.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.839 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -48.47 135.76 13.7 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.846 0.355 . . . . 0.0 110.378 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 72.12 39.34 58.45 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.424 -0.893 . . . . 0.0 110.914 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -132.04 106.48 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.291 0.236 . . . . 0.0 110.518 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.3 mt -60.03 149.76 31.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.699 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.17 132.72 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.0 126.9 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.508 177.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.51 152.65 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.864 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HD3' ' CG2' ' A' ' 67' ' ' VAL . 24.5 mtpp -114.64 170.53 8.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.229 0.537 . . . . 0.0 111.264 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -50.43 -41.61 52.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.713 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.8 9.02 5.21 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.734 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.563 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 14.9 m -155.03 -152.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 O-C-N 122.661 -0.317 . . . . 0.0 110.4 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.2 130.55 39.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.78 0.324 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.887 HD11 HG23 ' A' ' 35' ' ' VAL . 2.1 tp -96.15 134.0 39.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.987 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -135.77 111.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.159 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.524 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -111.12 156.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.333 0.587 . . . . 0.0 111.915 -178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.34 145.27 63.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.684 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 74.3 Cg_exo -48.89 -32.31 22.41 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.092 2.528 . . . . 0.0 112.511 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.533 ' HA ' HE22 ' A' ' 77' ' ' GLN . 0.6 OUTLIER -57.13 -47.65 80.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.845 0.831 . . . . 0.0 109.706 179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.911 ' O ' HD13 ' A' ' 79' ' ' LEU . 42.7 m -73.46 -30.41 63.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.353 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -46.13 -45.86 16.76 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.424 -179.37 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.968 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -73.91 -21.62 60.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.446 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.0 m-85 -87.39 -36.97 17.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.911 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.6 -17.93 26.05 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.886 HD11 ' CA ' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -17.93 127.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 122.379 1.085 . . . . 0.0 113.442 -178.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.87 28.2 0.01 OUTLIER Glycine 0 CA--C 1.524 0.606 0 CA-C-N 113.185 -1.825 . . . . 0.0 116.492 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -87.11 -154.05 25.53 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.943 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ASN . 21.1 m -147.96 131.58 16.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.877 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -121.8 153.3 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 112.11 -179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.6 OUTLIER -151.21 144.6 24.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.95 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -118.45 144.94 45.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.761 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 89.5 m -150.38 89.66 1.59 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' CB ' ' HA ' ' A' ' 93' ' ' SER . 6.8 pm0 -99.12 162.57 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.051 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.68 -79.56 0.36 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.75 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 91' ' ' GLU . 21.0 tp -49.14 -96.92 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 90' ' ' LEU . 4.9 mm-40 -75.69 -18.22 59.69 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.173 -0.329 . . . . 0.0 111.299 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.22 164.96 10.11 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.271 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.508 ' HA ' ' CB ' ' A' ' 88' ' ' GLU . 79.0 p -59.89 89.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.872 0.368 . . . . 0.0 111.495 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.452 ' O ' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -93.35 164.53 13.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 49' ' ' PHE . 4.7 t80 -137.8 133.69 34.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 m -143.19 119.16 10.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.84 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.787 HG21 ' HD2' ' A' ' 47' ' ' TYR . 6.1 t -106.0 169.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.435 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.541 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.4 m-80 -122.75 172.17 8.63 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER 66.57 106.62 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 43' ' ' SER . 10.3 Cg_endo -52.65 -37.33 74.67 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.778 1.652 . . . . 0.0 110.738 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.886 ' CA ' HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER 167.34 31.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.987 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' N ' ' OD1' ' A' ' 99' ' ' ASN . . . 62.35 61.51 1.27 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.8 p -148.84 -47.37 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.637 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.9 t -151.05 78.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.775 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.31 151.66 19.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.994 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.1 p -144.85 119.74 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.49 -20.24 1.17 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.654 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 51.5 m 59.39 31.43 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.31 136.51 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 -48.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.09 -173.04 2.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 60.28 -169.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.051 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.2 p -80.62 -165.33 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.451 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.266 -0.874 . . . . 0.0 111.492 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 mmm . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -98.57 -162.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.765 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.47 -38.17 0.01 OUTLIER 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.752 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.24 -66.66 0.47 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.058 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.498 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 27.2 mmt -58.58 168.53 1.14 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.155 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 65.95 52.14 1.27 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.238 0.542 . . . . 0.0 109.799 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.654 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -70.92 -68.05 0.53 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.416 -177.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -109.14 -124.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.076 2.517 . . . . 0.0 113.843 -177.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.698 HD22 ' HA3' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -59.51 126.86 29.31 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.434 0.694 . . . . 0.0 112.442 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.611 ' N ' HD12 ' A' ' 9' ' ' LEU . 39.3 m -100.54 122.51 43.36 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.385 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 29.4 p90 -89.8 -179.58 5.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.922 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.6 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.2 t -83.47 -160.73 0.45 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 111.407 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 12.4 t70 -91.43 -42.41 10.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.194 0.521 . . . . 0.0 110.692 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.67 -41.89 95.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.369 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.826 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.6 -31.54 36.96 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -74.29 -41.59 60.95 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.986 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.2 m-80 -53.99 -52.2 61.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.556 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -55.49 -34.44 64.59 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.697 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 HD23 ' A' ' 33' ' ' LEU . 67.9 t -71.58 -70.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.418 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -55.14 -20.13 9.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.474 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 26.0 t -88.1 -44.19 11.12 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.874 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.13 -25.2 32.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.399 -179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.705 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -73.41 -48.3 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-O 121.314 0.578 . . . . 0.0 110.064 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.667 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.6 m -59.27 -23.65 62.56 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.99 -19.84 39.69 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.298 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.2 mm-40 -80.23 -18.84 48.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.901 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 10.8 tt0 81.5 10.88 0.81 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.695 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -56.52 -70.28 0.12 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.604 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.74 -46.28 0.0 OUTLIER 'General case' 0 C--N 1.344 0.358 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.897 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.56 67.77 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.705 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -59.35 154.06 17.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.958 -177.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' CE ' ' HG2' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -117.11 122.52 44.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.976 179.177 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD22 ' O ' ' A' ' 50' ' ' THR . 2.1 tm? -59.34 143.24 50.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.999 0.428 . . . . 0.0 110.929 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.819 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER -134.24 94.07 3.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.388 0.613 . . . . 0.0 110.076 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 49' ' ' PHE . 18.9 t -72.85 152.47 7.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.333 -0.848 . . . . 0.0 113.108 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -141.62 -179.82 6.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.891 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.744 HD11 ' HA ' ' A' ' 75' ' ' SER . 18.1 mm -85.93 117.29 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 0.0 111.196 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' THR . 21.0 m -158.71 38.79 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.608 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.81 -144.34 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.627 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.15 -69.48 1.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 -106.06 0.3 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.328 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 34.1 m -59.03 -28.25 66.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.789 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.07 -165.7 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.11 114.66 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.091 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 97' ' ' VAL . 1.6 p90 -143.73 2.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 14.3 mt-30 -110.51 -71.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.791 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HD2' HG21 ' A' ' 97' ' ' VAL . 36.9 m-85 73.16 128.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.438 . . . . 0.0 110.838 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -80.69 130.83 10.0 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.916 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.866 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -104.49 132.62 50.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.906 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.6 t -130.1 163.59 26.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.785 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.726 ' HD1' HG13 ' A' ' 19' ' ' VAL . 6.0 m-85 -107.44 97.99 7.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.415 0.626 . . . . 0.0 109.98 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . 3.2 t70 -118.21 106.87 13.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.374 -178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -78.69 -18.33 54.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.795 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -62.54 -103.47 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.195 -178.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -163.15 -65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.202 0.525 . . . . 0.0 111.268 -179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.9 m120 84.82 84.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.845 -178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.72 132.48 17.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.488 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 77.46 39.02 27.11 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.08 -1.057 . . . . 0.0 110.835 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -133.64 107.24 7.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 76' ' ' LEU . 3.4 mt -62.16 156.34 21.99 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.575 ' C ' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -137.9 151.27 47.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.505 0.669 . . . . 0.0 112.624 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -143.14 93.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.187 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 21.9 tt0 -59.3 153.29 19.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 3.6 mmmt -161.04 -169.31 2.32 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.46 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.7 -72.28 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -149.32 18.96 1.18 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 119.979 -1.105 . . . . 0.0 114.397 -178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 68' ' ' GLN . 4.7 m -149.19 -157.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.637 0.719 . . . . 0.0 110.816 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -131.47 116.16 17.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.43 . . . . 0.0 109.993 179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.899 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.2 mm? -88.3 99.26 12.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.38 -178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -105.72 112.85 40.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 0.0 110.019 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -109.35 161.99 7.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.517 . . . . 0.0 111.993 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.3 t70 -85.18 145.27 42.58 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.837 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 84.0 Cg_exo -48.08 -39.29 33.34 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.301 2.668 . . . . 0.0 113.248 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.659 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -53.1 -42.89 66.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.823 0.821 . . . . 0.0 109.434 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.883 ' O ' HD13 ' A' ' 79' ' ' LEU . 1.3 m -75.5 -32.25 60.48 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.976 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.994 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.01 -45.25 3.8 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.899 -179.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.994 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.88 -20.09 36.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.391 -179.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -83.36 -40.22 19.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.957 0.408 . . . . 0.0 111.212 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.62 -16.05 29.38 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.223 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.39 122.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -177.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 30.75 33.65 0.01 OUTLIER Glycine 0 CA--C 1.521 0.421 0 CA-C-N 113.981 -1.463 . . . . 0.0 115.81 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.698 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -85.8 -150.13 14.01 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.748 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.457 ' CA ' HD11 ' A' ' 9' ' ' LEU . 3.5 m -150.1 136.06 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.865 0.332 . . . . 0.0 110.244 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -132.01 154.0 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.932 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.9 p-10 -151.28 145.45 25.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.758 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.52 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -118.08 143.81 46.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 86.9 m -150.12 89.49 1.6 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.91 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 92' ' ' GLY . 16.6 mt-10 -90.24 164.4 14.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.4 -75.05 0.34 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.461 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mp -52.37 -75.03 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -92.03 26.69 2.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.63 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 92.09 -86.21 1.24 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.175 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 89.9 p -150.99 89.72 1.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.612 0.244 . . . . 0.0 110.444 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.447 ' H ' ' HG3' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -96.72 142.91 28.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 3.5 t80 -123.82 134.89 53.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.905 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.48 120.76 13.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.098 0.475 . . . . 0.0 111.856 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.682 HG22 ' HB ' ' A' ' 84' ' ' VAL . 2.9 t -118.29 166.31 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.24 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 97' ' ' VAL . 30.0 m-80 -148.65 129.86 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.966 0.412 . . . . 0.0 111.52 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -147.6 166.91 14.67 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.308 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 99' ' ' ASN . 29.6 Cg_endo -63.21 -43.04 20.04 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.386 2.057 . . . . 0.0 112.412 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.26 0.12 38.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.646 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HB2' ' ND2' ' A' ' 99' ' ' ASN . . . -91.36 39.23 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.778 0.323 . . . . 0.0 111.35 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 30.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -114.98 147.43 40.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 65.2 p -119.58 81.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 29.0 t -84.25 89.65 7.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -111.35 -17.59 8.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.638 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 58.4 m -68.22 124.43 23.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 129.39 156.16 8.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.462 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -156.94 135.57 11.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.69 162.94 40.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -74.85 -171.59 1.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.001 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -130.67 160.73 33.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.685 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.578 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.689 0.28 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.617 HD13 ' N ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -97.23 -160.04 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.66 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -162.59 24.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -123.32 -45.21 2.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 110.595 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.58 ' HE1' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -137.09 177.4 7.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.134 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 62' ' ' ILE . . . 58.53 79.47 0.21 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.332 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.617 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -119.37 -68.13 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.106 -178.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.624 ' CD ' HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -105.17 -125.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.076 2.517 . . . . 0.0 113.176 -178.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.51 127.0 29.9 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.19 0.596 . . . . 0.0 112.3 -179.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 9' ' ' LEU . 32.1 m -99.77 121.58 41.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.309 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' HB2' HG22 ' A' ' 84' ' ' VAL . 28.1 p90 -88.49 -179.59 6.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.981 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.4 t -83.34 -161.47 0.51 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.96 0.41 . . . . 0.0 111.283 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 68.5 m-20 -91.62 -41.79 10.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.225 0.536 . . . . 0.0 110.973 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -60.73 -42.0 96.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.212 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -52.03 -33.44 38.65 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -72.09 -42.23 66.39 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.934 177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.4 m-80 -56.08 -51.59 67.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.934 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -55.1 -30.26 59.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.959 0.409 . . . . 0.0 110.365 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.765 HG13 ' HD1' ' A' ' 51' ' ' PHE . 94.2 t -76.53 -69.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.312 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.73 -20.24 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.035 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 17' ' ' ASN . 64.3 m -84.84 -46.45 11.32 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.884 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -82.73 -26.45 31.95 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.376 -178.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -74.24 -47.25 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.409 0.624 . . . . 0.0 109.559 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.671 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.9 m -58.51 -24.41 60.48 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 -19.59 42.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.272 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.8 mm-40 -80.66 -18.49 47.84 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.277 0.56 . . . . 0.0 110.525 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 6.0 tt0 81.39 10.95 0.82 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.672 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.694 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -55.27 -70.75 0.1 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.02 0.438 . . . . 0.0 109.821 179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.2 OUTLIER 159.76 -46.73 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.285 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 172.88 68.03 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.694 HD23 ' ND2' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -59.08 152.58 19.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.042 -177.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -115.89 122.18 44.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.179 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.946 HD12 ' CD1' ' A' ' 69' ' ' LEU . 2.5 tm? -59.95 144.27 49.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.936 0.398 . . . . 0.0 111.454 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.788 ' N ' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -135.06 100.49 4.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.517 0.675 . . . . 0.0 109.62 178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 49' ' ' PHE . 16.0 t -77.47 149.68 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.065 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -138.13 -179.92 6.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.32 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 75' ' ' SER . 16.7 mm -87.22 111.28 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.022 0.439 . . . . 0.0 111.209 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 38' ' ' THR . 22.5 m -147.08 31.72 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA3' ' HA2' ' A' ' 44' ' ' GLY . . . -58.7 -154.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.067 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.97 26.32 10.08 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.875 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.28 -84.95 1.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.531 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -27.38 64.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 111.055 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.67 -168.24 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.014 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HA3' ' A' ' 39' ' ' GLY . . . -145.64 102.14 0.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.229 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 2.8 p90 -138.39 -1.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.452 ' O ' ' CE2' ' A' ' 95' ' ' PHE . 22.9 mt-30 -107.13 -71.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.823 0.345 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.635 ' HD2' HG21 ' A' ' 97' ' ' VAL . 27.6 m-85 73.3 112.26 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.171 0.51 . . . . 0.0 110.393 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 36' ' ' TYR . . . -66.17 132.19 33.34 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 113.301 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.908 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -106.2 134.53 49.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.944 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.4 t -130.5 163.32 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.622 178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.765 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.85 98.28 7.79 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.215 0.531 . . . . 0.0 110.205 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 11.7 p-10 -117.13 111.65 19.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.664 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.559 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.91 -24.2 60.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.356 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.63 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -49.76 -94.38 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.141 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 14.7 p 156.57 -20.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 124.128 0.893 . . . . 0.0 111.587 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 1.9 m-80 47.07 91.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.5 . . . . 0.0 110.178 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -47.06 -43.21 19.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.403 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.73 53.68 3.71 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.237 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -155.54 113.13 3.33 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 110.568 -179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.547 HD11 HD12 ' A' ' 76' ' ' LEU . 4.7 mt -59.61 139.43 57.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -122.04 134.01 54.79 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 121.514 0.674 . . . . 0.0 112.547 -178.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -123.43 96.32 3.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.547 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' GLN . 28.1 tt0 -59.64 151.86 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 11' ' ' PHE . 2.2 mmmt -161.47 -170.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.452 ' CB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER 4.92 -71.78 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -150.86 23.8 1.02 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 119.91 -1.138 . . . . 0.0 114.293 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 68' ' ' GLN . 7.5 m -155.5 -156.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 117.203 0.502 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -130.94 126.86 37.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.401 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.946 ' CD1' HD12 ' A' ' 33' ' ' LEU . 2.1 mm? -97.94 95.66 7.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.372 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 34' ' ' ARG . 0.7 OUTLIER -103.52 107.3 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.561 . . . . 0.0 110.845 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -101.48 167.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.525 -179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -92.03 142.93 26.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.497 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 90.4 Cg_exo -43.97 -38.14 9.93 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.309 2.672 . . . . 0.0 112.892 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.668 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -56.83 -43.73 81.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.711 0.767 . . . . 0.0 109.553 179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.889 ' O ' HD13 ' A' ' 79' ' ' LEU . 17.6 m -77.0 -31.0 56.16 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.93 178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.995 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.72 -44.63 4.43 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.799 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.995 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.62 -21.58 35.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.249 -179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CD1' ' O ' ' A' ' 74' ' ' MET . 3.7 m-85 -81.35 -40.11 24.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.905 0.383 . . . . 0.0 111.272 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.889 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.66 -16.42 28.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.79 122.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.77 31.84 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 114.143 -1.39 . . . . 0.0 115.887 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.677 ' CA ' HD22 ' A' ' 9' ' ' LEU . . . -85.54 -148.68 11.0 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.804 -1.188 . . . . 0.0 111.631 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.496 ' CA ' HD11 ' A' ' 9' ' ' LEU . 5.1 m -150.12 135.28 17.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.868 0.334 . . . . 0.0 110.271 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -131.24 155.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.201 0.524 . . . . 0.0 111.702 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 1.5 p-10 -151.18 146.76 26.32 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.609 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.508 ' HB2' ' CA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -121.49 142.59 49.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.03 0.443 . . . . 0.0 111.088 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 94' ' ' ARG . 88.9 m -150.05 89.44 1.6 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.398 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -62.55 163.59 8.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.62 -178.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.69 -131.5 2.58 Favored Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.487 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.0 91.58 8.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.819 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 51.41 25.63 2.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -154.06 66.06 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.649 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 88.1 p -59.43 118.1 5.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 111.147 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -84.62 154.83 22.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.483 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 46' ' ' GLN . 4.1 t80 -139.14 132.88 30.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.305 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.44 130.05 27.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.019 0.438 . . . . 0.0 111.218 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' HB ' ' A' ' 84' ' ' VAL . 3.4 t -127.57 166.31 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.664 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.447 ' N ' HG12 ' A' ' 97' ' ' VAL . 65.5 m-20 -143.46 148.0 35.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.364 . . . . 0.0 111.097 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.578 ' HB2' ' HD2' ' A' ' 100' ' ' PRO . 7.2 p30 -175.44 164.9 2.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.53 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 99' ' ' ASN . 18.1 Cg_endo -58.82 -36.74 96.52 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.655 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' ND2' ' OD1' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -68.89 -31.03 69.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.828 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HB2' ' OD1' ' A' ' 99' ' ' ASN . . . -77.45 61.49 2.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.135 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.26 -30.64 11.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.803 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.2 p 58.1 164.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.1 125.34 5.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 4.6 m -103.83 102.54 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.14 -18.13 1.73 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 77.2 m -81.02 -54.2 5.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.816 0.341 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.71 -165.23 24.95 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.549 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m 62.35 117.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.973 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 m -154.78 115.26 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -77.3 -173.78 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.077 0.465 . . . . 0.0 110.953 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.7 p -114.65 162.83 16.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.659 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.505 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.968 0.413 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.54 -174.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.006 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 p30 174.14 -50.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.97 -48.17 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.561 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER 52.07 -171.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 -179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 62' ' ' ILE . . . 75.29 71.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.038 0.447 . . . . 0.0 110.262 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.602 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -86.72 -63.12 0.23 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.453 -178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -107.63 -125.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.169 2.58 . . . . 0.0 113.798 -177.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -59.1 126.61 28.39 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.327 0.651 . . . . 0.0 112.538 -179.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 9' ' ' LEU . 24.3 m -98.78 122.16 41.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.227 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.862 ' HB2' HG22 ' A' ' 84' ' ' VAL . 25.9 p90 -88.08 -179.55 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.288 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.638 ' O ' ' CD2' ' A' ' 11' ' ' PHE . 4.7 t -85.47 -159.96 0.48 Allowed 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.416 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 46.0 m-20 -91.45 -43.13 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.234 0.54 . . . . 0.0 110.815 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 17' ' ' ASN . . . -61.23 -39.37 90.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.501 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.821 ' HB3' ' HD2' ' A' ' 11' ' ' PHE . . . -53.74 -32.56 52.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . -70.62 -44.09 67.95 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.688 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 3.8 m-80 -56.36 -46.28 80.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.497 -1.229 . . . . 0.0 111.301 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -56.85 -28.99 62.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.918 0.39 . . . . 0.0 110.269 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.78 HG13 ' HD1' ' A' ' 51' ' ' PHE . 58.4 t -83.76 -68.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.284 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -53.52 -18.93 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.5 m -85.81 -46.38 10.7 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.87 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -83.57 -25.07 31.26 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.71 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' LEU . 2.5 pp -72.61 -47.87 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.509 0.671 . . . . 0.0 109.709 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' HD12 ' A' ' 23' ' ' ILE . 3.1 m -61.58 -22.53 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.272 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.62 -19.72 34.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.04 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.518 ' HB2' ' ND2' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -79.93 -18.67 49.92 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.142 0.496 . . . . 0.0 110.263 178.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' GLU . 4.0 tt0 80.76 11.65 0.91 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.855 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.702 ' ND2' HD23 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -56.43 -70.85 0.1 Allowed 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.562 HG22 ' C ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 160.34 -46.33 0.0 OUTLIER 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.018 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 172.02 67.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -58.96 152.97 18.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.004 -177.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 68' ' ' GLN . 30.0 mtpt -115.27 123.99 50.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.336 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 50' ' ' THR . 2.4 tm? -59.15 147.28 35.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.838 0.351 . . . . 0.0 110.744 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.822 ' HA ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.04 96.79 3.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.29 0.567 . . . . 0.0 110.184 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.931 HG23 HD11 ' A' ' 69' ' ' LEU . 9.4 t -73.03 155.53 6.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.806 0.812 . . . . 0.0 113.173 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.86 173.87 11.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.245 177.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.721 HD11 ' HA ' ' A' ' 75' ' ' SER . 12.0 mm -78.58 118.93 26.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.068 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 2.6 m -162.59 49.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.451 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.04 -132.36 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -124.22 -77.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.621 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.9 130.35 2.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.817 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.1 m 54.97 26.21 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.625 0.25 . . . . 0.0 111.296 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.2 p -177.55 -174.12 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.968 0.413 . . . . 0.0 111.047 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.58 105.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.069 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' HG23 ' A' ' 97' ' ' VAL . 2.6 p90 -135.46 1.07 2.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.444 ' HA ' HG23 ' A' ' 97' ' ' VAL . 29.9 mt-30 -112.7 -71.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.626 ' HD2' HG21 ' A' ' 97' ' ' VAL . 25.3 m-85 73.52 135.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.055 0.455 . . . . 0.0 111.085 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' O ' ' CE1' ' A' ' 36' ' ' TYR . . . -85.34 130.54 9.91 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.824 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' A' ' 33' ' ' LEU . 3.2 m-85 -103.34 133.57 48.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.935 ' O ' HD22 ' A' ' 33' ' ' LEU . 5.7 t -130.27 166.46 20.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.51 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.78 ' HD1' HG13 ' A' ' 19' ' ' VAL . 8.3 m-85 -108.26 98.61 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.55 0.69 . . . . 0.0 109.946 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' CG ' ' HG2' ' A' ' 54' ' ' LYS . 1.4 t70 -118.08 106.96 13.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.517 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.491 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -80.01 -23.44 41.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.48 -100.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.71 -178.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -165.54 -66.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.219 0.533 . . . . 0.0 111.502 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 55' ' ' VAL . 2.7 m120 85.65 84.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.347 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -48.48 135.19 14.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.216 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' PRO . . . 74.6 39.78 40.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.102 -1.046 . . . . 0.0 110.777 -178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' OD1' HG23 ' A' ' 70' ' ' VAL . 9.8 t70 -135.95 110.04 8.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.72 0.408 . . . . 0.0 110.51 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.671 ' N ' HD23 ' A' ' 60' ' ' LEU . 1.4 mt -60.57 140.33 57.42 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 70' ' ' VAL . 1.6 p -124.07 127.26 47.59 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.74 HG22 ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -119.34 125.04 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.937 178.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.59 153.89 18.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.883 0.373 . . . . 0.0 111.484 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 11' ' ' PHE . 12.8 mtpp -115.05 170.2 8.53 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -49.82 -41.4 44.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.931 -179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' C ' HG13 ' A' ' 67' ' ' VAL . . . -131.69 6.47 5.52 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.644 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.568 ' CG2' ' HD3' ' A' ' 64' ' ' LYS . 13.3 m -154.29 -147.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 122.78 -0.247 . . . . 0.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' N ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -132.77 136.46 46.34 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.861 0.363 . . . . 0.0 110.905 179.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.931 HD11 HG23 ' A' ' 35' ' ' VAL . 2.7 tp -104.67 137.22 42.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.885 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -139.89 116.07 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 HD11 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -113.24 158.62 13.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.249 0.547 . . . . 0.0 111.915 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 6.0 t70 -83.6 145.03 46.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.052 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 76' ' ' LEU . 95.6 Cg_exo -45.44 -37.46 14.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.395 2.73 . . . . 0.0 113.226 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.684 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -55.75 -44.18 77.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.673 0.749 . . . . 0.0 109.376 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -76.48 -31.73 57.93 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.849 178.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.993 HD23 ' N ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -42.56 -44.76 4.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.757 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.993 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -82.06 -21.84 36.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.228 -179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 74' ' ' MET . 4.1 m-85 -81.47 -40.82 22.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.016 0.436 . . . . 0.0 111.274 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -90.4 -16.32 29.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -16.59 121.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -177.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 32.46 32.09 0.01 OUTLIER Glycine 0 CA--C 1.521 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 115.79 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD22 ' A' ' 9' ' ' LEU . . . -83.73 -149.65 9.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.518 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.472 ' CA ' HD11 ' A' ' 9' ' ' LEU . 18.5 m -150.19 129.94 13.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.954 0.377 . . . . 0.0 110.748 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.862 HG22 ' HB2' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -123.3 152.43 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.267 0.556 . . . . 0.0 111.552 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' HA ' ' CG2' ' A' ' 12' ' ' THR . 0.7 OUTLIER -151.21 142.72 23.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.21 178.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.542 ' CD2' ' CD1' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -112.06 146.54 37.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.893 0.377 . . . . 0.0 110.914 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.443 ' O ' ' CD ' ' A' ' 94' ' ' ARG . 85.9 m -149.01 89.53 1.68 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.909 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 93' ' ' SER . 11.4 mt-10 -93.12 164.73 13.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.672 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 91' ' ' GLU . . . 113.11 144.11 8.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.303 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.5 tp 63.65 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.603 0.239 . . . . 0.0 110.519 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 89' ' ' GLY . 30.3 mm-40 -74.81 -8.81 57.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.787 0.327 . . . . 0.0 110.577 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 88' ' ' GLU . . . 112.94 -95.53 0.77 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.626 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' GLU . 59.8 p -150.52 89.81 1.59 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.695 0.283 . . . . 0.0 110.634 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' CD ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -88.22 140.84 29.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.857 0.361 . . . . 0.0 110.955 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.542 ' CD1' ' CD2' ' A' ' 86' ' ' TYR . 4.6 t80 -124.39 137.4 54.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.33 126.03 14.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.101 0.477 . . . . 0.0 112.0 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.636 HG13 ' CB ' ' A' ' 84' ' ' VAL . 1.6 t -123.36 161.41 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' THR . 71.8 m-20 -141.09 131.6 25.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.978 0.418 . . . . 0.0 111.576 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -149.39 166.35 15.46 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.365 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 99' ' ' ASN . 24.2 Cg_endo -61.85 -55.59 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.455 2.103 . . . . 0.0 112.716 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -23.24 48.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.34 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.74 -70.34 0.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 54.8 p -98.73 129.28 45.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 105' ' ' THR . 78.1 p -176.56 -46.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -160.4 159.76 31.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 31.99 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.68 27.06 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.603 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.8 t -139.13 160.04 40.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -152.14 -138.23 2.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.537 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m 63.0 -79.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.01 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.82 120.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -78.21 -168.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.996 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 m -96.09 -165.38 1.27 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.448 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.53 -179.893 . . . . . . . . 2 2 . 1 stop_ save_